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Abstract 
 
Peripheral nerves have a remarkable ability to regenerate following nerve injury, 
unlike their counterparts in the central nervous system. This phenomenal ability of 
nerves to regenerate in the peripheral nervous system is due to cross communication 
between different cell populations, a focal group being the glial cells known as 
Schwann cells.  
 
The transcription factor c-Jun is highly expressed in distal stump Schwann cells 
following injury. It is this c-Jun expression in Schwann cells following peripheral 
nerve injury that is crucial for the cellular reprogramming of mature Schwann cells 
(Remak and Myelin Schwann cells) into repair Bungner Schwann cells. Repair 
Bungner Schwann cells are important for providing the necessary maintenance and 
trophic support to regenerating axons. Mice that lack c-Jun in their Schwann cells and 
therefore fail to express it after injury have impaired regeneration.  
 
With this idea in mind, it was of interest to see what happens when c-Jun is 
overexpressed in Schwann cells. Thus, a new transgenic mouse was bred to 
conditionally overexpress c-Jun in Schwann cells only. c-Jun protein levels were 
elevated 5 fold and 7 fold in heterozygous and homozygous mice respectively, in 
developing Schwann cells. The elevation of c-Jun specifically in Schwann cell nuclei 
in c-Jun overexpressing mice (heterozygous and homozygous), allowed in vivo 
examination of the effects of a graded increase in c-Jun expression on Schwann cells 
in uninjured and injured nerves.  
 
Evidence presented below suggests that Schwann cells can tolerate moderately 
elevated levels of c-Jun expression from birth (5 fold) without it being detrimental to 
nerve development. These observations demonstrate that heterozygous c-Jun 
overexpressing mice which show a substantial elevation in c-Jun protein level (which 
is localized to Schwann cell nuclei) compared to wildtype (WT), although there is an 
initial delay in myelination at postnatal day (P) 7, in adult life they achieve normal 
Schwann cell and nerve architecture, with the exception of modestly reduced myelin 
thickness. However in contrast to the heterozygotes, higher levels of c-Jun in 
Schwann cells from birth in homozygous mice results in severe myelin inhibition, 
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which manifests itself very early on at P1. In the homozygous mice the strongly 
increased c-Jun expression in Schwann cells resulted in defects that included an 
obvious delay in myelination, thinner myelin sheaths (in those Schwann cells that 
eventually myelinated axons), increased Schwann cell proliferation and an increase in 
nerve area. These homozygous overexpressing mutant nerves were also examined for 
the presence of tumours or cellular arrangements that precede tumour formation, but 
no evidence was found to support this. 
 
To elucidate the potential significance of c-Jun elevation in Schwann cells after injury 
specifically in the proximal stump (where axons are still in contact with the neuronal 
cell body), the proximal stump of WT mice was compared with that of Schwann cells 
and axons in the proximal stump of a well-established Schwann cell c-Jun conditional 
knockout mouse (cKO). 
Proximal stump Schwann cell c-Jun was expressed very rapidly and the profile of 
Schwann cells was highly elevated as early as 1 hour following sciatic nerve 
transection, with this elevation being maintained up to 48 hours after nerve injury and 
further away from the injury site.  
The lack of Schwann cell c-Jun in the proximal stump did not affect the expression of 
some well known regeneration associated genes (RAGs), including c-Jun, ATF3, p-
STAT3 Ser727 and Tyr705, yet had a modest effect on the elevation of GAP43, after 
injury in L4 DRG neurons. Schwann cell c-Jun in Schwann cells of the proximal 
stump has a small effect on axonal outgrowth following a conditioning lesion, shown 
in vivo. Neuronal cultures from L4 DRGs derived from WT and cKO mice (with 
sciatic nerve injuries), grown on myelin inhibitory substrate in vitro, suggest that 
Schwann cell c-Jun is not affecting neuronal outgrowth.  
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Impact Statement 
 
The remarkable ability of peripheral nerves to regenerate following nerve injury 
remains an area of high importance and interest. Central nervous system nerves, 
unlike their peripheral counterparts do not have the intrinsic ability to regenerate. 
Schwann cells, the glial supporting cells of these nerves, play a crucial role in 
enabling the regeneration of axons to occur after injury.  Despite this, in humans 
injured peripheral nerves often fail to regenerate properly.  
Research in the field has shown that the important transcription factor c-Jun, is a 
crucial regulator of the Schwann cell injury response.  
 
The findings outlined in this thesis focus on the role of levels of Schwann cell c-Jun 
in development, adulthood and after nerve injury. With this in mind, the research 
questions addressed and the results presented in this work aim to widen the 
knowledge and insight into the potential of peripheral nerves to regenerate, by 
exploiting mouse models that conditionally overexpress and conditionally knockout c-
Jun specifically in Schwann cells.  
 
In terms of academic and clinical research, the possibility of identifying factors that 
will promote more successful regeneration of injured mouse nerves opens up avenues 
for improved treatments of peripheral nerve injury in humans. Further insight into 
mechanisms that influence successful peripheral nerve regeneration can also assist in 
understanding why nerves of the central nervous system do not react in the same way. 
This will ultimately be important in the translational studies from laboratories into a 
clinical setting.   
 
The work presented here is not only important in an academic and potentially medical 
setting, but also of value for non-academic platforms such as undergraduate and 
postgraduate teaching programmes, where this information will broaden the current 
knowledge and insight into Schwann cell biology and peripheral nerve regeneration.  
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1. Introduction 
1.1 Schwann cells: the glial cells of peripheral nerves 
 
The peripheral nervous system is made up of a network of neurons and glia that work 
synchronously with each other to ensure there is proper transmission of information 
from sensory organs to the central nervous system (CNS), as well as from the CNS to 
various muscles and effectors that are located throughout the body. The complex 
relationship between neurons and glia is crucial in determining the proper functioning 
and development of nerves.  
Theodor Schwann first described Schwann cells over 200 years ago. Schwann cells 
deriving from neural crest cells are the principal glia of peripheral nerves. They wrap 
around axons, and classically can form a 1:1 relationship with large calibre axons 
(>1.5μm in diameter) resulting in Myelin Schwann cells, or ones that associate with 
several axons, known as non-myelin Schwann cells (Remak Schwann cells) (Jessen 
and Mirsky, 1997; Dong et al., 1999; Armati, 2007; Griffin and Thompson, 2008). It 
is important to note that the term “non-myelin Schwann cell” encompasses several 
subtypes including Remak Schwann cells, terminal Schwann cells and satellite 
Schwann cells, however more commonly this term refers to Remak Schwann cells. 
Remak Schwann cells are found in spinal nerves and nerve roots, and small diameter 
axons get enveloped in invaginations of the Remak Schwann cell membrane 
(Berthold et al., 2005; Jessen and Mirsky, 2005; Armati, 2007). Myelin Schwann cells 
are better characterised and studied than Remak Schwann cells due to the extensive 
research on myelination in development and commonly in demyelinating diseases, 
where disruption of Myelin Schwann cells is the defining feature (Bunge, 1993; 
Garbay et al., 2000; Jessen and Mirsky, 2002; Corfas et al., 2004; Sherman and 
Brophy, 2005; Jessen et al., 2015a; Monk et al., 2015). The myelin sheaths formed are 
essential for the rapid transmission of action potentials along axons, a process known 
as saltatory conduction (Huxley and Stämpfli, 1949; Rasminsky et al., 1978; Salzer et 
al., 2008).  
The interdependence and communication between the Schwann cell and neuron 
determines the functioning of the peripheral nervous system (Armati, 2007). Nerve 
cells and Schwann cells essentially form a symbiotic relationship where each cell type 
is dependent on the other for normal development, maintenance and function. Signals 
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from axons control the initiation of myelination and the maintenance of the complex 
Schwann cell organisation, yet it is the Schwann cell that regulates axonal diameter 
and the clustering of ion channels around the Nodes of Ranvier, to name a few of its 
functions (Hsieh et al., 1994; Poliak and Peles, 2003; Michailov et al, 2004).  
It is important to note however, that work has demonstrated that multipotent Schwann 
cell precursors which are present in peripheral nerves at E14-17, can also give rise to 
endoneurial fibroblasts, parasympathetic neurons, melanocytes and tooth pulp cells 
through multi-lineage differentiation (Morrison et al., 1999; Bixby et al., 2002; Joseph 
et al., 2004; Jessen et al. 2015). 
 
1.2 Schwann cell development 
 
Mature Myelin and Remak Schwann cells are generated from the neural crest through 
two intermediary cell types: (i) the Schwann cell precursor and (ii) the immature 
Schwann cell. The transition step from neural crest cell to Schwann cell precursor 
takes places between embryonic day (E) 12-13 in the mouse (E14-15 in the rat). The 
next stage in this lineage is the formation of immature Schwann cells from Schwann 
cell precursors, which takes place between E13-15 in the mouse (E15-17 in the rat). 
Immature Schwann cells persist until the perinatal period (Jessen et al., 1994; Dong et 
al., 1995; Dong et al., 1999; Jessen and Mirsky, 2005). The final transition step in the 
Schwann cell lineage is, on one hand, the formation of mature Myelin Schwann cells 
that occurs via a step involving a pro-myelin Schwann cell, and on the other hand, the 
formation of Remak Schwann cells (Salzer et al., 1980; Bunge et al., 1982; Mirsky 
and Jessen, 1996; Dong et al., 1999; Jessen and Mirsky, 2015; Monk et al., 2015). 
These transition steps are summarised in the diagram below (Figure 1.1). 
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Figure 1.1 | Schwann cell lineage
A schematic representation of  the main transition stages that  take place within the Schwann cell  lineage and the 
different molecular markers expressed by different types of Schwann cells. 
Adapted from Jessen and Mirsky, 2005.
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1.2.1 Schwann cell precursors 
 
Growing nerves initially consist of outgrowing axons with closely associated 
Schwann cell precursors, essential for proper development of both the nerve and 
maturation of Schwann cells into later developmental stages (Jessen and Mirsky 
2005). At this early stage, the nerve lacks blood vessels, and fibrous connective tissue 
within and around the nerve is rare. Blood vessels invade and the nerve begins to 
develop its connective tissue layer, which coincides with the time immature Schwann 
cells are formed (Ziskind-Conhaim, 1988; Jessen and Mirsky 2005; Jessen and 
Mirsky, 2008; Wanner et al., 2006; Jessen et al., 2015a; Monk et al., 2015).  
 
Schwann cell precursors, like neural crest cells, are proliferative and migratory. They 
are found closely associated along the length of axons during peripheral nerve 
development and require axonal signals for survival (Jessen and Mirsky, 1991; Dong 
et al., 1995; Mirsky et al., 2002; Mirsky et al., 2007). This constant axon-glial cross-
talk is crucial for the maintenance and survival of the lineage (Levi et al., 1995; 
Morrissey et al., 1995; Wolpowitz et al., 2000; Jessen and Mirsky, 2002; Gomez-
Sanchez et al., 2009).  
 
The molecular mechanisms that determine the changes that have to occur for 
transition of neural crest cells into Schwann cell precursors are still not completely 
understood and this therefore remains an active area of research in the field, though 
some key players have been identified. Among them, the transcription factor Sox10 
(SRY-related HMG-box10), is expressed very early in neural crest cells. Its 
expression is maintained in peripheral nerve glia, including Schwann cell precursors, 
Schwann cells and in melanocytes, while this expression is later down-regulated in 
both neurons and other neural crest cell derivatives (Kuhlbrodt et al. 1998; Woodhoo 
and Sommer 2008).  
 
Another important determining factor in the early stage of Schwann cell precursor 
formation is the trophic factor Neuregulin 1 (NRG1), which favours glial specification 
by suppressing neuronal differentiation (Shah et al., 1994; Mei and Xiong, 2008). 
Exposure of Schwann cell precursor cultures in vitro to NRG1 supports the survival 
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of Schwann cell precursors and results in the generation of Schwann cells within a 
similar time frame to that seen when Schwann cells appear in peripheral nerves in 
vivo. This is indicative of the fact that NRG1 is important in the survival of the 
precursors and the progression of the Schwann cell lineage (Jessen et al.1994; Dong et 
al., 1995).  
NRG1 binding to ErbB2/3 (receptor tyrosine kinases) on Schwann cell precursors 
activates important downstream signaling cascades. This binding of NRG1 to 
ErbB2/3 receptors is also crucial for Schwann cell precursor proliferation and 
migration (Shah et al., 1994; Taveggia et al., 2005; Aquino et al., 2006; Newbern and 
Birchmeier, 2010; Monk et al., 2015).  
Using the sympathetic nervous system as an example, in mice in which NRG 
signaling is deficient (knocking out NRG1, ErbB2 or ErbB3), neural crest cells fail to 
migrate past the dorsal aorta to the point where sympathetic ganglia are formed 
(Britsch et al., 1998).  
In mice deficient in NRG1 or NRG1 Type III, or in erbB2 or ErbB3 receptors almost 
no Schwann cell precursors are present in developing peripheral nerves although the 
satellite cells of the DRG do develop (Meyer and Birchemeier, 1994; Meyer and 
Birchmeier, 1995; Syroid et al., 1996; Meyer et al., 1997; Morris et al., 1999; 
Newbern and Birchmeier, 2010). Thus NRG signalling, particularly NRG1 types I and 
III with the receptors ErbB2 and ErbB3, is required to maintain the migratory ability 
of neural crest cells, but more importantly to maintain the survival and progression of 
Schwann cell precursors. NRG signaling also has important roles to play in 
myelination.  
 
More recent research in the field has also highlighted the importance of histone 
deacetylases 1 and 2 (HDAC1/2) in the development of the lineage. Among other 
functions they induce the expression of the paired box family transcription factor 
Pax3. Pax3 is important for Schwann cell differentiation and proliferation (Kioussi et 
al. 1995; Blanchard et al. 1996; Doddrell et al., 2012) and also induces the expression 
of important Schwann cell lineage genes such as myelin protein zero (Mpz) (Jacob et 
al., 2014; Monk et al., 2015).  
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1.2.2 Immature Schwann cells 
 
Several days following specification, Schwann cell precursors develop further to form 
immature Schwann cells. As mentioned earlier, at this transition point between 
Schwann cell precursors and immature Schwann cells, which occurs between E13-15 
in the mouse, immature Schwann cells gradually acquire the ability to support their 
own survival by an autocrine signaling system through the release of a cocktail of 
survival factors, without being reliant on axonal signals in the way that Schwann cell 
precursors are. At this point in the lineage, the cytoarchitecture of the nerve 
transforms and immature Schwann cells surround smaller bundles of axons and start 
to deposit a basal laminae around them, which adds to the defining features that make 
them different from Schwann cell precursors (Jessen and Mirsky, 2005; Monk et al., 
2015).  
 
Up to the point of the generation of immature Schwann cells, the composition of 
peripheral nerves consists of axons and Schwann cells. As immature Schwann cells 
develop, they signal to surrounding mesenchymal cells to differentiate into arterial 
and perineurial cells, which ultimately populate and surround mature nerves 
(Parmantier et al. 1999; Mukouyama et al. 2005; Monk et al., 2015). The mechanisms 
that determine the transition of Schwann cell precursors into immature Schwann cells 
are still poorly understood. 
 
An important regulator of this process however, is Notch1. Schwann cells are derived 
from Schwann cell precursors through continual proliferation, which reaches a peak at 
the immature Schwann cell stage (Stewart et al., 1993; Yu et al., 2005; Woodhoo and 
Sommer, 2008). Inactivation of Notch1 specifically in Schwann cells results in lower 
Schwann cell precursor proliferation, and delayed immature Schwann cell formation 
(Woodhoo et al., 2009; Jessen et al., 2015). It is important to note that Notch1 has 
also been implicated in other aspects of Schwann cell biology such as controlling the 
responses of mature Schwann cells to nerve injury (Woodhoo et al., 2009). Endothelin 
and AP2 act to delay this transition (Brennan et al., 2000; Stewart et al., 2001). 
 
Another defining function of immature Schwann cells is their role in isolating 
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individual large diameter axons to be ensheathed by a single Schwann cell. Immature 
Schwann cells extend radial lamellipodia into the axon bundles and via this process 
separate out large diameter axons (Webster and Favilla, 1984). This is known as 
radial sorting.  
 
1.2.3 Radial Sorting 
 
Immature Schwann cells take distinct pathways determined by many factors, to form 
mature Remak or Myelin Schwann cells. Immature Schwann cells accomplish two 
important steps: (1) radial sorting (separation of axons, most of which are destined to 
be myelinated) and (2) cell differentiation (signalling to perineurial cells) (Monk et 
al., 2015). The process of radial sorting is discussed below.  
 
As immature Schwann cells form in the nerve, axons are separated into smaller 
bundles surrounded by a “family” of 3-8 immature Schwann cells that deposit a basal 
lamina. The work of Henry D Webster and others in 1973 showed that these 
“families” surrounded mixed calibre axons. Immature Schwann cells further segregate 
these axon bundles by extending lamellipodia processes between individual large 
diameter axons, isolating them towards the periphery of the bundle. Schwann cells 
surrounding a single axon divide and separate from the bundle so that these axons can 
form a 1:1 relationship with Schwann cells that will individually surround it. These 
axons then have the possibility to become myelinated axons (Webster et al., 1973; 
Jessen and Mirsky, 2005; Feltri et al., 2016).  
As Schwann cells in families continue to proliferate, with progressive axonal 
segregation, the axonal bundles become smaller as more and more large caliber ones 
are segregated away. Axon bundles made up of small diameter axons are left behind, 
and will develop into Remak bundles (one Remak Schwann cell associated with 
several axons) (Feltri et al., 2016).  
 
Radial sorting is a multi-faceted process that requires a fine balance between many 
different aspects including the deposition of extracellular matrix (ECM) components 
and their organisation within the basal lamina, Schwann cell-axon interactions and the 
correct amount of Schwann cell proliferation and differentiation, to name a few 
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(Jessen and Mirsky, 2005; Porrello et al., 2014; Feltri et al., 2016). The appropriate 
control of the number of Schwann cells and their proliferation is crucial for 
coordinating the proper segregation of axons. In order for pro-myelinating Schwann 
cells to be formed, that will ultimately result in Myelin or Remak Schwann cells, there 
needs to be a timely withdrawal of immature Schwann cells from the cell cycle (Monk 
et al., 2015; Feltri et al., 2016).  
 
These important morphogenetic changes ultimately lead to the mature nerve 
architecture which consists of 1:1 myelinated fibres with Schwann cells and Remak 
bundles (several small calibre axons ensheathed by one Schwann cell), all surrounded 
by extracellular matrix consisting prominently of collagen fibres and blood vessels 
(Monk et al., 2015). The process of radial sorting is summarised in a simplified 
diagram shown below (Figure 1.2).  
 
  
Figure 1.2 | Radial sorting
A schematic representation showing radial sorting. Radial sorting is performed by immature Schwann cells and can be 
divided in stages. The basal lamina is deposited and the formation Schwann cell  “families” begins. Schwann cell 
processes are inserted into axonal bundles. Large calibre axons are recognised as shown by the turquoise asterisk above 
and are radially sorted and segregated to the periphery as shown by the purple asterisk above. 
Adapted from Feltri et al., 2016.
axon
Basal lamina 
Proliferation
Immature Schwann cell 
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1.2.4 Pro-myelin Schwann cell  
 
Radial sorting is the final step that determines the transition of a pro-myelin Schwann 
cell, into a mature Myelin Schwann cell (Pereira et al., 2012). It was well established 
in the beginning of 1970s that large caliber axons, greater than a certain diameter 
became myelinated (Friede, 1972), yet the way in which this process was regulated 
only became apparent by the mid 1970s through cross-anastomosis experiments. 
When myelinated axons were cross-anastomosed into a non-myelinating environment, 
the axons that were initially non-myelinated, became myelinated, confirming earlier 
suggestions that it was signals from the axons that determined when myelination by 
Schwann cells would ensue (Weinberg and Spencer 1975; Aguayo et al. 1976; Monk 
et al., 2015). Many factors are involved in the process of myelination among the most 
important of which are NRG1 (specifically type III), Oct-6, Krox20 and Sox10 
(Bermingham et al., 1996; Jaegle et al., 2003; Michailov et al., 2004; Parkinson et al., 
2004; Svaren and Meijer, 2008; Mei and Xiong, 2008; Monk et al., 2015).  
 
As already discussed, the long lasting embryonic period of gliogenesis originating 
from neural crest cells, beginning with the formation of Schwann cell precursors, 
followed by immature Schwann cells (Jessen and Mirsky, 1991; Jessen et al., 1994), 
is controlled by many signals that determine the progression of this development. The 
subsequent postnatal formation of mature Schwann cells (Remak and Myelin 
Schwann cells) from immature Schwann cells is determined by the cessation of 
proliferation and resistance to cell death (Jessen and Mirsky, 2005; Armati, 2007). 
This nerve maturation process can be defined as a balance between signals that act as 
promoters of myelination such as Krox20 and Oct-6, or those that act as brakes on the 
system such as c-Jun or Sox2 (Topilko et al., 1994; Bermingham et al., 1996; Jaegle 
et al., 1996; Jaegle and Meijer, 1998; Le et al., 2005; Parkinson et al., 2008).  
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1.2.5 Myelin Schwann cells 
 
As mentioned above, Schwann cells that form a 1:1 relationship with a single large 
calibre axon are called Myelin Schwann cells. The process of ensheathing these single 
large diameter axons begins when the leading edge of the Myelin Schwann cell’s 
inner-mesaxon starts to extend and wrap in a spiral manner around the axon. The 
synthesis of this membrane and the continual spiral wrapping around the axon is what 
generates the complex myelin structure (Bunge et al., 1989). Schwann cell 
myelination is determined by strict transcriptional control of opposing signals, viz 
positive and negative regulators of myelination. As previously mentioned, such 
positive transcriptional regulators of myelination include Sox10 and Oct-6, where 
they are able to work together to induce the expression of a crucial positive regulator 
of myelination, Krox20 (Jagalur et al., 2011; Pereira et al., 2012). 
 
1.2.6 Regulation of myelination 
Krox20 has been shown to be a regulator of Schwann cell myelination. Krox20 is able 
to not only activate myelin genes, but also inhibit negative regulators of myelination, 
such as c-Jun and Notch, and maintain the myelination phenotype (Topilko et al., 
1994; Topilko and Meijer, 2001; Parkinson et al., 2004; Ghislain and Charnay, 2006; 
LeBlanc et al., 2006; Svaren and Meijer, 2008; Mirsky et al., 2008; Woodhoo et al., 
2009; Pereira et al., 2012). Krox20 inactivation in Schwann cells resulted in arrest at 
the pro-myelinating stage and when inactivated in adult Schwann cells, resulted in 
severe demyelination, indicating that Krox20 is important both for the onset of 
myelination and for the maintenance of the myelinating phenotype (Topilko et al., 
1994; Nagarajan et al., 2001; Decker et al., 2006). 
 
Oct-6 expression is important in timing the onset of myelination. Schwann cells of 
peripheral nerves express the POU domain transcription factor Oct-6 from E16 
onwards (Monuki et al., 1990; Jaegle et al., 1996). During postnatal development, the 
expression of Oct-6 mRNA is present in both Myelin and Remak Schwann cells. Oct-
6 expression is gradually down-regulated and then diminishes, up to the point where 
in Schwann cells of adult nerves, Oct-6 expression is infrequent. Schwann cells 
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lacking Oct-6 showed a transient delay in myelination (Jaegle et al., 1996). The work 
of Ghislain and others in 2002 identified a transcriptional enhancer known as the 
myelinating Schwann cell element (MSE), which regulates Krox20 and is under the 
control of Oct-6 (Ghislain et al., 2002; Ghislain and Charnay, 2006). The use of cell 
culture experiments and transgenics demonstrated that during the transition from pro-
myelin Schwann cell to Myelin Schwann cell, Krox20 expression is directly 
controlled by Oct-6 and another POU domain transcription factor Brn-2 binding to the 
transcriptional enhancer of Krox20. From this work, it also became apparent that 
Sox10 along with the POU transcription factors Oct-6 and Brn-2 are needed for 
Krox20 expression (Ghislain and Charnay, 2006). 
As stated above, myelin is important for saltatory conduction and therefore successful 
transmission of impulses. The identification of the axonal signals that induce the 
formation of the myelin sheaths was originally thought to either be based on a critical 
axonal size that triggers myelination, or alternatively specific biochemical signals 
stemming from the axon itself determining ensheathment (Salzer, 1995; Salzer, 2012). 
It later became apparent that these two hypotheses were not mutually exclusive. 
Therefore, the thickness of myelin sheaths around axons is tightly regulated and 
linked to the axon diameter. NRG1 is the most well studied determinant of myelin 
sheath thickness. NRG1 exists in many isoforms, however it is the expression of the 
membrane bound type III specifically, found on the axonal membrane, which is 
important for myelination (Birchmeier and Nave, 2008). The first indication that 
NRG1 type III was important in determining myelination of axons was through the 
inactivation of its receptor (ErbB2 expressed by Schwann cells), where 
hypomyelination of peripheral nerves was noted (Garratt et al., 2000). Conversely, 
overexpression of NRG1 type III led to hypermyelination (Michailov et al., 2004). 
Another indication that myelination of axons is dependent on NRG1 type III was from 
experiments where overexpression on NRG1 type III in sympathetic neurons (which 
are normally unmyelinated) became myelinated (Taveggia et al., 2005), indicating 
that the axonal NRG1 type III signal is what dictates the amount of myelin that needs 
to be produced to wrap around axons (Garratt et al., 2000; Birchmeier and Nave, 
2008; Raphael and Talbot, 2011; Salzer, 2012).  
 
Multiple negative regulators of myelination have been identified including Sox2, 
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Notch1 and more importantly in the context of the work presented below, c-Jun (Le et 
al., 2005, Parkinson et al., 2008; Woodhoo et al., 2009).  
 
c-Jun is strongly expressed in immature Schwann cells, prior to the beginning of 
myelination, as shown in vivo (Parkinson et al., 2008) and in cultured Schwann cells, 
as well as following nerve injury in the distal nerve stump (De Felipe and Hunt, 1994; 
Stewart, 1995; Shy et al., 1996; Parkinson et al., 2004; Arthur-Farraj et al., 2012). c-
Jun levels present in myelinating Schwann cells are low, while Krox20 levels in these 
cells are high (Parkinson et al., 2001; Parkinson et al., 2004; Parkinson et al., 2008).  
 
Notch signaling is down-regulated at the onset of myelination by Krox20, similar to c-
Jun. In Krox20 knockout mutant nerves, a downstream component of the Notch 
pathway, NICD, remains highly expressed and this enforced expression in vivo, 
reduces myelination (Jessen and Mirsky, 2008; Woodhoo et al., 2009).  
The evidence above indicates that Krox20 works antagonistically to both Notch and c-
Jun, as well as the fact that Notch and c-Jun negatively regulate the myelin 
differentiation program of immature Schwann cells, by acting as myelination brakes 
(Jessen and Mirsky, 2008; Parkinson et al., 2008; Woodhoo et al., 2009).  
 
New evidence has shown that the zinc-finger E-box-binding homeobox 2 (Zeb2) 
transcription factor is important in antagonising inhibitory effectors such as Notch and 
Sox2, but not c-Jun, therefore making Zeb2 a crucial timer for controlling Schwann 
cell differentiation both at the onset of myelination during development, and in 
remyelination following nerve injury (Wu et al., 2016; Quintes et al., 2016). 
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1.2.7 Remak Schwann cells  
 
Many nerve fibres of the peripheral nervous system can be non-myelinated, including 
C fibre nociceptors, post-ganglionic sympathetic and parasympathetic fibres and 
motor nerve terminals found at the neuromuscular junctions (Monk et al., 2015). 
Remak Schwann cells, as briefly described above, enclose several small diameter 
axons, forming a Remak bundle. Remak Schwann cells vastly outnumber Myelin 
Schwann cells present in peripheral nerves, which reflects the presence of large 
numbers of non-myelinated axons compared to myelinated ones (Dyck et al., 1972; 
Griffin and Thompson, 2008). Morphological studies have shown that in peripheral 
nerves Remak Schwann cells are shorter in length than Myelin Schwann cells 
(Aguayo et al. 1972; Monk et al., 2015). 
 
1.2.8 Repair Bungner Schwann cells 
 
A recent addition to the Schwann cell lineage is the repair Bungner Schwann cell. 
Nerve injury triggers both Myelin and Remak Schwann cells to convert into a cell 
type that is specific and specialised in promoting nerve repair. It was previously 
thought that Myelin and Remak Schwann cells reverted to a cell type reminiscent of 
their original immature Schwann cell counterparts following nerve injury (Jessen and 
Mirsky, 2008). However, more recent evidence has in fact confirmed that the cell type 
produced following nerve injury, is a distinct cell which is unlike the immature 
Schwann cell, both in terms of its molecular profile and morphology (Arthur-Farraj et 
al., 2012; Jessen and Mirsky, 2016). The process through which this unique repair 
Bungner Schwann cell is formed is through a combination of both de-differentiation 
and activation, as following nerve injury Schwann cells not only down-regulate their 
characteristic myelin gene expression (sign of de-differentiation), but also activate a 
repair program (sign of activation) (Jessen et al., 2015a; Jessen and Mirsky, 2016). 
The transcription factor c-Jun is a key regulator of this process following nerve injury. 
 
The development of Schwann cells from embryonic stages, into adulthood and after 
injury are summarised in Figure 1.3 shown below. 
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Figure 1.3 | Summary of Schwann cell development
A schematic representation of the transitional steps that occur during Schwann cell development. Neural crest cells 
give rise to Schwann cell precursors. Schwann cell precursors give rise to immature Schwann cells, as well as other 
cell types including melanocytes and endoneurial fibroblasts. Radial sorting is performed by immature Schwann cells 
and can be divided in stages.  Firstly,  the basal  lamina is  deposited and the formation of Schwann cell  and axon 
“families” begins. Schwann cell processes are inserted into axonal bundles (shown above E12.5-P2). Large calibre 
axons  are  recognised  as  shown by the  turquoise  asterisk  above.  Large  axons  are  then  radially  segregated  to  the 
periphery as  shown by the purple  asterisk above between E17.5-P10.  The final  stage is  the establishment  of  1:1 
relationship between an axon and a pro-myelin Schwann cell), which can then become a mature Myelin Schwann cell 
depending  on  the  timely  activation  of  positive  and  negative  regulators  of  myelination  (shown above).  Immature 
Schwann cells form Remak Schwann cells when Schwann cells are in contact with small caliber axons, that they 
eventually surround. Following nerve injury, both Myelin and Remak Schwann cells form a new and unique repair 
Bungner Schwann cell which is essential for successful nerve regeneration. Blue solid lines indicate transition steps 
along the Schwann cell lineage, dark red arrows indicate the Schwann cell injury response and the blue dotted lines 
indicate the re-formation of Myelin and Remak Schwann cells following nerve injury. 
Adapted from Feltri et al., 2016 and Jessen and Mirsky, 2016. 
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1.3 Nerve injury  
 
Axons of peripheral nerves have the remarkable ability to successfully regenerate and 
re-innervate their targets to result in functional recovery (though it may be poor, 
especially in humans). As previously discussed, this ability of peripheral nerves to 
regenerate is reliant on the plasticity of the Schwann cells of the distal stump that can 
be reprogrammed into a new, distinct and functional cell known as the repair Büngner 
Schwann cell. This repair Bungner Schwann cell is essential for successful nerve 
regeneration, as well as the cellular events that take place soon after nerve injury 
(Rotshenker, 2011; Arthur-Farraj et al., 2012; Jessen et al., 2015; Jessen and Mirsky 
2016). 
Sciatic nerve crush models are a common way of studying nerve regeneration. In this 
model axons are severed but the basal lamina of Schwann cells is not interrupted, to 
allow for a permissive environment for optimal regeneration (Sunderland, 1951; 
Fowler et al., 2015). In contrast, after nerve transection basal lamina tubes are severed 
and become discontinuous at the point of transection. Peripheral nerves are reliant on 
the fine details of their structures and the communication between axons and Schwann 
cells for correct function.  
Upon nerve injury, peripheral nerve structures and the cross-talk between Schwann 
cells and axons are disrupted, which brings about Wallerian degeneration, particularly 
to the distal stump of the nerve, where axons are separated from the neuronal cell 
body (Waller, 1850; Kaplan et al., 2009). Axons of the distal stump do not breakdown 
immediately; there is a delay of 24-48 hours in rodents (and several days in humans) 
(Lubinska, 1977; Chaudry and Cornblath 1992).  Upon nerve transection both ends 
(proximal and distal) retract and outgrowths occur from both proximal and distal 
ends, yet the reaction of the proximal stump is slower than that of the distal stump 
(Thomas, 1966; Thomas and Jones, 1967). These proximal and distal reactions to 
nerve injury are important for successful nerve repair.  
The distal stump disintegrates due to Wallerian degeneration, which is a multi-faceted 
process (Rotshenker, 2011), whereas the proximal stump acts to transmit injury 
signals from the site of injury retrogradely to the neuronal cell body, to make it switch 
from a transmission mode to one of growth (Abe and Cavalli, 2008). 
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1.3.1 Wallerian degeneration and events that follow  
 
Wallerian degeneration describes the events that take place distally to the injury site 
in a peripheral nerve injury.  
Following nerve injury, the disconnection of the nerve trunk from its “trophic” centre 
(neuronal cell body) is what Augustus Waller described as being the cause of axons 
degenerating during Wallerian degeneration (Gutmann and Holubar, 1950). Work 
carried out using mice and rats has provided better insight into blebbing, and swelling 
of the axolemma (axon membrane), and “granular disintegration” (subsequent 
breakdown of cytoskeletal elements), all of which are characteristic features of 
Wallerian degeneration (George et al., 1995). The more recent use of the Wallerian 
degeneration (Wld
S
) mouse model has helped to understand and clarify the process of 
Wallerian degeneration in greater detail. Axons in Wld
S
mouse nerves, are shown to 
collapse more slowly than those of wild-type (WT) mice, and the axonal granular 
disintegration of the cytoskeleton is delayed (Coleman et al., 1998). 
 
The process driving successful nerve repair after injury is a complex one. It is not 
only the axonal response that is important, but also other changes that take place 
within the distal stump after nerve injury. These include: increase in blood-tissue 
barrier permeability, Schwann cell demyelination, cellular reprogramming of 
Schwann cells to become a repair cell phenotype (Arthur-Farraj et al., 2012; Jessen et 
al., 2015; Jessen and Mirsky, 2016), the recruitment and influx of macrophages 
(Rotshenker, 2011; Benowitz and Popovich, 2011), and finally the removal of myelin 
and axonal debris (Gaudet et al., 2011). Wallerian degeneration is the key process that 
accounts for the hospitable environment created in and around axons and which 
allows them to regenerate following nerve injury (Dubovy, 2011). 
 
Following nerve injury Schwann cells play a key role in myelin breakdown, 
macrophage recruitment, the formation of regeneration tracts (bands of Büngner) and 
the expression of proteins which promote axon outgrowth; thereby providing trophic 
support and creating a favourable environment for regenerating axons (Gaudet et al., 
2011; Arthur-Farraj et al., 2012; Gomez-Sanchez et al., 2015). The Schwann cell 
response to nerve injury is very rapid (as early as 48 hours) and is evident even before 
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any visible axonal degeneration has occurred. Within 48 hours after nerve injury the 
Schwann cell stops producing myelin proteins and begins to up-regulate the 
expression of genes that are involved in potentiating and promoting neuronal survival 
and axonal outgrowth, including neurotrophic factors, adhesion proteins, 
inflammatory cytokines and extracellular matrix components (Arthur-Farraj et al., 
2012). Schwann cells of the distal stump, within a short space of time, release pro-
inflammatory cytokines including tumour necrosis factor-α (TNF-α), interleukin (IL)-
1α and IL-1β as well as IL-6, Leukaemia Inhibitory Factor (LIF) and Macrophage 
Chemoattractant Protein1 (MCP-1), in response to peripheral nerve injury. These 
factors are important because they are required for immune cell chemotaxis including 
recruitment of macrophages to the injury site (Tofaris et al., 2002; Rotshenker, 2011). 
Although it is commonly thought that the release of pro-inflammatory factors are 
detrimental, the release of certain pro-inflammatory cytokines and chemokines (such 
as LIF and MCP-1) have been shown to be important for successful peripheral nerve 
regeneration (Tofaris et al., 2002; Painter et al., 2014).  
The ability of Schwann cells to recruit macrophages to the site of injury appears to 
have an importance in other aspects of peripheral nerve repair including new blood 
vessel formation (Cattin et al., 2015), as complete ablation of myeloid cells reduces 
axon outgrowth and prevents functional recovery (Barrette et al., 2008). 
 
Macrophages are a major cell type found in sciatic nerves with important functions in 
allowing for successful nerve regeneration following injury. Resident macrophages 
account for 2-9% of the cell populations present in peripheral nerves. These resident 
macrophages are thought to originate from circulating monocytes (Mueller et al., 
2003). Nerve injury triggers an inflammatory response, involving the recruitment of 
macrophages to the injured nerve. Macrophages are known as the secondary 
responders to injury after Schwann cells (primary responders), where they assist in the 
break down of myelin and its clearance through phagocytosis (Gaudet et al., 2011). 
Recent evidence has highlighted that in the absence of macrophages in the nerve, 
regeneration is severely compromised (Barrette et al., 2008; Cattin et al., 2015). 
Macrophages are already present as early as 4 hours at the injury site and steadily 
increase in numbers up to 2 days. The presence of macrophages along the distal stump 
peaks between 7 and 21 days post injury, depending on the type of injury and the 
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macrophage marker used. As the nerve regenerates these macrophages diminish in 
number (Perry et al., 1987; Stoll et al., 1989; Perry and Brown, 1992; Dailey et al., 
1998). 
Therefore, following nerve injury, Schwann cells and macrophages work in 
conjunction with each other.  
 
Schwann cells then begin to proliferate (Gaudet et al., 2011), forming bands of 
Büngner within their basal lamina tubes. Schwann cell proliferation and their 
alignment to form these bands of Büngner, along with the removal of myelin debris 
(which acts as a barrier to re-growing axons in the distal nerve) is a process now 
known as myelinophagy. These events are important for providing the growth 
supportive environment to allow axons to regenerate (Gomez-Sanchez et al., 2015).  
 
As already mentioned, the ability of the Schwann cells to carry out these different 
functions is due to their highly plastic nature. In response to nerve injury, Schwann 
cells distal to the lesion site undergo a process of cellular reprogramming (down-
regulating myelin genes and in addition express new genes related to its function as a 
repair cell) (Jessen et al., 2015; Jessen and Mirsky, 2016) but also adopt a unique 
phenotype to produce repair Bungner Schwann cells (Arthur-Farraj et al., 2012). 
 
The end of Wallerian degeneration is marked by re-myelination, where axons have re-
grown and Schwann cells have been able to myelinate them. By this point in nerve 
regeneration following peripheral nerve injury, newly regenerated axons will have 
reached their targets, and functional recovery is regained (Gaudet et al., 2011; Fricker 
et al., 2011).  
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1.4 The proximal stump 
 
The proximal stump is of great interest as the Schwann cells remain in close contact 
with the axons throughout the regenerative process, unlike in the distal stump, where 
Schwann cell-axonal contact is lost. Studies into the proximal stump resulting from 
nerve transection originate from studies dating back to the 1920s and earlier. 
Following nerve transection, outgrowths are seen from the transected nerves at both 
ends, and Schwann cells multiply in both proximal and distal stumps during the 
immediate days following nerve transection (Young et al., 1940; Thomas and Jones, 
1967). Axons of the proximal stump quickly seal their ends to prevent loss of 
axoplasm (Waller, 1850). 
Within 1-2 days of the nerve transection, axons of the proximal stump begin to 
develop swellings often referred to as boutons, which have been suggested to 
influence nerve regeneration through the release of regeneration promoting molecules 
such as calcitonin gene related protein (CGRP) and nitric oxide (Li et al., 2004). The 
axonal sprouts originating from the proximal stump are important as it is these that 
advance across the “nerve bridge” (consisting mainly of fibroblasts and Schwann 
cells) which is formed between the proximal and distal stumps following nerve 
transection. This sprouting is thought to originate from either the first or second node 
of Ranvier (Friede and Bischhausen, 1980). The rate at which axonal sprouts advance 
is much slower than compared to axonal sprouts in a nerve crush, where the 
endoneurial tubes are intact and Schwann cells line these structures to form the 
guiding regeneration tracks: the Bands of Büngner (Zochodne, 2008). 
 
More recent work shows that the changes that occur within the proximal stump axons 
and their neuronal cell bodies vary based on the location of the injury. The closer the 
nerve transection is to the neuronal cell body, the more chance of neuronal apoptosis. 
Breakdown of proximal stump axons is limited to the point up to the first Node of 
Ranvier (Tetzlaff and Bisby, 1989, Zochodne, 2003), unlike in the distal stump where 
axons are broken down in their entirety (Stoll et al., 1999; Rotshenker et al., 2011; 
Gomez-Sanchez et al., 2015).  
Within hours of nerve transection, the axonal cytoskeleton is re-arranged and 
microtubules are re-organised to form microtubule based traps for anterogradely 
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transported vesicles that are important for forming the growth cone complex (Erez et 
al., 2007).  
 
The anterograde response is not the only important response that takes place. The 
influx of calcium ions (Ca2+) into the severed axons determines calcium-dependent 
axonal degeneration, which begins to take place immediately after nerve injury 
(Mandolesi et al., 2004). Recent evidence has highlighted that the retrograde calcium 
signalling that takes place following nerve injury transection, can cause the export of 
histone deacetylase 5 (HDAC5) in the neuronal nucleus, which is able to remodel the 
chromatin and in this way prime the neuron for an injury response through epigenetic 
changes (Cho et al. 2013).  
 
This limited breakdown of the axons in the proximal stump is expected because they 
are still connected to the cell bodies after transection. This enables a switch to a 
growth mode from a neuro-transmitting mode, unlike the distal stump, which is no 
longer connected to the cell body and breaks down. The importance of Schwann cells 
within the proximal stump is investigated in this thesis (Chapter 5). 
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1.5 c-Jun and nerve regeneration 
 
The timely down-regulation of c-Jun expression in Schwann cells during development 
is a determinant of the progression of immature Schwann cells into mature 
myelinating Schwann cells (Monuki et al., 1989; Shy et al., 1996; Parkinson et al., 
2004; Jessen and Mirsky, 2005). The activation of JNK/c-Jun pathway is involved in 
regulating proliferation in many cell types (Leppa and Bohmann, 1999; Shaulin and 
Karin, 2001; Parkinson et al., 2008). In Schwann cells the JNK/c-Jun pathway is 
important in apoptosis induced by TGF-β and in regulating Schwann cell proliferation 
in cultured cells (Parkinson et al., 2001; Parkinson et al., 2004). Nevertheless, c-Jun 
can also be activated by other cell signalling pathways such as ERK and P38 
pathways (Monje et al., 2005; Yang et al., 2012). 
 
The process of cellular reprogramming that Schwann cells in the distal stump undergo 
after nerve injury, relies on the ubiquitin-proteasome system (Lee et al., 2009) and is 
driven by re-expression of the transcription factor c-Jun, which forms part of the AP-1 
early response transcription factor complex (Parkinson et al., 2008; Arthur-Farraj et 
al., 2012; Jessen et al., 2015; Jessen and Mirsky, 2016). In order to form 
transcriptionally active complexes, c-Jun has to homo or hetero-dimerise with itself or 
another member of the AP-1 transcription factor family (Deng and Karin, 1992; May 
et al., 1998).  
 
c-Jun is an immediate early gene and its expression in Schwann cells is seen very 
rapidly after nerve injury. As mentioned earlier, recent work shows that c-Jun is a 
global regulator of the Schwann cell injury response, and is important in the cellular 
reprogramming process of Schwann cells (an important step in response to nerve 
injury) in achieving successful nerve repair. This is highlighted by the fact that in 
mice where c-Jun is ablated specifically from Schwann cells, there is impaired and 
delayed axon outgrowth, neuronal death and minimal functional recovery (Arthur-
Farraj et al., 2012).  
It is currently unknown which family member(s) of the AP-1 transcription factors 
may be the binding partners for c-Jun in repair Bungner Schwann cells, however 
recent evidence would suggest they may include Fosl2 and ATF3 (Arthur-Farraj et al., 
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2017, in preparation and personal communication).  
 
It is now accepted that c-Jun within Schwann cells governs major aspects of the injury 
response. This includes determining the expression of trophic factors and adhesion 
molecules, myelin clearance, and its importance in the cellular reprogramming 
process, which governs the formation of bands of Büngner. However, it appears that 
c-Jun is less important in controlling the expression of Schwann cell cytokines, which 
are important for macrophage invasion after injury (Arthur-Farraj et al., 2012; Napoli 
et al., 2012; Martini et al., 2013; Jessen et al., 2015; Jessen and Mirsky, 2016). 
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1.6 Neuronal regeneration associated gene (RAG) expression following nerve 
injury 
 
As previously mentioned, a phenomenon that is commonly seen when peripheral 
nerves are transected is their ability to regenerate, whereas this is not often the case 
within the CNS. The regenerative ability of the PNS is due to both the activity of non-
neuronal cells distal to the lesion site, as well as specific changes that take place 
within the neuronal cell body. These changes result in a change in the neuronal 
phenotype of the cell soma from a state of “transmission” of specific signals, to a 
“regenerative” mode, essential for outgrowth (Navarro et al., 2007). 
Successful nerve repair within the PNS is reliant on the ability of the dorsal root 
ganglia (DRG) of sensory neurons and motor neurons that project from the CNS to 
the PNS, to become activated and switch from a signalling state to one of growth in 
response to nerve injury. Compared with the minimal neurite outgrowth seen after 
CNS injury, the ability of PNS neurons to be activated after nerve injury represents a 
significant difference, resulting in successful nerve regeneration. Even if CNS axons 
are provided with a favourable substrate such as a PNS graft, outgrowth is 
comparatively poor compared with that seen when similar grafts are attached to PNS 
nerves (David and Aguayo, 1981). 
 
Peripheral nerve axotomy also triggers morphological changes within the neuronal 
cell body, known as chromatolysis, which includes the dispersal of the Nissl 
substance, the movement of the nucleus to the periphery of the cell, the swelling of 
the cell body, and the retraction of the synaptic terminals at the neuromuscular 
junction (Fawcett and Keynes, 1990). 
 
Neuronal activation is thought to be caused by signals originating from the injury site. 
Studies carried out in the late 1990s in the mollusc Aplysia californica provided 
evidence for the existence of multiple injury signals (Ambron and Walters, 1996).  
Not much is known about the mechanism which initiates the increase in retrograde 
signals, but as mentioned earlier, injured Schwann cells release cytokines and growth 
factors including LIF, IL-6, IL-1α, IL-1β, TNF-α and MCP-1 (Banner et al., 1994; 
Bolin et al., 1995; Kurek et al., 1996; Tofaris et al., 2002; Rotshenker, 2011; Arthur-
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Farraj et al., 2012), which are capable of activating MAPKs and the JAK-STAT 
pathway.  
Additionally, in IL-6 knockout mice, GAP43 (a known RAG) is not up-regulated in 
DRG neurons following peripheral nerve injury (Cafferty et al., 2004), showing that 
the release of cytokines and chemokines is important in successful initiation of 
retrograde axonal injury signals and their transport to the neuronal cell bodies.  
Retrograde axonal injury signals are the important link between the site of injury and 
the neuronal cell body response, because if there is a delay or ablation of certain 
axonal injury signals, then the neuronal cell body response will not be able to up-
regulate specific RAGs and therefore change from a “transmission” mode to a 
“growth” mode (Abe and Cavalli, 2008). 
 
Neuronal activation (in terms of its growth activation), involves significant changes in 
the gene transcription profile of the neuron. Many RAGs including members of the 
immediate-early gene families c-Jun and JunD (Leah et al., 1991; Jenkins and Hunt, 
1991; Abe and Cavalli, 2008), as well as constitutive transcription factors such as 
CREB, STAT3, SOX11, ATF3 and SMAD1 (Schwaiger et al., 2000; Tanabe et al., 
2003; Abe and Cavalli, 2008; Fagoe et al., 2015) are up-regulated in response to 
neuronal activation, while other genes such as SMAD2 and ATF2 (Martin-Villalba et 
al., 1998) are down-regulated.  
To re-enforce the importance of RAG up-regulation, it has been shown that forced up-
regulation of RAGs even in CNS neurons is sufficient to promote some axon 
outgrowth (Kobayashi et al., 1997). A more recent large-scale gene screen analysis of 
the intrinsic axonal growth programme of peripheral nerves following injury was 
carried out highlighting how complex the gene network of RAGs is, however, Jun 
was shown to be a central component (Chandran et al., 2016).  
c-Jun acts as a key regulator of neuronal plasticity and is required for the initiation of 
additional transcriptional changes that not only play a role in successful axonal 
regeneration (Raivich et al., 2004), but also in the Schwann cell. Some of the genes 
up-regulated by c-Jun in neurons include CD44, galanin and integrin α7β1 which 
have themselves been implicated in regeneration (Holmes et al., 2000; Patodia and 
Raivich). 
As mentioned earlier, similarly to c-Jun, ATF3 and p-STAT3 are also up-regulated in 
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DRG neurons after peripheral nerve injury (Herdegen et al., 1997; Tsujino et al., 
2000; Cafferty et al., 2004; Raivich et al., 2004; Seijffers et al., 2007; Tedeschi, 
2012). Treatment with the JAK2 inhibitor AG490 blocks STAT3 phosphorylation and 
impairs axon outgrowth (Qiu et al 2005). A mouse model that shows the role of p-
STAT3 in retrograde axonal injury signalling is the Dual Leucine Zipper kinase 
(DLK) knockout model, which demonstrates that if the retrograde transport of p-
STAT3 to the neuronal cell body is disrupted, and its up-regulation is prevented 
within the soma, impaired axon outgrowth and regeneration results (Shin et al., 2012). 
Overexpression of ATF3 in neurons both in vivo and in vitro increases neurite 
outgrowth (Seijffers et al., 2006; Seijffers et al., 2007). Growth-associated protein 
(GAP43) also acts to promote regeneration, since its over-expression induces nerve 
sprouting in mouse nervous systems (Aigner et al., 1995). 
Neuronal activation following nerve injury is summarised in the diagram shown in 
Figure 1.4.  
 
 
  
Figure 1.4 | Neuronal expression of RAGs following nerve injury
A diagram to show the main events that take place following nerve injury in the neuronal cell body. Following nerve 
injury, multiple signaling events in the axon are triggered, including membrane depolarization, JNK activation, mRNA 
translation,  and cytokine-mediated STAT3 activation,  which in  turn activates  the  neuronal  cell  body.  When these 
signaling molecules reach the cell body, they mediate the expression of a number of transcription factors that regulate 
the expression of genes involved in neurite outgrowth. 
This diagram is taken from Abe and Cavalli, 2008
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1.7 Conditioning lesion paradigm 
 
The difference between the ability of peripheral and central nerves to regenerate was 
first described by Ramon y Cajal, who demonstrated that peripheral nerves could not 
regenerate through a central nerve graft tissue following injury (Cajal, 1928). It was 
later shown that CNS nerves that were transplanted to grow through peripheral nerves 
were able to, in contrast to their behaviour in the native CNS environment (David & 
Aguayo 1981; Richardson et al., 1980; Richardson and Verge, 1986). These 
experiments demonstrated that peripheral nerves provide the necessary growth 
permissive conditions to allow central nerves to have limited regeneration.  
As mentioned above, nerve injury causes the neuronal cell body to respond by 
activating a growth programme that supports regeneration (Abe and Cavalli, 2008; 
Huebner and Strittmatter, 2009). DRG sensory neurons are unique in that they possess 
a single branched axon that extends into the periphery, and the spinal column. These 
two branches elicit different responses. Experiments showed that when the peripheral 
branch of DRG neurons is injured first, followed by a lesion in the central branch of 
DRG neurons, these central neurons are able to project axons into the CNS 
(McQuarrie, 1985; Neumann and Woolf, 1999; Chong et al., 1999; Hoffman, 2010). 
The idea of having a ‘conditioning’ lesion, is a way of exaggerating the neuronal cell 
body response to injury, and is a commonly used paradigm, particularly in the central 
nervous system where limited axonal regeneration is seen. 
 
1.7.1 Myelin as an inhibitory substrate 
 
As mentioned earlier, trauma to the brain and spinal cord can produce irreparable 
damage It is thought that part of this failure of CNS neurons to regenerate is due to 
the inhibitory environment created by myelin (Buchser et al., 2012).  
Although myelin is considered an inhibitory substrate, work by Davies et al., 1997 
showed that DRG neurons were able to grow across the corpus callosum along the 
myelin rich substrate, yet a similar experiment carried out using CNS neurons failed 
to exhibit this outcome. For this reason and other evidence, it is widely accepted that 
PNS neurons have an intrinsic ability to grow on otherwise inhibitory substrates (Shen 
et al., 1998; Buchser et al., 2012; McKerracher and Rosen, 2015) 
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1.8 Aims 
 
Although c-Jun in Schwann cells is dispensible for normal Schwann cell 
development, it performs vital functions in controlling nerve regeneration following 
nerve injury (Arthur-Farraj et al., 2012). This thesis aims to investigate whether 
increasing c-Jun in Schwann cells to levels above those normally seen in developing 
or regenerating nerves would have beneficial or deleterious effects. It also aims to 
address the importance of Schwann cell c-Jun in the neuronal cell body response 
following nerve injury. This was approached in the following way: 
 
1. To characterise the development of postnatal and adult nerves in transgenic 
mice that overexpress Schwann cell c-Jun (Chapter 3) 
2. To determine whether c-Jun overexpression in Schwann cells accelerates 
nerve regeneration following nerve injury (Chapter 4) 
3. To establish the significance of c-Jun expression in the proximal stump 
following nerve injury (Chapter 5) 
4. To elucidate whether Schwann cell c-Jun can affect the ability of DRG 
neurons to respond to nerve injury (Chapter 6) 
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2. Materials and Methods 
 
2.1 List of abbreviations 
 
ADS-    Antibody Diluting Solution 
APS-    Ammonium Persulfate 
AraC-    Cytosine Arabinoside 
ATF3-    Activating Transcription Factor 3 
BDMA-   N-benzyldimethylamine 
BSA-    Bovine Serum Albumin 
dbcAMP-   dibutyryl Cyclic Adenosine Monophosphate 
DDSA-   Dodecenyl Succinic Anhydride 
DM-    Defined Medium 
DMSO-  Dimethyl Sulphoxide 
DMEM-  Dulbecco’s Modified Eagle’s Medium 
DS-    Donkey serum 
FBS-    Foetal Bovine serum 
GAP43-   Growth Associated Protein 43 
GS-    Goat serum 
HS-    Horse serum 
MNA-   Methyl Nadic Anhydride 
NRG1-   Neuregulin 1 
PB-   Phosphate Buffer 
PBS-    Phosphate Buffered Saline 
PLL-    Poly-L-lysine 
RPMI-   Roswell Park Memorial Institute medium 
Sox10-   SRY-Box 10 
STAT3-   Signal Transducer and Activator of Transcription 3 
TEMED-   Tetramethylethylenediamine 
TBS-    Tris-Buffered Saline 
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2.2 List of materials and reagents 
 
2.2.1 List of recipes 
 
Alkaline lysis reagent- pH 12 (HOTShot) 
(make up to 50ml with dH2O without adjusting pH) 
Reagent Amount 
25mM NaOH 50mg 
0.2mM disodium EDTA 3.72mg 
 
Neutralising reagent- pH 5 
(make up to 50ml with Tris-HCl in dH2O without adjusting pH) 
Reagent Amount 
40mM Tris-HCl 315.2mg 
 
10X PBS 
(make up to 1L with dH2O) 
Reagent Amount 
NaCl 80g 
Na2HPO4 11.5g 
KCl 2g 
KH2PO4 (anhydrous) 2g 
 
5X Laemmli buffer 
(use at a final concentration of 1X) 
Reagent Amount 
1M Tris pH 6.8 1.25ml 
20% SDS 5ml 
glycerol 2.5ml 
β-mercaptoethanol 1ml 
dH2O 0.25ml 
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RIPA buffer  
(final volume of 20.2ml) 
Reagent Amount 
1M Tris-HCl pH 8 5ml 
5M NaCl 10ml 
20% Triton-X-100 5ml 
5mM EDTA 200 μl 
 
10X Running buffer 
(adjust pH to 8.3, make up to 1L with dH2O, and use at a final concentration of 1X) 
Reagent Amount 
Tris Base 30g 
Glycine 144g 
SDS 10g 
 
10X TBS 
(adjust pH to 7.4, make up to 1L with dH2O, and use at a final concentration of 1X) 
Reagent Amount 
Tris HCl (500mM) 78.6g 
NaCl (150mM) 87.6g 
 
8% Resolving gel 
(based on making 1 gel) 
Reagent Amount 
40% acrylamide 2.5ml 
1.5M Tris pH8.8 3.2ml 
10% SDS 125μl 
dH2O 6.8ml 
TEMED 10μl 
APS 100μl 
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10% Resolving gel 
(based on making 1 gel) 
Reagent Amount 
40% acrylamide 3.2ml 
1.5M Tris pH8.8 3.2ml 
10% SDS 125μl 
dH2O 6.1ml 
TEMED 10μl 
APS 100μl 
 
Stacking gel 
(based on making 1 gel) 
Reagent Amount 
40% acrylamide 625μl 
0.5M Tris pH6.8 1.25ml 
10% SDS 50μl 
dH2O 3.1ml 
TEMED 7.5μl 
APS 37.5μl 
 
Transfer buffer 
(adjust pH to 8.3, make up to 1L with dH2O) 
Reagent Amount 
48mM Tris Base 5.82g 
39mM Glycine 2.93g 
10% SDS 3.75ml 
100% methanol 200ml 
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Resin 
Reagent Amount 
Agar 12g 
DDSA 8g 
MNA 5g 
BDMA* 16 drops 
*Use a 1.5ml Pasteur pipette, this is counted dropwise 
 
Defined Medium 
Reagent Amount Concentration 
Ham’s/F12 48.3ml 50% 
DMEM 48.3ml 50% 
BSA 1ml 0.035% 
Putrescine 1ml 16 µg/ml 
Transferrin 1ml 100 µg/ml 
T4 (L-Thyroxine) 100µl 400 ng/ml 
Progesterone 100µl 60 ng/ml 
Insulin (High) 100µl 10-6M 
Dexamethasone 77µl 38 ng/ml 
T3 (L-Thyronine) 10µl 10.1 ng/ml 
Selenium 10µl 160 ng/ml 
 
Calcium and magnesium free medium 
(store at 4°C) 
Reagent Amount 
Water 80ml 
10X Krebs Solution 10ml 
50% amino acid 
solution 
2ml 
7.5% NaHCO3 2.5ml 
Phenol red solution 0.5ml 
50% glucose 0.4ml 
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10X Krebs solution 
(make up to 200ml with dH2O) 
Reagent Amount 
NaCl 14g 
KCl 0.7g 
KH2PO4 0.3mg/ml 
 
Enzyme cocktail  
(made up in calcium and magnesium free medium) 
Reagent Amount 
Collagenase 3mg/ml 
Hyaluronidase 1.2mg/ml 
Trypsin Inhibitor 0.3mg/ml 
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2.2.2 List of antibodies 
 
2.2.2.1 Immunofluorescence primary antibodies 
 
  
 
Name of 
Antibody 
 
Host species 
 
Dilution 
 
Diluent 
 
Company 
Anti-Sox10 Goat 1:100 10%HS/0.2%Triton-X-100/PBS R and D Sytems 
Anti-NF200 Chicken 1:10000 0.1%BSA/PBS Abcam 
F480 Rat 1:100 10%HS/0.2%Triton-X-100/PBS R and D Systems 
Anti-L1 
(supernatant) 
(324 
Hybridoma) 
Rat 1:10 10%HS/0.2%Triton-X-100/PBS Jessen/Mirsky Lab 
Anti-c-Jun Rabbit 1:800 
1:3200 
10%HS/0.2%Triton-X-100/PBS 
0.1%BSA/PBS 
New England Biolabs 
Anti-Krox20 Rabbit 1:100 10%HS/0.2%Triton-X-100/PBS Millipore 
Anti-Ki67 Rabbit 1:100 10%HS/0.2%Triton-X-100/PBS Abcam 
Anti-Tuj1 Rabbit 1:500 0.2%Triton-X-100/ADS Covance 
Anti-ATF3 Rabbit 1:500 0.1%BSA/PBS Santa Cruz 
Anti-p-STAT3 
tyr705 
Rabbit 1:500 0.1%BSA/PBS New England Biolabs 
Anti-p-STAT3 
ser727 
Rabbit 1:50 0.1%BSA/PBS New England Biolabs 
Anti-GAP43 Rabbit 1:1000 0.1%BSA/PBS Millipore 
Anti-CGRP Rabbit 1:10000 0.1%BSA/PBS 2BScientific 
Anti-Galanin Rabbit 1:10000 0.1%BSA/PBS 2BScientific 
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2.2.2.2 Immunofluorescence secondary/ biotinylated antibodies 
 
Name of 
Antibody 
 
Host species 
 
Dilution 
 
Diluent 
 
Company 
Anti chicken 
(IgG) 
alexafluor 488 
Goat 1:1000 10%HS/0.2%Triton-X-100/PBS 
0.1%BSA/PBS 
Molecular probes 
Anti chicken 
(IgG) cy3 
Donkey 1:500 10%HS/0.2%Triton-X-100/PBS 
0.1%BSA/PBS 
Jackson Immunoresearch 
Anti goat 
(IgG) 
alexafluor 488 
Donkey 1:1000 10%HS/0.2%Triton-X-100/PBS 
 
Molecular probes 
Anti rabbit 
(IgG) 
alexafluor 488 
Goat 1:1000 10%HS/0.2%Triton-X-100/PBS 
0.1%BSA/PBS 
Molecular probes 
Anti rabbit 
(IgG) cy3 
Donkey 1:500 10%HS/0.2%Triton-X-100/PBS 
0.1%BSA/PBS 
Jackson Immunoresearch 
Anti rat (IgG) 
alexafluor 488 
Goat 1:1000 10%HS/0.2%Triton-X-100/PBS 
 
Molecular probes 
Anti rat cy3 
(IgG) 
Donkey 1:500 10%HS/0.2%Triton-X-100/PBS Jackson Immunoresearch 
Anti rabbit 
(IgG), 
biotinylated 
species 
Donkey 1:600 10%HS/0.2%Triton-X-100/PBS Amersham 
Streptavidin- 
cy3 
Streptomyces 
avidinii 
1:500 10%HS/0.2%Triton-X-100/PBS Jackson Immunoresearch 
DAPI n/a 1:100000 Different per protocol used Thermofisher Scientifc 
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2.2.2.3 Western blot primary antibodies 
 
Name of Antibody 
 
Host species 
 
Dilution 
 
Diluent 
 
Company 
Anti- GAPDH Rabbit 1:5000 5% milk TBS-T Sigma 
Anti-Calnexin Mouse 1:1000 5% milk TBS-T Enzo Life Sciences 
Anti-c-Jun Rabbit 1:1000 5% milk TBS-T New England Biolabs 
Anti-Krox20 Rabbit 1:500 5% milk TBS-T Millipore 
Anti-Mpz Chicken 1:2000 5% milk TBS-T Aves Labs 
Anti-Cyclin D1 Rabbit 1:100 5% milk TBS-T Santa Cruz 
Anti-ATF3 Rabbit 1:500 5% milk TBS-T Santa Cruz 
Anti-p-STAT3 
tyr705 
Rabbit 1:1000 5% BSA TBS-T New England Biolabs 
Anti-p-STAT3 
ser727 
Rabbit 1:1000 5% BSA TBS-T New England Biolabs 
Anti-STAT3 Mouse 1:1000 5% BSA TBS-T New England Biolabs 
Anti-GAP43 Rabbit 1:1000 5% BSA TBS-T Millipore 
 
2.2.2.4 Western blot secondary antibodies 
 
 
 
  
 
Antibody 
 
Host species 
 
Dilution 
 
Diluent 
 
Company 
Anti-rabbit (IgG) 
HRP 
Rabbit 1:2000 5% milk TBS-T Promega 
Anti-mouse (IgG) 
HRP  
Mouse 1:2000 5% milk TBS-T Promega 
Anti-chicken (IgG) 
HRP 
Chicken 1:2000 5% milk TBS-T Promega 
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2.2.3 Transgenic mice 
 
All mice used were 6-10 weeks old and on a C57BL/6 background. Mice were housed 
in UCL Biological Services Unit (BSU). All mouse work was carried out in 
accordance with Home Office guidelines and mice 6-10 weeks old (unless otherwise 
specified) were culled using schedule 1. 
 
P0Cre transgenic mice (P0Cre) 
 
The P0Cre mice used in the following experiments were kindly gifted by Dr L. 
Wrabetz and Dr L. Fletri (Italy). The mice express mP0TOT(Cre) transgene (P0Cre), 
driven by the Mpz (P0) promoter (Feltri et al., 1999). The Cre-mediated recombination 
specifically in Schwann cells takes place between embryo day (E) 13.5 and E14.5 in 
the mouse and is activated by the P0Cre transgene. P0Cre activity is most strongly 
detected only in peripheral nerves, however there is minimal activity seen in the 
occipital lobe of the cerebral cortex, Purkinje cell layer of the cerebellum and in the 
heart (Feltri et al., 1999; Feltri, 2002; D’Antonio et al., 2006; Parkinson et al., 2008; 
Woodhoo et al., 2009; Yu et al., 2009).   
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c-Jun overexpressing mice (OE) 
 
The mice overexpressing c-Jun (OE) were kindly gifted by the lab of Klaus Rajewsky 
(Max Delbruck Center, Berlin). These mice carry a lox-P flanked STOP cassette in 
front of a CMV early enhancer/chicken β actin (CAG) promoter driven c-Jun cDNA, 
inserted into the ROSA26 locus (c-JunOE). These mice, c-JunOE/OE  were crossed with 
P0-Cre+ mice (Jackson Laboratories) to generate the P0-Cre+/c-JunOE/+  mice referred to 
as OE/+.  These mice were subsequently back-crossed with c-JunOE/OE  mice to 
generate P0-Cre+/c-JunOE/OE mice referred to as OE/OE. P0-Cre- littermates were used 
as controls and are referred to as wildtype (WT) in subsequent chapters.  
This is summarised in Figure 2.1 shown below.  
 
 
 
 
Schwann cell c-Jun conditional knockout mice (cKO) 
 
The c-Jun floxed mice (c-Junfl/fl) were kindly gifted by Dr A. Behrens (London). To 
generate Schwann cell c-Jun conditional knockout mice (cKO), the c-Junfl/fl mice were 
crossed with P0-Cre mice. The resulting P0Cre
+/c-Junfl/wt mice were back-crossed to c-
Junfl/ fl animals producing P0Cre+/c-Junfl/fl (cKO) mice and P0Cre-/Junfl/fl control litter-
mates (WT). Polymerase Chain Reaction (PCR) gel analysis was carried out to ensure 
that the mice used were P0Cre+/c-Junfl/fl. 
 
  
Rosa26 WT locus
Rosa26 OE locus
Rosa26 OE locus
217bp
271bp
x P0Cre
c-Jun
c-Jun
c-Jun
pCAG
pCAG
STOP
1
1
1
2
2
2
loxP loxP
Figure 2.1 | Summary diagram showing the construct of c-Jun overexpressing mice
The mice overexpressing c-Jun overexpressing (OE) carry a lox-P flanked STOP cassette in front of a CAG promoter 
driven c-Jun cDNA, inserted into the ROSA26 locus.  These mice,  c-JunOE/OE were,  crossed with P0-Cre+ mice to 
generate the P0-Cre+/c-JunOE/+  mice referred to as OE/+.  These mice were subsequently back-crossed  with  c-JunOE/OE 
to generate P0-Cre+/c-JunOE/OE mice referred to as OE/OE. 
Diagram courtesy of JA Gomez-Sanchez.
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2.2.4 Genotyping 
 
2.2.4.1 List of primers 
 
Primers listed below were used to genotype transgenic mice using PCR gel analysis. 
 
P0cre Forward: 5’-GCTGGCCCAAATGTTGCTGG-3’ 
P0cre Reverse: 5’-CCACCACCTCTCCATTGCAC-3’ 
 
Rosa26 Forward: 5'-GGAGTGTTGCAATACCTTTCTGGGAGTTC-3' 
Rosa26 Reverse: 5'-TGTCCCTCCAATTTTACACCTGTTCAATTC-3' 
 
c-JunOE Forward: 5'-TGGCACAGCTTAAGCAGAAA-3' 
c-JunOE Reverse: 5'-GCAATATGGTGGAAAATAAC-3' 
 
c-Junf/f Forward: 5’-CCGCTAGCACTCACGTTGGTAGGC-3’ 
c-Junf/f Reverse: 5’-CTCATACCAGTTCGCACAGGCGGC-3’ 
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2.2.4.2 PCR mastermix recipes and list of conditions 
 
To determine whether or not mice were OE/+ or OE/OE, a combination of P0cre and 
Rosa26WT PCRs were carried out. To check for the presence of the c-JunOE, the c-
JunOE PCR was run in parallel. 
 
 
P0cre 
   Sample Volume (ml) PCR conditions 
Buffer 5X 5 4 minutes at 94ºC   
MgCl2 (25mM) 1.5 30 seconds at 94ºC 
x30 cycles P0cre forward (10μM) 1.25 1 minute at 50ºC 
P0cre reverse (10μM) 1.25 1 minute at 72ºC 
dNTPs (10mM) 0.5 10 minutes at 72ºC   
Taq 0.2 PCR sizes: 500bp 
H2O 13.05 
  DNA (HOTSHOT) 1 
  Final volume 25 
  DMSO 1.25 
  
    Rosa26 WT 
   Sample Volume (ml) PCR conditions 
Buffer 5X 5 4 minutes at 94ºC 
MgCl2 (25mM) 1.5 15 seconds at 94ºC 
x36 cycles Rosa26 WT forward (10μM) 1.25 40 seconds at 60ºC 
Rosa26 WT reverse (10μM) 1.25 40 seconds at 72ºC 
dNTPs (10mM) 0.5 2 minutes at 72ºC 
Taq 0.2 PCR sizes: 350bp 
H2O 12.05 
  DNA (HOTSHOT) 2 
  DMSO 1.25 
  Final volume 25 
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c-JunOE 
   Sample Volume (ml) PCR conditions 
Buffer 5X 5 5 minutes at 94ºC 
MgCl2 (25mM) 1.5 30 seconds at 94ºC 
x34 cycles c-JunOE forward (10μM) 1.25 45 seconds at 55ºC 
c-JunOE reverse (10μM) 1.25 1 minute at 72ºC 
dNTPs (10mM) 0.5 7 minutes at 72ºC 
Taq 0.2 PCR sizes: 271bp 
H2O 12.05 
  DNA (HOTSHOT) 2 
  DMSO 1.25 
  Final volume 25 
  
    
    c-Junf/f 
   Sample Volume (ml) PCR conditions 
Buffer 5X 5 2 minutes at 94ºC 
MgCl2 (25mM) 1.5 40 seconds at 94ºC   
c-Junf/f forward (10μM) 1.25 40 seconds at 57ºC x35-37 
cycles c-Junf/f reverse (10μM) 1.25 1 minute at 72ºC 
dNTPs (10mM) 0.5 7 minutes at 72ºC 
Taq 0.2 PCR sizes: 271bp 
H2O 14.3 
  DNA (HOTSHOT) 1 
  Final volume 25 
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2.2.5 Surgical 
 
Tools used for surgeries and dissections were bought from Fine Science Tools 
(Germany). These included number 2, 3, 5 forceps, curved forceps, crushing forceps, 
spring scissors, bone crushing scissors and fine scissors. Isofluorane, sterile drapes 
and sutures were provided by the Biological Services Unit (BSU) at University 
College London (UCL). Veterinary autoclips were obtained from VET-TECH. 
Bupivacaine was diluted 1:10 in sterile saline bought from the BSU. 
 
2.2.6 Functional recovery tests 
 
The wooden walking beam was made by UCL estates. 180gsm paper used for 
footprints, black paint and pencils were bought from Ryman (UK). Canon Pixma 
Scanner used to scan and analyse footprints was purchased from Office Depot (UK). 
 
2.2.7 Histology 
 
Glutaraldehyde, Agar 100 Resin, MNA, DDSA, BDMA, Tissue Tek OCT compound 
and rubber coffin moulds were bought from Agar Scientific. DPX mountant was from 
Merck Biosciences. Propylene oxide, osmium tetroxide, uranyl acetate, lead citrate, 
Na2HPO4 and NaH2PO4 were bought from Sigma. 
 
2.2.8 Immunohistochemistry 
 
Paraformaldehyde was bought from Fluka Chemicals Ltd. Triton-X-100 was bought 
from Sigma. Fluoromount-G was bought from SouthernBiotech. Superfrost slides 
were bought from Fisher Scientific. Mouse serum was bought from Serotec. 
For a list of primary and secondary antibodies used in both Immunofluorescence and 
Western blotting, please see tables listed in section 2.2.2. 
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2.2.9 Molecular biology 
 
Genotyping: EDTA disodium salt, ethidium bromide and sodium hydroxide were 
bought from Sigma. Taq DNA-polymerase, dNTPs, 100mM dNTP set and Agarose 
were bought from Invitrogen Limited. TAE 50X buffer was bought from VWR. 
100bp DNA ladder was bought from Fisher Scientific Limited (Loughborough, UK). 
 
Western blotting: Bis-Acrylamide 19:1, 1.5M Tris HCl, 0.5M Tris HCl, mini protean 
tank system, semi-dry transfer system and Chemidoc were bought from Bio-rad 
Laboratories. 15ml and 50ml Falcon tubes were bought from BD Biosciences. 5ml, 
10ml and 25ml stripettes were bought from Costar. Nitrocellulose Hybond membrane, 
ECL and ECL Prime were bought from Amersham. Semi-skimmed milk powder was 
bought from Sigma. BCA protein assay, Halt protease inhibitior cocktail and EDTA 
were bought from Thermoscientific. 
 
2.2.10 Tissue Culture 
 
Tissue culture 35mm dishes, 4 well plates and centrifuge tubes were bought from 
VWR, UK. Round 13mm coverslips were bought from BDH (Lutterworth). 
Transferrin, selenium, putrescine, triiodothyronine (T3), thyroxine (T4), progesterone, 
dexamethasone, BSA, insulin, AraC, PLL, laminin, RPMI medium and Percoll were 
bought from Sigma. NRG1 was bought from R&D Systems. Collagenase was bought 
from Worthington. DMEM, Ham’s F-12 medium and L15 medium were bought from 
Invitrogen Ltd. Trypsin, trypsin/EDTA and penicillin were bought from PAA. FBS 
was bought from Perbio. Forskolin was bought from Calbiochem.  Horse serum was 
bought from Jackson Immunoresearch. 
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2.3 List of methods 
 
2.3.1 Genotyping 
 
DNA was extracted from fresh mouse ear notches, or for re-genotyping tail extracts 
were used. The tissue sample was incubated in 75μl of HotSHOT (recipe in section 
2.2.1) solution for 1 hour at 95°C. This solution was then neutralised by adding 75μl 
of neutralising agent (recipe in section 2.2.1) and vortexing for 20s. The master mixes 
were made up according to the recipes above in section 2.2.4.2.  
For Rosa26 WT and c-JunOE PCR reactions, 23μl of master mix and 2μl of extracted 
DNA were pipetted into thin walled PCR reaction tubes.  
For P0cre reactions, 24μl of master mix and 1μl of extracted DNA was pipetted into 
thin walled PCR tubes. 
For c-Jun f/f PCR reactions, 21μl of master mix, and 4μl of extracted DNA were 
pipetted into thin walled PCR tubes.  
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2.3.2 Peripheral nerve surgeries and dissections 
 
All peripheral nerve surgeries were carried out in accordance to Home Office 
Guidelines (UK) with the use of 2% isofluorane at the time of surgeries and when 
wounds were closed, bupivacaine diluted 1:10 in saline was administered. All wounds 
were closed using autoclips. All animals were culled using Schedule 1. 
 
2.3.2.1 Uninjured sciatic nerve dissections 
 
Sciatic nerves were dissected from WT, OE/+ and OE/OE mouse pups at postnatal (P) 
day 1, P7 and P21 for Western blot, Immunofluorescence and Electron Microscopy 
analyses. 
 
For Immunofluorescence analysis, both nerves were dissected from WT, OE/+ and 
OE/OE animals at P7 and P60 and embedded in OCT compound (Tissue-Tek) ready 
for cryosectioning. P60 uninjured nerve samples were also dissected for teased nerve 
fibre preparation.  
 
For Western blots, both nerves were dissected out from animals at P1, P7 and P60 
from WT, OE/+ and OE/OE mice and put into clean eppendorf tubes before snap 
freezing them in liquid nitrogen. These nerves were then stored at -80°C ready for 
protein extraction. Western blot analysis was done by pooling both nerves from 6 
animals at P1, both nerves from 3 animals at P7 and using 1 nerve from P60 mice. 
 
For electron microscosopy (EM) studies, both nerves from WT, OE/+ and OE/OE 
mice at P1, P7, P21 and P60 were fixed inside the culled animal using EM fixative 
solution containing glutaraldehyde and PFA, before being dissected out and stored in 
fixative solution at 4°C ready to be processed for EM. 
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2.3.2.2 Crush injury 
 
For sciatic nerve injuries, 6-10 week old mice (WT, OE/+ and OE/OE) had their right 
sciatic nerves exposed, which were crushed at the level of the sciatic notch, using fine 
forceps. The muscle was carefully put back in place to cover the nerve and 
bupivacaine diluted in saline 1:10 was administered to the muscle area before closing 
the wound.  
 
The mice were allowed to recover for 1 day (D), 7D or 14D following injury. The 
distal stump of the nerve was dissected out from the crush point and separated into the 
first 0-2mm and the remaining 2-6mm. These segments were used for Western blot 
analysis by placing nerve segments into clean eppendorf tubes and snap freezing them 
in liquid nitrogen before storing them at -80°C ready for protein extraction.  
 
The contralateral uninjured nerve was also dissected and divided into two 5mm 
segments- one of which was snap frozen for Western blot analysis, and the other was 
embedded in OCT compound ready for cryosectioning. 
 
Some of the mice that had sciatic nerve crush surgeries were allowed to recover for 
14D, 28D or 70D before dissecting out their sciatic nerves. From these mice, the 
distal stump was dissected 5.5mm from the crush point and fixed in the culled mouse 
using EM fixative solution containing 2.5% glutaraldehyde and 2% PFA for 15 
minutes, before being dissected out and stored in fixative solution at 4°C overnight to 
a few days before being processed for EM. 
 
WT, OE/+ and OE/OE mice that had sciatic nerve crush surgeries were also allowed 
to recover for 70D post crush for studying functional recovery through a series of 
behavioural tests at various time points. The nerves from these mice were then 
analysed for EM, in the same way as described above. 
 
	   60	  
2.3.2.3 Transection injury 
 
For all sciatic nerve transection injuries, 6-10 week old WT and cKO mice had their 
right sciatic nerves exposed, then were transected at the level of the sciatic notch, 
using fine scissors. The muscle was carefully put back in place to cover the nerve and 
bupivacaine diluted in saline 1:10 was administered to the muscle area before closing 
the wound.  
These operated mice were allowed to recover for 1 hour, 6 hours, 48 hours or 2.5D 
depending on the experiment. 
 
For teased nerve fibre preparations, only the first 2mm (0-2mm) which included the 
injury site of proximal stump was dissected out. This was then fixed for 10 minutes in 
4% PFA and washed three times for 5 minutes each with 1XPBS. Samples were 
stored at 4°C ready to be teased out.  
 
For Immunofluorescence analysis, the sciatic nerve of these injured mice was exposed 
at the transection site after 1 hour, 6 hours and 48 hours. In nerve transection 
experiments there was a clear separation of the intact nerve into a proximal and distal 
stump. From the proximal stumps, a 6mm segment beginning at the injury site was 
excised and cut into further 2mm segments (0-2mm, 2-4mm and 4-6mm). These 
individual segments were embedded separately in moulds using OCT compound 
ready for cryosectioning. A 6mm piece of the contralateral uninjured nerve of these 
mice was also dissected and embedded in OCT compound ready for analysis. 
 
For Western blot analysis at 6 hours after nerve transection, the first 3mm of the 
proximal and distal stump was dissected out and 6mm of the contralateral uninjured 
nerve. These samples were placed into eppendorf tubes and snap frozen in liquid 
nitrogen before being stored at -80°C ready for protein extraction. 
 
For L4 DRG (uninjured and injured) Western blots and immunofluorescence 
analyses, WT and cKO mice were allowed to recover for 48 hours following sciatic 
nerve transection. The L4 DRGs (uninjured and injured) from these mice were then 
dissected by excising the whole spine from the mouse to break away the vertebrae in 
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order to expose the spinal cord and DRGs. The L4 DRGs (both the injured and 
uninjured) were located and excised, carefully removing as much connective tissue 
and nerve roots as possible. The L4 DRGs were either snap frozen in liquid nitrogen 
or embedded in OCT compound for cryosectioning. Samples were stored at -80°C 
ready for processing. 
 
For L4 DRG neuronal cultures, WT and cKO mice were allowed to recover for 2.5D 
following sciatic nerve transection. Only the L4 injured DRGs from these mice were 
dissected by excising the whole spine from the mouse to break away the vertebrae in 
order to expose the spinal cord and DRGs. L4 DRG cultures were made from the 
injured right L4 DRGs and plated both on PLL/laminin or PLL/myelin coated 
coverslips to analyse the conditioned growth response from these DRG neurons.  
 
 
  
Figure 2.2 | Summary diagram showing the different types of peripheral nerve surgeries and how the tissue was 
processed 
The  control  for  all  peripheral  nerve  experiments  was  the  contralateral  uninjured  nerve  (A)  (blue  dotted  box). 
Depending  on  the  experiment,  the  sciatic  nerve  was  either  transected  (scissor  symbol)  or  crushed  (grey  forceps 
symbol) at the sciatic notch (shown by the red lightning bolt). For sciatic nerve transection experiments, the proximal 
stump (B) (black dotted box) was processed for immunofluorescence in 2mm segments, or for Western blot analysis. 
The L4 DRGs (C) (green dotted box) were dissected for immunofluorescence, Western blot analysis or culture. For 
sciatic nerve crush experiments, the distal stump (D) (bottom orange dotted box) was used for electron microscopy, 
and Western blot analysis. 
L4 DRG 
Uninjured 
Left
Injured 
Right 
Proximal Stump 
2-6mm (IF) 0-2mm (IF)/
(WB) 
Distal stump 
2-6mm (WB) 0-2mm (WB) 
5-10mm (EM) 
Transection scissors
Crush forceps 
Injury site 
5mm (WB) 
Uninjured nerve 
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2.3.2.4 Conditioning lesion injury 
 
The right sciatic nerve was exposed in the same way as for nerve crush or transection 
surgeries. The first surgery involved transecting the right sciatic nerve at mid-thigh 
level. The muscle was carefully put back in place to cover the nerve and bupivacaine 
diluted in saline 1:10 was administered to the muscle area before closing the wound. 
The mice were allowed to recover for 2.5D after the initial surgery. 2.5D following 
this initial nerve transection at mid-thigh level, the right sciatic nerve was re-exposed, 
and the second injury (viz sciatic nerve crush at the sciatic notch), was performed 
using fine crushing forceps. Again, the muscle was put back in place, and bupivacaine 
diluted in saline 1:10 was administered. The mice were allowed to recover for a 
further 2.5D. This method is similar to the one described by McQuarrie et al., 1977. 
The sciatic nerves from these mice were dissected and removed from the injury site at 
the sciatic notch (where the crush injury was performed). The sciatic nerves were 
fixed for 2 hours in 4%PFA, washed 3 times with PBS before being embedded in 
15% sucrose overnight at 4°C ready for embedding in OCT the following day. These 
sciatic nerve moulds were then used for 10µm thick longitudinal cryosections. 
 
 
  
Figure 2.3 | Summary diagram to show how surgeries for conditioned lesion experiments in vivo were performed
Schematic representation of how conditioning lesion peripheral nerve surgeries were done in WT and cKO mice. (A) 
The conditioning injury is the first surgery done on the mouse which is a sciatic nerve transection at mid-thigh level. 
The mouse is allowed to recover before a second injury is carried out. (B) The second injury is a sciatic nerve crush at 
the sciatic notch. The mouse is again allowed to recover.
Transection at 
mid-thigh
Conditioning injury
Crush at 
sciatic notch 
Second injury Transection
Crush 
Injury site 
A B
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2.3.3 Behavioural tests 
 
Sciatic functional index (SFI): Paw prints were taken from 6 week old mice to 
calculate the SFI. The SFI formula correlates mouse paw prints with nerve function as 
described by Inserra et al., 1998. The hindlimb paws of the mice were painted on the 
plantar surface with black paint. Mice then walked down a 54cm x 5cm wooden track 
lined with 180gsm highly absorbent paper (Goldline). Prints were subsequently 
scanned using a Canon pixma scanner to generate digital paw prints. Toe spread (the 
distance between the first and fifth toes) and print length (the distance between the 
third toe and the heel) were measured using ImageJ and Microsoft Excel was used to 
convert the measurements into SFI values using an established formula (Inserra et al., 
1998). An SFI value of -100 represents complete loss of function. This is summarised 
in Figure 2.4 below.   
 
 
 
SFI = 118.9(ETS-NTS/NTS)-51.2(EPL-NPL/NPL)-7.5 
 
ETS = Experimental Toe Spread 
NTS = Normal Toe Spread 
 EPL = Experimental Print Length 
NPL = Normal Print Length 
 
  
Figure 2.4 | Summary diagram showing typical mouse footprints used in SFI analysis
Scanned  mouse  footprints  to  show  the  typical  print  seen  in  an  uninjured  (A)  and  injured  situation  (B).  SFI  is 
determined by several parameters that include the Normal Print Length (NPL), the Normal Toe Spread (NTS) seen in 
(A) and the Experimental Print Length (EPL), Experimental Toe Spread (ETS) seen in (B). In a normal uninjured 
situation (A), the NPL is short and NTS is long, whereas after injury, the length of the footprint (EPL) becomes 
elongated, and the spread of the toes (ETS) gets shorter. 
X days post injury
EPL 
ETS
Uninjured 
A B
NPL 
NTS
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Toe spread reflex: Each mouse was carefully lifted from the tail and given a score of 
0  or 1 based on how well they were able to spread each of their toes apart. A score of 
0 meant no spreading of the toes at all, and a score of 1 meant a full toe spread. The 
toe of the uninjured side was always used as control and compared when giving a 
score (Siconolfi et al, 2001). 
 
Toe pinch test: As mice were lifted from the tail they were allowed to grip onto the 
cage with their forelimbs and the 3rd, 4th and 5th digits of the hindlimbs were 
pinched. The retraction of the paw from the stimulus was recorded as a positive 
response. This is a modification of the method first described by Collier et al., 1961. 
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2.3.4 Electron microscopy 
 
Sciatic nerves processed for EM were from WT, OE/+ and OE/OE samples that had 
been dissected at different ages from P1-P60, and also samples that came from sciatic 
nerve crush experiments.  
The nerves were fixed for 15 minutes inside the dissected mouse leg in fixative 
solution made up of 2% PFA, 2.5% glutaraldehyde diluted in 0.1M cacodylate buffer. 
The nerves were then transferred into 5ml bijous to be fixed in fixative solution for a 
further 24 hours at 4°C. The nerves were washed in 0.1M cacodylate buffer three 
times for 15 minutes each. They were then osmicated by adding 1% osmium tetroxide 
(1:1 ratio of osmium tetroxide in dH2O and 0.2M cacodylate buffer) for 1.5 hours at 
4°C. The nerves were rinsed twice for 15 minutes each using distilled water. To 
remove water from the samples, they were washed in progressively higher percentage 
alcohol solutions. 25% for 5 minutes, 50% for 5 minutes, 70% for 5 minutes, 90% for 
10 minutes, 100% for 10 minutes repeated four times and finally propylene oxide for 
10 minutes repeated three times. The nerves were then incubated in a 25:75 mixture 
of resin:propylene oxide for 1 hour at room temperature (RT). They were then 
changed into a 50:50 mixture of resin:propylene oxide for 1 hour at RT. The final 
change was into a 75:25 mixture of resin:propylene for 1 hour at RT. Nerves were 
blocked in resin and left shaking O/N at RT. These nerves were re-blocked the 
following day with fresh resin for 2 hours at RT. A change into fresh resin was carried 
out before the nerves were finally embedded in fresh resin and left in the oven for 24 
hours at 37°C. 
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2.3.5 Cryosectioning 
 
Dissected samples used for cryosectioning had been embedded in OCT compound 
and frozen in the gas phase of liquid nitrogen and stored at -80°C. The blocks 
obtained were mounted onto a chuck using OCT compound.  
5μm or 10μm thick serial tissue sections (depending on the experiment) were cut 
using a Bright M100487 cryostat (Bright, UK) and collected on Superfrost Plus 
microscope slides before being stored at -80°C ready for Immunofluorescence. 8-10 
sections per slide were collected serially onto Superfrost Plus slides.  
 
2.3.6 Immunofluorescence 
 
For teased nerve fibre preparations, Superfrost Plus slides were post fixed using 100% 
acetone for 10 minutes at RT. Slides were washed for 10 minutes with 1XTBS three 
times. Teased fibres were blocked with 5%BSA/0.2%Triton-X-100/1XTBS for 30 
minutes before adding c-Jun antibody diluted in 1%BSA/0.2% Triton-X-100/1XTBS 
for 24 hours at RT in a humidified chamber (see table 2.2.2.1). c-Jun antibody was 
drained off and slides were then washed for 10 minutes with 1XTBS three times 
before adding the corresponding secondary antibody diluted in 1%BSA/0.2%Triton-
X-100/1XTBS at RT for 1 hour (see table 2.2.2.2). Slides were washed for 10 minutes 
with 1XTBS three times before adding L1 antibody diluted in 1%BSA/0.2%Triton-X-
100/1XTBS at RT for 1 hour. Slides were washed again for 10 minutes with 1XTBS 
three times. L1 antibody was drained off and slides were then washed for a further 10 
minutes with 1XTBS three times before adding the corresponding secondary antibody 
and DAPI diluted 1%BSA/0.2%Triton-X-100/1XTBS at RT for 1 hour (see table 
2.2.2.2). Slides were washed for a final 10 minutes with 1XTBS three times before 
mounting with Citifluor and viewing the slides. Slides were sealed with clear nail 
polish.  
 
Superfrost slides with tissue sections were left to thaw for 5-10 minutes at RT.  These 
cryosections were then fixed for 4 minutes in 4% PFA at RT followed by washing 
three times for 5 minutes each with 1XPBS. Sections were incubated in a sequence of 
50% Acetone/H2O, 100% Acetone and 50% Acetone/H2O for 2 minutes each, then 
washed three times in 1XPBS, once every 5 minutes. They were blocked for 1 hour at 
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RT in 1XPBS solution containing 5% GS in a humidified chamber. The blocking 
agent was removed, and primary antibodies (see table 2.2.2.1) were diluted in 
1XPBS/0.1% BSA and left incubating overnight at 4°C. Sections were washed three 
times in 1XPBS. Appropriate secondary antibodies and DAPI (see table 2.2.2.2) were 
diluted in 1XPBS/0.1% BSA and incubated for 1 hour at RT in the dark. The 
secondary antibody was removed and sections were washed three times with 1XPBS 
for 5 minutes each. Slides were mounted using Citifluor and sealed with nail polish. 
To determine if any signal was due to non-specific antibody binding from secondary 
antibodies, primary antibodies were omitted from one sample in each experiment. 
 
For some antibodies (c-Jun, Sox10 and F480) a different protocol was used.  
Superfrost slides with tissue sections were left for 5-10 minutes to thaw at RT.  Nerve 
sections were fixed with 4% PFA for 10 minutes at RT, followed by three 5 minutes 
washes with 1XPBS. Sections were blocked for 1 hour at RT using 
10%HS/0.2%Triton-X-100/1XPBS. Primary antibodies (see table 2.2.2.1) were 
diluted in blocking solution and left incubating overnight at 4°C. The antibodies were 
drained off and then sections were washed three times using 1xPBS. Appropriate 
secondary antibodies and DAPI (see table 2.2.2.2) were diluted in blocking solution 
and left for 1 hour at RT, before washing sections three times with 1xPBS every 5 
minutes. Fluoromount G was used to mount slides and sealed with clear nail polish. 
Specifically for Krox20 and Ki67 immunofluorescence, the same protocol as above 
was used.  However, the secondary antibody used was anti rabbit biotin which was 
left for 2 hours at RT followed after washing by a third layer (see table 2.2.2.2), 
streptavidin cy3, which was also left for 2 hours at RT. DAPI in these cases was 
added at the same time as the third layer.  
 
For Superfrost Plus slides with longitudinal sections for immunolabelling with CGRP, 
Galanin and NF200, a separate protocol was used. The tissue sections on these slides 
were allowed to thaw for 5-10 minutes at RT before being fixed for 5 minutes at RT 
with 4%PFA/PB. The slides were then washed for 2 minutes in 0.1M PB. Slides were 
then incubated for 2 minutes each in the following solutions: 50% Acetone/H2O, 
100% Acetone and 50% Acetone/H2O. Following this, slides were washed twice for 2 
minutes each in 0.1M PB and then for a further 2 minutes in 0.1M PB/0.1%BSA. 
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Slides were blocked for 30 minutes with 5%GS/0.1M PB at RT in a humidified 
chamber. Primary antibodies (a combination of either anti CGRP/ anti NF200 or anti 
Galanin/ anti NF200 see table 2.2.2.1) were diluted in 0.1M PB/0.1%BSA and left at 
4°C for 24 hours. Slides were washed in 0.1M PB/ 0.1%BSA for 2 minutes. They 
were washed again twice in 0.1M PB for 2 minutes each time. The slides were then 
washed for a further 2 minutes with 0.1M PB/0.1%BSA. Appropriate secondary 
antibodies and DAPI (see table 2.2.2.2) were diluted in mouse serum (1:50) in 0.1M 
PB  at RT. The following washing steps were four times in 0.1M PB for 2 minutes 
each and then a final 2 minutes in 0.1M PB before mounting slides using CitiFluor 
and sealing them with clear nail polish. 
 
Macrophage cultures and Schwann cell cultures were immunolabeled by fixing the 
coverslips with 4% PFA for 10 minutes at RT. They were then washed 6x 1 minute 
washes with 1x PBS and blocked using 10% HS/ADS/0.2%Triton-X-100 for 1 hour at 
RT. Appropriate primary antibodies (see table 2.2.2.1) were diluted in the blocking 
solution and left overnight at 4ºC. The coverslips were again washed for 6x 1 minute 
with 1x PBS and then incubated with secondary antibodies and DAPI (see table 
2.2.2.2), diluted in blocking solution for 1 hour at RT in the dark. The coverslips were 
again washed for 6x 1 minute with 1x PBS and mounted using Citifluor and sealed 
with nail polish. 
 
Coverslips from injured L4 DRGs cultures were immunolabelled with Tuj1 and DAPI 
(to label nuclei) after being fixed in 4%PFA for 15 minutes. They were then washed 
by serially dipping each coverslip into universal tubes containing 1XPBS, three times 
each. Coverslips were blocked for 1 hour at RT in a humidified chamber with 
0.2%Triton-X-100/ADS. Primary antibody Tuj1 (see table 2.2.2.1) was diluted in 
blocking solution and added to coverslips overnight at 4ºC. Coverslips were then 
washed by serially dipping each coverslip into universal tubes containing 1XPBS, 
three times each. Appropriate secondary antibody and DAPI (see table 2.2.2.2) were 
diluted in blocking solution and added to coverslips for 1 hour at RT. Coverslips were 
washed for a final time by serially dipping each coverslip into universal tubes 
containing 1XPBS, three times each. These were then mounted using Citifluor and 
sealed with clear nail polish.  
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2.3.7 Western Blotting 
 
Sciatic nerves from newborn, adult or surgically operated mice along with L4 DRGs 
that were transferred to tubes containing nine 10B lysing matrix beads and 100μl of 
RIPA lysis buffer (see recipe in section 2.2.1). Samples were placed in a Fastprep 
fp120 homogeniser for 45 seconds at speed 6, chilled on ice and then re-homogenised 
for a second time with the same settings. Lysates were then centrifuged at 4°C at 
13,000rpm for 2 minutes before collecting the supernatants and transferring them to 
new eppendorf tubes. These were then centrifuged again at the same settings and this 
time the collected supernatants were stored at -80°C. 10μl from each sample was 
transferred to a new eppendorf tube to use for the BCA protein assay. 
 
A BCA protein assay (Thermo Scientific Pierce BCA Protein Assay) was carried out 
to determine how much sample would need to be added to 5X laemmli buffer and 
load 10μg of protein sample onto 8% or 10% acrylamide gels. The gels were run 
using the mini Protean II gel electrophoresis system at graded voltages starting at 60V 
for 30 minutes, 70V for another 30 minutes, 90V for 30 minutes and 120V for the 
final stage. These gels were then transferred to nitrocellulose membranes using the 
Biorad semi-dry transfer system set to 25V for 45 minutes. Membranes were blocked 
in 5% milk in TBS-T for 1 hour at RT and subsequently incubated overnight at 4°C 
with primary antibodies (see table 2.2.2.3) diluted in 5% milk TBS-T or 5% BSA in 
TBS-T. Primary antibodies were removed and membranes were washed three times 
for 10 minutes each with TBS-T. HRP-conjugated secondary antibodies were added 
for 1 hour at RT in 5% milk  (see table 2.2.2.4). Secondary antibodies were removed 
and membranes were washed three times for 10 minutes each with TBS-T. The 
membranes were subsequently developed with ECL detection reagent using the 
Chemidoc MP system. 
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2.3.8 Tissue culture methods 
 
2.3.8.1 Myelin extraction 
 
(adapted from Nicolo Musner and Norton and Poduslo 1973) 
Two brains from WT mice were homogenised in 1ml of 0.32M homogenizing sucrose 
(diluted in sterile ddH2O) using a glass homogeniser and glass pestle (roughly 7-10 
strokes). 
Using sterile glass pipettes, 1ml of 0.32M tissue suspension was added on top of 1ml 
of 0.85M sucrose solution. This was then centrifuged for 30 minutes at 4°C and spun 
at 34,000rpm (75000g) using a Beckman Optima TLX Rotor TLS 55. 
The interphase (crude myelin membranes) was pipetted into a new clean centrifuge 
tube and filled to the top (roughly 2ml) with sterile water (osmotic shock). This was 
then centrifuged at 13,000rpm for 15 minutes at 4°C. The supernatant was discarded 
and the resulting pellet was re-suspended in sterile water (roughly 2ml). This was then 
centrifuged again at 13,000rpm for 15 minutes at 4°C. The cloudy supernatant fluid 
was discarded and the resulting pellet was re-suspended in 1ml 0.32M homogenizing 
sucrose and carefully added on top of 1ml 0.85M sucrose. This was then centrifuged 
at 34,000rpm for 30 minutes at 4°C, re-suspending the resulting interphase layer in 
sterile water  (roughly 2ml). This was centrifuged at 34,000rpm for 15 minutes at 4°C. 
The resulting pellet of myelin was re-suspended in 50μl of sterile water and stored at -
20°C until required for use. 
To determine how much myelin to use on each coverslip and the dilution needed, a 
BCA protein (myelin) assay was carried out. The stock solution of myelin should be a 
10μg/ml solution. 
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2.3.8.2 Coating coverslips and dishes 
 
PLL: 13mm coverslips were coated at least 1 week prior to being used with PLL at a 
concentration of 1mg/ml. This was done by adding 25ml of PLL to a dish full of 
sterile 13mm coverslips, which were kept on a shaker for 24 hours at RT. The PLL 
was then removed and coverslips were washed with 6 changes of sterile ddH2O over 3 
days on the shaker. The coverslips were then individually dried on coverslip racks in 
the hood overnight. They were stored dessicated, ready for use. 
35mm culture dishes were coated on the same day as the intended use with PLL at a 
concentration of 100µg/ml. This was done by adding 2-3ml of PLL onto each dish 
which was left in the hood for 2 hours. The PLL was then removed and dishes were 
washed 3 times with ddH2O. They were subsequently stored and dessicated at RT 
ready for use. 
 
Laminin: Laminin (1mg/ml) was diluted 1:50 in DMEM to have a working 
concentration of 20µg/ml for coverslips, and diluted 1:100 for coating dishes. 
Laminin was added either as a 50µl drop onto the surface of the 13mm coverslip or 
1ml was added to 35mm dishes to coat the entire surface. This was left on for at least 
1 hour in the hood, before removal just prior to plating cells. 
 
Myelin: Myelin was diluted in ddH2O to generate a 1μg/ml stock solution and added 
as a 50µl drop to coat the surface of a PLL coated 13mm coverslip. This was left 
overnight in the hood to dry, ready to be used the next day for the experiment. 
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2.3.8.3 Mouse Schwann cell culture from pups 
 
Sciatic nerves from mouse pups (P8-P10) were dissected and placed in L15 medium 
on ice. The nerves were desheathed by removing epineurium and connective tissue 
using forceps. These desheathed nerves were digested in a 1:1 mixture of trypsin 
(0.25%) and collagenase (10μg/ml). Subsequently, they were incubated for 2 hours at 
37°C/5%CO2. They were then triturated ten times with a blue eppendorf tip and a 
further ten times with a yellow eppendorf tip. The reaction was stopped using DMEM 
and 5% HS. After centrifugation at 1000rpm for 10  minutes, the cell pellet was re-
suspended in defined medium (DM) (Meier et al., 1999), containing 10-6M insulin and 
5%HS and plated in 25μl drops onto coverslips coated with PLL/laminin (10μg/ml). 
Cells were incubated at 37°C/5%CO2 and allowed to adhere for 24 hours. After 24 
hours, the medium was topped up with DM/0.5% HS (controls), or  DM with NRG1 
(10ng/ml) alone, or DM with NRG1 (10ng/ml) and dbcAMP (10-3M) for 48 hours. 
 
2.3.8.4 Adult mouse Schwann cell culture 
 
Sciatic nerves were dissected from at least two adult mice, de-sheathed and placed 
into a 35mm tissue culture dish containing L15 on ice. They were then cut into 2mm 
segments and transferred to a separate dish containing enzyme cocktail (see section 
2.2.1) at least 1 hour in the incubator at 37°C/5%CO2. The cells were triturated with a 
blue eppendorf tip ten times followed by twenty times with a yellow tip after 1 hour. 
The segments were re-incubated for a further 1 hour at 37°C/5%CO2 until fully 
digested. The reaction was stopped with DMEM/5%HS and the cells plated in 
DM/HI/ 0.5% HS (see DM recipe in section 2.2.1) on coverslips in 25μl drops. The 
cells were left in the incubator for 48 hours at 37°C/5%CO2, being topped up 24 hours 
after plating.  
 
2.3.8.5 Macrophage culture 
 
Making sure the culled animal was well secured, the abdominal skin was pulled 
upwards and a small incision was made with scissors over the abdominal area, whilst 
trying not to pierce the abdominal wall itself. 5ml of sterile 1XPBS using a 23G 
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needle was injected into the incision, whilst at the same time massaging the abdomen 
of the mouse to ensure that the injected PBS is being moved around within the cavity. 
A sterile Pasteur pipette was inserted into the abdominal cavity and the liquid inside 
slowly withdrawn, being careful only to take liquid and nothing else.  This was 
collected in a sterile 5ml Falcon tube and the cells were spun for 10 minutes at 
1000rpm. The cells were then re-suspended in warm RPMI medium with 10%FBS 
and cultured for at least 24 hours on coverslips in 25μl drops at 37°C/5%CO2. 
 
2.3.8.6 Conditioning lesion L4 DRG culture 
 
In the following section, “L4 injured DRG” refer to L4 DRGs dissected from the right 
side of the mouse where the sciatic nerve had been transected.  
L4 DRG cultures were made from the injured right L4 DRGs and plated both on 
PLL/laminin or PLL/myelin coated coverslips to analyse the conditioned growth 
response from these DRG neurons. WT and cKO mice were allowed to recover for 
2.5D following sciatic nerve transection. Mice had undergone a sciatic nerve 
transection at the level of the sciatic notch and allowed to recover for 2.5 days 
following this injury. 
24 hours prior to culling the mouse, extracted brain myelin (see section 2.3.8.1) at a 
concentration of 1μg/ml was plated onto 13mm PLL coated coverslips and left to dry 
overnight in the tissue culture hood. 
Only the L4 injured DRGs from these mice were dissected by excising the whole 
spine from the mouse to break away the vertebrae in order to expose the spinal cord 
and DRGs. The injured L4 DRGs were located and excised, carefully removing as 
much of the connective tissue and nerve roots as possible. The cleaned injured L4 
DRGs were placed into a clean 35mm dish containing L15 on ice before replacing the 
L15 with 300μl trypsin and 300μl collagenase per one L4 DRG. The injured L4 
DRGs were left in the incubator at 37°C/5%CO2 for 2 hours and in the meantime two 
sets of fire polished glass pipettes were being made by fire polishing for 2 seconds 
and 5 seconds. Laminin (10μg/ml) 1:50 in DMEM was plated on 13mm coverslips 
and left in the hood for 2 hours. One Percoll gradient per L4 DRG was made by 
mixing 4ml of L15 and 1ml of Percoll in a 15ml Falcon tube. L4 DRGs were 
mechanically triturated 4 times using the 2 second fire polished glass pipette and then 
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four times with the 5 second fire polished glass pipette. The reaction was stopped by 
adding 100μl warm HS to each of the 35mm dish. 700μl of this L4 DRG mixture was 
gently pipetted on top of the Percoll gradient. Centrifugation was carried out at 
1400rpm for 8 minutes using brake setting 1. The supernatants were very carefully 
and slowly removed and discarded leaving behind 500μl of solution in the falcon 
tube. 2ml of L15 was added to this 500μl solution and the tube was gently tapped to 
re-suspend the cells. Following this, they were centrifuged at 2300rpm for 2 minutes 
using brake setting 9. The supernatant was carefully and slowly removed leaving 
behind a small volume (~10μl), which was re-suspended in 100μl DRG medium 
(DM/0.5%HS/50mM glucose). Cells were counted in a haemocytometer and ~40 
cells/μl were plated onto the PLL/laminin or PLL/myelin coated coverslips in 25μl 
drops left at 37°C/5%CO2 overnight, topping up with 500μl DRG medium the 
following day. These were left for 20 hours if on PLL/laminin and 48 hours if on 
PLL/myelin before fixation was carried out ready for immunolabelling. 
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2.3.9 Microscopy and quantification 
 
Stained tissue sections and coverslips using immunofluorescence were all examined 
using a Nikon Labophot 2 fluorescence microscope. 
All statistical analysis is represented relative to a WT control, in most cases being the 
contralateral uninjured nerves, unless specified otherwise. 
 
2.3.9.1 Sciatic nerve analysis and quantification 
 
5µm thick uninjured sciatic nerve sections from WT, OE/+ and OE/OE mice at 
different developmental stages were quantified using images taken at x25 
magnification with a Nikon Labophot 2 fluorescence microscope. The number of 
DAPI, Sox10, Krox20 and Ki67 positive cells were quantified using Cell Counter 
plugin in ImageJ software. The experiment was repeated at least 3 times and at least 3 
independent sections were counted. The average of the results from each experiment 
was used to calculate the standard error of the mean (with results being plotted on a 
bar chart).  
 
5μm thick transverse uninjured and proximal stump nerve tissue sections from both 
WT and cKO mice were quantified using a Nikon Labophot 2 fluorescence 
microscope at x63 magnification. Different areas along a distance of 6mm of the 
proximal stump (cut nerve) and the contralateral uninjured nerve were analysed 1 
hour, 6 hours and 48 hours after nerve transection. The percentage of c-Jun positive 
nuclei was counted as a percentage of the total nuclei present. The experiment was 
repeated 3 times. The average of the results from each experiment was used to 
calculate the standard error of the mean (with results being plotted on a bar chart).  
 
The transverse sections at 48 hours after nerve transection were also used to 
determine the expression of macrophage population using antibodies to the general 
macrophage marker F4/80. For these analyses, images were taken at a magnification 
of x25 magnification and then the Cell Counter plugin within ImageJ was used to 
quantify the percentage of F4/80 positive macrophages. The experiment was repeated 
3 times. The average of the results from each experiment was used to calculate the 
standard error of the mean (with results being plotted on a bar chart).  
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Teased nerve fibres were quantified using antibodies to c-Jun and L1 (Remak 
Schwann cell marker) as described in Hantke et al., 2014, as well as identification by 
phase contrast microscopy of c-Jun positive Myelin fibres.  The number of c-Jun and 
L1 positive fibres were counted at x63 magnification using a Nikon Labophot 2 
fluorescence microscope. The experiment was repeated 3 times. The average 
percentages of c-Jun positive Remak and Myelin Schwann cells were used to 
calculate the standard error of the mean, with results being plotted on a bar chart.  
 
2.3.9.2 DRG analysis 
 
Images were taken at x25 magnification using a Nikon Labophot 2 fluorescence 
microscope with its digital camera (model: DXM1200, Nikon) and ACT-1 acquisition 
software (Nikon). The number of c-Jun, ATF-3, p-STAT3 Tyr705, p-STAT3 Ser727 
and GAP-43 positive immunofluorescent neurons across independent sections at least 
100μm apart were counted representing the entire L4 DRG. Immunolabeling with 
NF200 antibody was used to identify and quantify the total number of neurons in each 
section. The number of c-Jun, ATF-3, p-STAT3 ser727, p-STAT3 tyr705 and GAP-
43 positive neurons 48 hours after sciatic nerve cut, were then expressed as a 
percentage of the total number of neurons on each section using the Cell Counter 
plugin in ImageJ software. Strongly expressing neurons were identified as those that 
were immunofluorescently labelled more intensely than the signal present in the 
contralateral uninjured L4 DRG sections. The experiment was repeated three times. 
The average of the results from each experiment was used to calculate the standard 
error of the mean (with results being plotted on a bar chart).  
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2.3.9.3 Conditioning lesion in vivo analysis 
 
Slides were marked along nerve sections at 2mm and 3mm from the crush site using 
permanent marker pens. These marked distances were found under the microscope 
(Nikon Labophot 2 fluorescence microscope) at x25 magnification, and the number of 
positively immunofluorescently labelled CGRP and galanin axon fibres were counted. 
Positive regenerating axons were those that crossed the “X” visible under the 
microscope lens. At least four individual sections per slide per genotype were counted 
and normalised to each other by nerve width. The width of the nerve was determined 
by using the size of the field of view under the microscope (shown in Figure 2.5).  
The experiment was repeated at least three times. The average of the results from each 
experiment was used to calculate the standard error of the mean (with results being 
plotted on a bar chart).  
 
 
 
  
Figure 2.5 | Summary diagram for analysis of conditioning lesion in vivo
Schematic representation of how regenerating axons were quantified. (A) Distances of 2mm and 3mm from the crush 
site (marked with *) were marked along the nerve sections (black arrows). (B) Under the microscope at a magnification 
of x25 regenerating axons (blue) were quantified. Firstly, the width of the nerve (red double headed arrow) was noted 
in relation to the grid present in the lens of microscope (red dotted box) and given a width of 1. All nerve sections were 
normalised this way. Regenerating axons were only counted as positive if the entirety of the axon crossed the “X” 
which again is visible down the microscope lens and moves as the field of view is moved. An imaginary line (green) 
down the middle of the nerve was made to define the area of nerve where regenerating axons were counted from. 
Regenerating
axon
2 mm
1
2mm 3mmA B
Nerve
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2.3.9.4 Schwann cell, macrophage and fibroblast culture analysis 
 
Coverslips with Schwann cells, macrophages and fibroblasts from both WT and c-Jun 
cKO nerves were analysed and quantified using a Nikon Labophot 2 fluorescence 
microscope. Images were taken at x25 magnification from 15 individual fields across 
coverslips using a digital camera (model: DXM1200, Nikon) and ACT-1 acquisition 
software (Nikon). The number of Schwann cells, macrophages and fibroblasts 
expressing c-Jun were expressed as a percentage of total cells using the Cell Counter 
plugin in ImageJ software. A summary of how the quantification was done is shown 
below in Figure 2.6. 
The experiment was repeated at least three times. The average of the results from each 
experiment was used to calculate the standard error of the mean, with results being 
plotted on a bar chart.  
 
 
 
  
Figure 2.6 | Summary diagram for Schwann cell, fibroblast and macrophage culture analysis
Schwann cell, fibroblast and macrophage cultures were analysed in the same way. (A) Slides with cultured coverslips 
were divided up equally as shown by the blue dotted in lines. This was to make sure that the same area of the coverslip 
was not imaged and therefore quantified multiple times. (B) A magnified image of the red dotted rectangle which 
shows the field of view down the microscope lens. 
Schwann cell
Fibroblast
Macrophage
A B
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2.3.9.5 Conditioning lesion DRG cultures 
 
The coverslips fluorescently labelled using Tuj1 and DAPI were analysed in several 
different ways. Images of the entire population of neurons on these coverslips were 
taken at x25 magnification using a digital camera (model: DXM1200, Nikon) and 
ACT-1 acquisition software (Nikon). The number of neurons on each coverslip on 
both PLL/laminin and PLL/myelin from WT and cKO mice were counted using DAPI 
to identify the nucleus and Tuj1 for the neuronal processes. The neurons counted were 
divided into subgroups:- 
1. Does the neuron have neurites and if so how many? A neurite for the purpose 
of this analysis was defined as any process longer than half the diameter of the 
cell body of that particular neuron. If there are neurites, how many are there? 
2. Does the particular neuron being analysed have any supporting glial cells 
associated with it? Association with the neuron in terms of this analysis was 
defined as any cell within the distance of the diameter of the neuronal cell 
body 
3. The length of the longest neurite was measured (in μm) using the tracing 
program in NeuronJ. 
The experiment was repeated twice and the average of the results from each 
experiment was used to calculate the standard error of the mean, with results being 
plotted on a bar chart using Prism 6. The analysis carried out in shown in Figure 2.7. 
 
  
Figure 2.7 | Summary diagram for conditioned lesion L4 DRG culture analysis
Schematic representation of the step-by-step process of analysing conditioned lesion DRG cultures. Each panel A-C 
represents a magnified area on a coverslip on which cultured neurons are plated. They represent both PLL/laminin and 
PLL/myelin coverslips. (A) Diagram to show how neurons are identified by using DAPI which is blue, and the black 
arrowheads represent the processes from the neuron which would be counted as processes as their lengths are longer 
than half the diameter of the cell body of that neuron. (B) Diagram to show how supporting glial cells are counted as 
being associated with the neuron on or not based on their proximity to the cell body or process, as depicted by the red 
arrowheads. (C) Diagram to show how the NeuronJ software was used to trace the length of the longest neurite as 
depicted by the yellow line along the neurite. 
1. Does the neuron have 
neurites? If so, how many?
2. Does the neuron have 
supporting glial cells?
3. Length of longest 
neurite- trace
A B C
	   80	  
2.3.9.6  Western blot analysis and quantification 
 
All Western blot membranes were analysed using Bio-rad software Imagelab which 
converts the signal visible on a membrane into pixels. These values were then 
normalised to those of the reference genes, which in the case of Chapters 3 and 4 was 
firstly Calnexin and then GAPDH. These values were then expressed as a fold change 
relative to WT levels in arbitrary units (au). These experiments were repeated at least 
three times unless stated otherwise. The average of the results from each experiment 
was used to calculate the standard error of the mean, with results being plotted on a 
bar chart. A One-way ANOVA was performed using Prism 6. A p value of <0.0001, 
unless stated otherwise was considered to be statistically significant.  
 
For Western blot analysis in Chapters 5 and 6, GAPDH was the only reference gene 
used for normalisation. For cases where phosphorylation levels were analysed, the 
total protein present of the phosphorylated protein of interest, was used for 
normalisation. These values were then expressed as a fold change relative to WT 
levels in arbitrary units (au). These experiments were repeated at least three times 
unless stated otherwise. The average of the results from each experiment was used to 
calculate the standard error of the mean (with results being plotted on a bar chart).  
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3. The effect of Schwann cell c-Jun overexpression throughout 
postnatal development into adulthood 
3.1 Introduction 
 
Normal function of peripheral nerves is strongly determined by the correct 
development of all peripheral nerve components which include axons, Schwann cells 
and connective tissue sheaths, along with the integrity of the communication network 
between all these components (Kaplan et al., 2009).  Most of the studies carried out in 
this field have used animal models. Understanding the concomitant development of 
peripheral nerves (Schwann cells, axons, connective tissue) is important for further 
study of peripheral nerve injury and repair (Kaplan et al., 2009; Jessen and Mirsky 
2016). The transcription factor c-Jun is involved in nerve development and has a 
particularly important role in controlling the response of Schwann cells following 
nerve injury to promote nerve repair (Parkinson et al., 2008; Arthur-Farraj et al., 
2012; Fontana et al., 2012; Jessen et al., 2015; Jessen and Mirsky, 2016).  
 
Although there is some evidence to suggest the importance and significance of 
interfering with levels of Schwann cell c-Jun expression (Parkinson et al., 2008), it 
was of interest to find out the possible effects of c-Jun overexpression in Schwann 
cells from early development into adulthood.  
 
The transcription factor c-Jun, part of the AP-1 complex, regulates key cellular 
processes including proliferation and apoptosis in response to JNK and RAS/MAPK 
signalling (Chakraborty et al., 2015). c-Jun is an immediate early gene that is 
important in negative regulation of myelination (Parkinson et al., 2008), Schwann cell 
proliferation (Mirsky et al., 2008) and promotion of successful peripheral nerve 
regeneration, through the formation of repair Bungner Schwann cells following nerve 
injury (Arthur-Farraj et al., 2012; Jessen et al., 2015).  
Elevated levels of c-Jun are also seen in a number of neuropathic conditions both in 
humans (Hutton et al., 2011) and animal studies (Hantke at al., 2014; Klein et al., 
2014), where no cut or crush injuries are involved.  
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To address the importance of c-Jun elevation in Schwann cells, Schwann cell c-Jun 
overexpressing mice (OE/+ and OE/OE) were used (please see Chapter 2, section 
2.2.3 for further details). These mice overexpress c-Jun in Schwann cells specifically 
in a gene-dose dependent manner. These mice have therefore been useful both in 
characterising the development of mouse nerves in vivo, and also in assessing the 
effect of increased c-Jun expression in Schwann cells on peripheral nerve injury and 
remyelination. 
 
The objective of this chapter is to increase understanding of the significance of c-Jun 
expression, in Schwann cells. The results presented below address the effects of 
elevated levels of Schwann cell c-Jun on several aspects of nerve development 
including: (i) radial sorting, (ii) myelination, (iii) cell proliferation and (iv) nerve 
architecture.  
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3.2 Results 
 
In the following sections, “development” refers to postnatal stages (P) 1-21.  
3.2.1 c-Jun is overexpressed specifically in Schwann cells only 
 
c-Jun is up-regulated during nerve development (Parkinson et al., 2008), and is vital 
for successful nerve repair following injury (Arthur-Farraj et al., 2012; Jessen et al., 
2015). The evidence to suggest that c-Jun is an important negative regulator of 
myelination was shown in vitro (Parkinson et al., 2008), however a mouse model that 
has c-Jun conditionally ablated from Schwann cells did not show any obvious effect 
on myelination (Arthur-Farraj et al., 2012).  
To address the significance of c-Jun elevation in Schwann cells in vivo, new c-Jun 
overexpressing mice, (both OE/+ and OE/OE) were used.  This mouse provides a 
novel tool for elevating Schwann cell c-Jun in vivo, in a gene-dose dependent manner, 
which will prove useful in studies of nerve development and nerve injury and repair. 
As the P0Cre transgene is activated from E13.5-E14.5 in the mouse (Feltri et al., 
2002), the c-Jun overexpressing mice were useful for characterising the early 
influences postnatally of c-Jun elevation in Schwann cells.  
This chapter aims to characterise the OE/+ and OE/OE mice at different stages 
through postnatal development (P1-P21) to adulthood at P60.  
 
To confirm that c-Jun was overexpressed in Schwann cells, Western blot analysis and 
immunofluorescent labelling of WT, OE/+ and OE/OE nerves were performed at P1 
and P7. From the result shown in Figure 3.1, it is clear from Western blot analysis, 
both at P1 and P7, that there is a significant 3 fold elevation from P1 WT to OE/+ in 
c-Jun protein expression (Figure 3.1A and 3.1B), and that this is further increased at 
P7 where it reaches 5 fold elevation compared to WT levels (Figure 3.1C and 3.1D). 
This  elevation in c-Jun expression in sciatic nerves of P7 mice is higher in the OE/OE 
mouse (7 fold) compared to WT levels. This confirms the expectation and suggests 
very strongly that the c-Jun overexpressing mouse is a suitable subject of inquiry into 
the effects of c-Jun overexpression. The results showing the differences in Schwann 
cell c-Jun elevation in OE/+ and OE/OE mice compared to WT, correlates with the 
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presence of an extra copy of the c-JunOE transgene in OE/OE mice compared to the 
single copy in OE/+ mice. To confirm that this elevated c-Jun expression seen in 
OE/+ and OE/OE nerves (Figure 3.1A-D) was in Schwann cells, two different types 
of peripheral nerves were used: (i) brachial nerves and (ii) sciatic nerves. The brachial 
nerves were dissected from WT and OE/+ mice at P7 and immunofluorescently 
labelled with Sox10 used as a Schwann cell marker (Kuhlbrodt et al., 1998; Finzsch et 
al., 2010), and c-Jun, while DAPI was used as nuclear marker. (Figure 3.1E). From 
these results, it was clear that c-Jun overexpression seen in the overexpressing mice 
(OE/+ and OE/OE) by Western blot in Figure 3.1A-D, was specific to Schwann cells. 
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Figure 3.1 | c-Jun is significantly overexpressed specifically in peripheral nerve Schwann cells in OE/+ and OE/
OE compared to WT 
(A) Representative Western blot image of nerve extracts from P1 WT and OE/+ nerves to show the levels of c-Jun 
expression. GAPDH and calnexin are used as reference genes. (B) Graph to quantify c-Jun levels of OE/+ nerves at P1 
relative to WT. c-Jun was normalised to calnexin and GAPDH, and then expressed as a fold change relative to WT. WT 
(n=3) and OE/+ (n=3); Mann-Whitney test, p=0.0286. (C) Representative Western blot image of nerve extracts from 
P7 WT, OE/+ and OE/OE nerves to show the levels of c-Jun expression. GAPDH and calnexin are used as reference 
genes. (D) Graph to quantify c-Jun levels of OE/+ and OE/OE nerves at P7 relative to WT. c-Jun was normalised to 
calnexin and GAPDH, and then expressed as a fold change relative to WT. WT (n=3), OE/+ (n=3) and OE/OE (n=3); 
One-way ANOVA with Tukey comparison,  p<0.0001.  All  statistical  analysis  is  represented relative to WT unless 
shown otherwise. (E) Representative immunofluorescence images from brachial nerves of WT and OE/+ mice at P7 to 
show that c-Jun overexpression is specifically in Schwann cells.  These 5μm thick cryosections were fluorescently 
immunolabelled with Sox10 (Schwann cell marker) and c-Jun antibodies and with DAPI to label nuclei.  Scale bar 
represents 50μm.
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From Figure 3.1 there is strong evidence to show that in c-Jun overexpressing mice, 
the expression of Schwann cell c-Jun is higher compared to WT levels. To 
demonstrate that the c-Jun overexpressing transgene is working, a series of in vitro 
experiments were carried out using WT and OE/+ mice (Figure 3.2).  
WT and OE/+ Schwann cell cultures were cultured in DM/0.5% HS (control), 
DM/0.5%HS/dbcAMP (10-3M) or a combination of DM/0.5%HS/NRG1 (10ng/ml)/ 
dbcAMP (10-3M), for 48 hours before being fixed and immunolabelled with Sox10 
and c-Jun antibodies and with DAPI to label nuclei.  
 
When Schwann cells are plated and exposed to basal conditions in vitro, they 
constitutively express c-Jun (De Felipe and Hunt, 1994; Stewart, 1995; Shy et al., 
1996; Parkinson et al., 2004; Parkinson et al., 2008). For this reason, no obvious 
difference was seen in c-Jun expression between WT and OE/+ Schwann cell cultures 
under control conditions. 
cAMP elevation down-regulates expression of genes, such as c-Jun, that are normally 
suppressed during myelination. dbcAMP (a cell permeable cAMP analogue) was used 
to activate the cAMP pathway in vitro (Jessen et al., 1987; Mokuno et al., 1988; 
Morgan et al., 1991; Parkinson et al., 2004; Parkinson et al., 2008; Arthur-Farraj et 
al., 2011). When WT and OE/+ Schwann cell cultures were treated with 
DM/0.5%HS/dbcAMP (10-3M), there was an obvious down-regulation of c-Jun seen 
in WT cultures, however in OE/+ cultures c-Jun levels remained elevated and were 
similar to those seen in the control. This is strongly indicative of the fact that in the 
WT culture, endogenous levels of c-Jun are down-regulated in the presence of 
dbcAMP, however in OE/+ cultures, due to the presence of the transgenic c-Jun 
overexpression, c-Jun remains elevated (Figure 3.2). 
 
NRG1 is a critical axon-derived survival and mitogenic signal that Schwann cells are 
reliant on (Jessen and Mirsky, 2005). NRG1 axon-associated signalling also drives 
Schwann cell division prior to myelination at least in vivo (Jessen and Mirsky, 2005).  
In vitro, NRG1 alone, applied exogenously to mouse Schwann cell cultures does not 
induce myelin protein expression, although NRG1 promotes myelination in vivo 
(Jessen and Mirsky, 2008; Arthur-Farraj et al., 2011).  
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Activation of the cAMP pathway alone (in vitro) can mimic axonal signals that 
normally suppress myelination inhibitory signals in vivo, (such as c-Jun), however in 
the mouse, in order to suppress myelination inhibitory signals and elevate the 
expression of myelin related genes,  NRG1 and cAMP pathways need to be activated 
together.  
When WT and OE/+ cultures were exposed to DM/0.5%HS/NRG1 (10ng/ml)/ 
dbcAMP (10-3M) (Figure 3.2), the increased elevation of c-Jun in overexpressing 
Schwann cells (OE/+) suggested that in the presence of axonal signals that would 
normally supress c-Jun during myelination in vivo, did not do so in the OE/+ mice 
(Parkinson et al., 2008; Jessen and Mirsky, 2008; Arthur-Farraj et al., 2011). This is 
expected due to the fact that the c-Jun overexpressing transgene has different genetic 
control elements than the endogenous gene (see Chapter 2, section 2.2.3).  
 
The obvious down-regulation of c-Jun protein expression seen in WT cells treated 
with a combination of NRG1 and dbcAMP, in comparison to the lack of down-
regulation seen in OE/+ cells when both WT and OE/+ cultures were compared to the 
control, indicate that transgenic c-Jun is still overexpressed in OE/+ cells (Figure 3.2). 
In summary, the results shown in Figures 3.1 and 3.2 provide proof in vivo and in 
vitro that the c-Jun overexpressing transgene is active in both OE/+ and OE/OE mice, 
and that c-Jun levels are elevated in a gene-dose dependent manner.  
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Figure 3.2 | Endogenous Schwann cell c-Jun expression in vitro is down-regulated by dbcAMP and NRG1 yet 
transgenic c-Jun overexpression is maintained
(A) Immunofluorescence images taken at x25 magnification showing Schwann cell cultures from P8-P10 old WT and 
OE/+  nerves.  Scale  bar  represents  50μm. These  cultures  were  treated  with  DM/0.5%HS (control),  DM/0.5%HS/
dbcAMP (10-3M) and DM/0.5%HS/ dbcAMP (10-3M) NRG1 (10ng/ml) and cultured for 48 hours in vitro. dbcAMP 
was added in order to mimic the activation of the cAMP pathway that occurs in vivo. The combination of dbcAMP and 
NRG1 was added in order to mimic axonal signals that normally activate myelination signals in vivo, but also suppress 
c-Jun. The cultures were then fixed ready for fluorescent immunolabelling with Sox10 (Schwann cell marker) and c-
Jun  antibodies,  to  determine  the  amount  of  transgenic  c-Jun  that  was  overexpressed  in  Schwann  cells  in  OE/+ 
compared to WT cultures. 
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The normal development of peripheral nerves is heavily reliant on the correct 
functioning of Schwann cells and their integrity for bidirectional cross-talk with axons 
(Lobsiger et al., 2002; Kaplan et al., 2009). 
The regulation of c-Jun levels and the times at which its expression is present or 
absent during nerve development is key. Results so far have shown that the c-Jun 
overexpressing mouse elevates c-Jun in a gene-dose dependent manner in Schwann 
cells. Schwann cells have a major role in peripheral nerve development. Therefore, to 
further assess these effects, many different parameters of WT OE/+ and OE/OE mice 
were analysed from electron microscope images. Each developmental time point (P1, 
P7 and P21), was analysed in turn (shown in Figures 3.3-3.5) to determine the effects 
of  elevated c-Jun in Schwann cells.  
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3.2.2 Overexpression of c-Jun in Schwann cells does not have an obvious effect 
on nerve development at P1 
 
Figure 3.3A shows representative electron microscopy images from P1 WT, OE/+ and 
OE/OE at a low magnification of x3000 to show the overall nerve cytoarchitecture 
and at higher magnification of x10000 to focus on finer details of the nerve.  
 
At P1, the total number of axons >1.5μm in diameter (regardless of whether they were 
non-myelinated or myelinated) was quantified in WT, OE/+ and OE/OE nerves. There 
was a tendency towards fewer axons being present in the nerve in OE/OE mice 
compared to both WT and OE/+ (Figure 3.3B). This decrease in the number of axons 
in OE/OE (666) mice compared to WT (894) was however not statistically significant.  
The number of myelinated axons present in WT (454), OE/+ (364) and OE/OE (229) 
nerves was not significantly different (Figure 3.3C), although suggestive of the fact 
that elevated levels of c-Jun in Schwann cells may affect the timing of the onset of 
myelination.  
As previously mentioned, once Schwann cell families are formed, a process termed 
radial sorting occurs, where individual large diameter axons are isolated and become 
ensheathed and associated with one Schwann cell in a 1:1 relationship (Webster et al., 
1973; Jessen and Mirsky, 2005; Monk et al., 2015; Feltri et al., 2016). Schwann cell 
families are highlighted by red outlines in Figure 3.3A.  
When the percentages of radially sorted axons (inclusive of myelinated and non-
myelinated axons >1.5μm in diameter) were quantified in WT, OE/+ and OE/OE 
mice at P1, there was a lower percentage of axons being radially sorted in OE/OE 
(56%) compared to WT (73%) and OE/+ (68%), although this was not statistically 
significant (Figure 3.3D). These results could indicate that c-Jun elevation in 
Schwann cells is affecting radial sorting, but that this effect may only become 
statistically significant later on in development, as radial sorting begins perinatally 
and continues to P10 (Feltri et al., 2016). This becomes clearer in results discussed 
later.  
The total number of non-myelinated axons >1.5μm in diameter (whether in a 1:1 
relationship with a Schwann cell or part of a Remak bundle or Schwann cell family), 
was not statistically different in all three genotypes WT (440), OE/+ (509) and OE/OE 
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(437) at P1 (Figure 3.3E). Myelin competent axons are defined as those that are non-
myelinated and >1.5μm in diameter in a 1:1 relationship with a Schwann cell and 
therefore radially sorted. These are the axons that can later become myelinated. In 
OE/OE (142) nerves there seemed to be fewer axons that are non-myelinated and 
>1.5μm in diameter in a 1:1 relationship with a Schwann cell, compared to WT (222) 
and OE/+ (229), but again this difference did not reach statistical significance (Figure 
3.3F). The number of non-myelinated axons >1.5μm in diameter in Remak bundles or 
Schwann cell families is also slightly higher in OE/OE (295) compared to OE/+ (280) 
and more obviously so when compared to WT (218), yet these differences do not 
reach statistical significance (Figure 3.3G). This slight difference in the number of 
non-myelinated axons (Figure 3.3E-G) may suggest a possible delay in myelination, 
which correlates with the number of myelinated axons quantified in WT, OE/+ and 
OE/OE nerves (Figure 3.3C).  
Following on from the results already shown, the percentages of non-myelinated and 
myelinated axons were not  statistically different between with WT, OE/+ and OE/OE 
nerves on day 1 (P1) (Figure 3.3H), indicating that this early postnatally, c-Jun 
elevation in Schwann cells does not significantly affect the ability of axons to be 
myelinated.  
 
c-Jun elevation in P1 c-Jun overexpressing nerves is already substantially elevated 
compared to WT (Figure 3.1B). There is already evidence in the literature implicating 
the role of c-Jun in Schwann cell proliferation (Parkinson et al., 2008; Arthur-Farraj et 
al., 2011; Blom et al., 2014).  Keeping in mind the results already shown above 
(Figure 3.1B) and the literature, it is surprising that the number of Schwann cell nuclei 
quantified per nerve profile in WT (263), OE/+ (284) and OE/OE (309) nerves was 
only marginally different and did not reach statistical significance (Figure 3.3I). This 
may indicate, however, that there are other drivers of cell proliferation that may be 
more important.  
At P1 there was no statistically significant difference in nerve area between WT, 
OE/+ and OE/OE (Figure 3.3J). 
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Figure 3.3 | Developmental characterisation of WT, OE/+ and OE/OE nerves at P1
(A) Representative electron microscopy images taken at x3000 and x10000 magnification to show more detail of the 
ultrastructure of WT, OE/+ and OE/OE nerves at P1. The red outlines highlight examples of Schwann cell families. Scale 
bar represents 5μm (x3000) and 2μm (x10000). Graphs shown in panels B-J are all quantified from WT (n=5), OE/+ 
(n=4) and OE/OE (n=5) mice at P1. (B) Graph to quantify the total number of axons >1.5μm per nerve profile. (C) Graph 
to quantify the number of myelinated axons per nerve profile. (D) Graph to quantify the percentage of axons >1.5μm that 
are segregated per nerve profile. (E) Graph to quantify the number of non-myelinated axons >1.5μm per nerve profile. (F) 
Graph to quantify the number of non-myelinated axons >1.5μm that are in a 1:1 relationship per nerve profile. (G) Graph 
to quantify the number of non-myelinated axons >1.5μm that are in Schwann cell families or Remak bundles per nerve 
profile. (H) Graph to quantify the percentage of 1:1 >1.5μm myelinated compared to non-myelinated axons per nerve 
profile. (I) Graph to quantify the number of Schwann cell nuclei per nerve profile. (J) Graph to show the nerve area. One-
way ANOVA with Tukey comparison. All statistical analysis in all graphs is represented relative to WT unless shown 
otherwise. 
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In summary, the electron microscopy analysis presented in Figure 3.3 shows that 
although c-Jun is elevated substantially in OE/+ and OE/OE Schwann cells at P1 
compared to WT, this is not enough to cause significant effects on Schwann cell 
biology, nor nerve development. Keeping in mind the arguments put forward at P1 of 
the likely expected outcomes of c-Jun elevation on various aspects of peripheral nerve 
development including: (i) Schwann cell proliferation, (ii) radial sorting and (iii) 
myelination, the next postnatal development stage P7, was analysed in the same way 
as P1.  
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3.2.3 c-Jun overexpression in Schwann cells causes a transient delay in radial 
sorting, yet a severe inhibition in myelination at P7 
 
Figure 3.4A shows representative electron microscopy images both at low 
magnification of x3000 to show the gross ultrastructure of P7 WT, OE/+ and OE/OE 
nerves, as well as at higher magnification of x10000 that allows focus on finer details 
on the nerve cytoarchitecture. The nerve cytoarchitecture as depicted by electron 
microscope images show more obvious differences at P7, unlike what was seen at P1 
(Figure 3.3A). Specifically, differences that were obvious between WT, OE/+ and 
OE/OE nerves at P7 were: (i) the reduced presence of myelinated axons in both OE/+ 
and OE/OE nerves, (ii) the presence of larger Remak bundles or Schwann cell 
families specifically in OE/OE nerves, (iii) the reduced myelin thickness in OE/+ and 
OE/OE and (iv) the visible increase in collagen, specifically in OE/OE nerves 
compared to both WT and OE/+. These differences are explained in more detail below 
(Figure 3.4).  
 
The total number of axons >1.5μm in diameter regardless of whether they were non-
myelinated or myelinated quantified at P7, showed a statistically significant decline 
from WT (3573) to OE/+ (2940) to OE/OE (2325), respectively as seen in Figure 
3.4B.  
The higher the c-Jun elevation in Schwann cells, the lower the number of myelinated 
axons there are in the nerve, from WT myelinated axons at 3385, compared to 2247 in 
OE/+ and 1054 in OE/OE nerves shown in Figure 3.4C. These differences were 
statistically significant when compared to WT levels, but also when compared 
between OE/+ and OE/OE. 
Radial sorting is a process that takes place over a relatively long period of time 
throughout perinatal and postnatal development, with completion expected around 
P10 (Feltri et al., 2016). To this effect, by P7, radial sorting should almost be 
complete, which is what is observed in WT and OE/+ nerves where the percentage of 
radially sorted axons is 97% and 92% respectively. However, in OE/OE nerves, this 
percentage is statistically significantly lower at 79% (Figure 3.4D). This is the first 
indication of the detrimental effects of c-Jun elevation on radial sorting.  
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The number of non-myelinated axons >1.5μm in diameter (those that were in a 1:1 
relationship with a Schwann cell, or part of a Remak bundle or Schwann cell family), 
were all statistically significantly elevated in OE/OE nerves compared to WT (Figure 
3.4E-G). Yet, in OE/+ nerves, these differences were not of statistical significance 
compared to WT, except for the number of non-myelinated axons >1.5μm in diameter 
that were in a 1:1 relationship with a Schwann cell (Figure 3.4F), where these, were 
also higher in OE/+ (483) compared to WT (113). 
Therefore as would be expected, the percentage of axons that are >1.5μm in diameter 
whether myelinated or non-myelinated, were also statistically significantly different, 
between WT, OE/+ and OE/OE nerves at P7 (Figure 3.4H). The higher the elevation 
of Schwann cell c-Jun (OE/+ and OE/OE), the higher the percentage of non-
myelinated axons present, or inversely, the lower the percentage of myelinated axons 
present (Figure 3.4H).  
 
The number of Schwann cell nuclei quantified in OE/OE (808) was significantly 
elevated compared to WT (413). The number of Schwann cell nuclei in OE/+ nerves 
was also statistically significantly elevated compared to WT nerves, 589 and 413 
respectively, as shown in Figure 3.4I.  
 
A 5 fold elevation of c-Jun in Schwann cells (OE/+) is enough to delay myelination, 
and higher levels of 7 fold c-Jun elevation in Schwann cells (OE/OE), has a 
significantly more detrimental effect on the ability of Schwann cells to myelinate 
(Figure 3.4C-G). Elevated levels of Schwann cell c-Jun also have a clear impact on 
the thickness of myelin sheaths present around those axons that have been myelinated. 
Levels of c-Jun expression above the norm, cause myelin sheaths around axons to be 
considerably thinner. Myelin sheaths present in OE/+ and OE/OE nerves are 
statistically thinner compared to WT as shown in Figure 3.4J.  
 
The nerve area of WT (44907μm2), OE/+ (48221μm2) and OE/OE (51994μm2), was 
not significantly different, although there is a trend towards OE/OE nerves being 
bigger (Figure 3.4K). 
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Figure 3.4 | Developmental characterisation of WT, OE/+ and OE/OE nerves at P7
(A) Representative electron microscopy images taken at x3000 and x10000 magnification to show more detail of the 
ultrastructure of WT, OE/+ and OE/OE nerves at P7. Scale bar represents 5μm (x3000) and 2μm (x10000). Graphs 
shown in panels B-K are all quantified from WT (n=5), OE/+ (n=5) and OE/OE (n=5) mice at P7. (B) Graph to quantify 
the total number of axons >1.5μm per nerve profile. (C) Graph to quantify the number of myelinated axons per nerve 
profile. (D) Graph to quantify the percentage of axons >1.5μm that are segregated per nerve profile. (E) Graph to quantify 
the number of non-myelinated axons >1.5μm per nerve profile. (F) Graph to quantify the number of non-myelinated 
axons >1.5μm that are in a 1:1 relationship per nerve profile. (G) Graph to quantify the number of non-myelinated axons 
>1.5μm that are in Schwann cell families or Remak bundles per nerve profile. (H) Graph to quantify the percentage of 
1:1  >1.5μm myelinated  compared  to  non-myelinated  axons  per  nerve  profile.  (I)  Graph to  quantify  the  number  of 
Schwann cell nuclei per nerve profile. (J) Graph to show the g-ratio. (K) Graph to show the nerve area. One-way ANOVA 
with Tukey comparison,  p<0.0001.  All  statistical  analysis  in  all  graphs is  represented relative to WT unless  shown 
otherwise. 
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In summary, the results presented in Figure 3.4, highlight the potentially detrimental 
effects that very high levels of c-Jun in Schwann cells may have on Schwann cell 
function and nerve development.   
 
These findings corroborate previous findings from Parkinson et al., 2008 that show 
the negative effect of elevated Schwann cell c-Jun on myelination in vitro. However, 
the results presented here provide evidence for this effect in vivo as well.  
Specifically, radial sorting and myelination are inhibited in OE/OE nerves, which can 
still be seen later in development. However in OE/+ nerves, this is only a transient 
delay, as will be discussed later.  
 
To determine whether these differences seen in c-Jun overexpressing mice compared 
to WT are maintained or diminished, a later developmental time point of P21 in WT, 
OE/+ and OE/OE nerves, was characterised in the same way as P1 and P7. 
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3.2.4 Radial sorting and myelination are still delayed in OE/OE nerves, yet seem 
comparable between WT and OE/+ nerves at P21 
 
At closer examination of electron microscopy images taken from P21 WT, OE/+ and 
OE/OE nerves, both at low magnification of x3000 and at higher magnification of 
x10000 (Figure 3.5A), the differences visible in P7 nerves (Figure 3.4A), were no 
longer apparent between WT and OE/+ nerves. However, the OE/OE nerve 
ultrastructure was still very different to the WT nerve (Figure 3.5A). Although at a 
glance, WT and OE/+ nerve cytoarchitecture seem similar (Figure 3.5A), OE/OE 
nerves have very significant changes in their nerve architecture, such as: (i) the 
obvious increase in collagen, (ii) the reduced thickness in myelin sheaths, (iii) the 
presence of many non-myelinated large diameter axons (both radially sorted and part 
of Remak bundles), and (iv) the irregular structure of the Remak bundles. By P21, no 
Schwann cell families were visible in WT, OE/+ or OE/OE nerves as expected 
(Webster et al., 1973), however in OE/OE nerves, there was the presence of slightly 
irregular Remak bundles compared to both WT and OE/+ nerves, as highlighted in 
Figure 3.5A with red outlines. These changes seen in OE/OE nerves at P21 (Figure 
3.5) appear to be an exaggerated change in the phenotype which had started to appear 
at P7 (Figure 3.4).  
 
WT and OE/+ nerves at P21 were more similar to each other compared to that seen at 
P7 (Figure 3.4). The total number of axons >1.5μm in diameter, both non-myelinated 
and myelinated, quantified in WT and OE/+ were not significantly different, 4180 and 
4229 respectively, however there was a notable decrease in OE/OE (3338) compared 
to WT (4229) (Figure 3.5B).  
The number of myelinated axons in WT and OE/+ nerves at P21 is very similar, at 
4110 and 3990 respectively. This is a strong indication that lower fold elevation of 
Schwann cell c-Jun (OE/+) does not have as great a negative effect on myelination 
when compared to a higher Schwann cell c-Jun elevation, such as the one seen in 
OE/OE (1912) nerves, where there is a significant decline compared to both WT and 
OE/+ nerves (Figure 3.5C). This is a strong indication that the very high levels of c-
Jun present in OE/OE Schwann cells strongly inhibit myelination in vivo, which was 
previously suggested by the work of Parkinson et al., 2008. 
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Radial sorting in normal nerves should be complete by P10, therefore the percentage 
of radially sorted axons at P21 should be 100%. From the analysis shown in Figure 
3.5D, WT and OE/+ nerves were almost entirely radially sorted at 99% and 98% 
respectively, unlike OE/OE nerves where only 84% of larger axons were radially 
sorted. This difference between OE/OE and WT and OE/+ nerves was statistically 
significant.  
In line with this, the number of non-myelinated axons >1.5μm in diameter were 69 in 
WT, 239 in OE/+ and 1425 in OE/OE nerves. There was no statistical difference 
between WT and OE/+, however in OE/OE nerves, the number of non-myelinated 
axons >1.5μm in diameter was significantly higher than WT and OE/+ (Figure 3.5E). 
The number of  non-myelinated axons >1.5μm that were in a 1:1 relationship with a 
Schwann cell (Figure 3.5F) or in Remak bundles (Figure 3.5G), was not significantly 
different between WT and OE/+. In OE/OE nerves the number of non-myelinated 
axons >1.5μm in diameter (including those that form a 1:1 relationship with a 
Schwann cell or part of a Remak bundle), is significantly higher compared to WT and 
OE/+ (Figure 3.5E-G), further confirming the severe inhibitory myelination 
phenotype seen with very high Schwann cell c-Jun levels.  
The percentage of large calibre axons that were myelinated (WT 98% and OE/+ 94%) 
or unmyelinated (WT 2% and OE/+ 6%) were similar in WT and OE/+ nerves. There 
was a significant decrease in the percentage of myelinated axons in OE/OE (57%) 
nerves and conversely a significant increase in the percentage of non-myelinated 
axons in OE/OE (43%), compared to WT and OE/+ nerves (Figure 3.5H).  
 
The number of Schwann cell nuclei counted in OE/+ compared to WT, though still 
slightly elevated in OE/+ (409) compared to WT (311), was not significantly different 
(Figure 3.5I), yet at P7 (Figure 3.4I) these differences were notably elevated in OE/+ 
(589) compared to WT (413). It seems that by P21, Schwann cell proliferation seen in 
OE/+ nerves has ceased. The number of Schwann cell nuclei quantified in P21 OE/OE 
(745) nerves was statistically higher compared to WT and OE/+ nerves (Figure 3.5I).  
 
The reduced myelin sheath thickness between OE/+ and OE/OE nerves compared to 
WT remained significantly different (Figure 3.5J).  
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The nerve areas of WT (91368μm2), OE/+ (99166μm2) and OE/OE (112536μm2), 
were not significantly different to each other, although there is still a trend towards 
OE/OE nerves being bigger (Figure 3.5K). 
 
The comparison of all these parameters between WT and OE/+ nerves indicates that 
Schwann cells can withstand moderate levels of c-Jun elevation without significant 
detrimental effects, yet, a very high elevation in Schwann cell c-Jun can be 
detrimental, as is seen when comparing WT and OE/OE nerves (Figure 3.5).  
OE/OE nerve development is severely impaired due to the substantially high levels of 
Schwann cell c-Jun. All the significant changes between WT and OE/OE nerves noted 
at P7 (Figure 3.4) were more pronounced at P21 (Figure 3.5), contrary to what was 
seen in OE/+ nerves.  
By P21, the initial transient delay in myelination seen in OE/+ nerves compared to 
WT at P7, was no longer evident, yet in these same nerves, the thickness of myelin 
sheaths remained significantly thinner in OE/+ compared to WT. Although the data 
presented would suggest that in OE/OE nerves radial sorting is affected (Figure 3.5D), 
the presence of  Remak bundles in these nerves, albeit slightly abnormal in form 
suggests that they eventually form. Myelination inhibition observed in OE/OE nerves 
at P7 (Figure 3.4) was still present at P21, but also more prominent compared to WT 
and OE/+ nerves (Figure 3.5). Myelin sheath thickness of the myelinated axons 
present in OE/OE nerves, was also significantly thinner than in WT nerves.  
The importance of myelin sheath thickness may prove to be important in sensory and 
motor reflexes. Myelin sheath formation is crucial for saltatory conduction, therefore 
one could assume that if such conduction velocity studies were carried out, they may 
provide more of an insight into how detrimental thinner myelin sheaths seen in OE/+ 
and OE/OE nerves may be (Figures 3.4J and 3.5J). Notwithstanding such future work, 
behavioural studies give an indication of how nerve conduction/transmission has been 
affected in the OE/+. 
There is strong indication from the results presented so far, that Schwann cells are 
tolerant of moderately high levels of c-Jun, such as those present in OE/+ nerves, and 
to a certain extent the higher levels expressed in OE/OE nerves. This conclusion is 
based on the lack of significant differences in OE/+ nerves compared to WT, except 
for those seen in g-ratios. There is also strong evidence to show that myelination and 
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radial sorting were only temporarily delayed in OE/+ nerves, but severely inhibited in 
OE/OE nerves. Therefore, this implies that there is a gene-dose dependent effect of 
Schwann cell c-Jun expression on both the function of Schwann cells and nerve 
development. Most importantly however is the obvious confirmation of previous in 
vitro studies, now done in vivo using a novel transgene expression dependent mouse 
model.  
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Figure 3.5 | Characterisation of WT, OE/+ and OE/OE nerves at P21
(A) Representative electron microscopy images taken at x3000 and x10000 magnification to show more detail of the 
ultrastructure of WT, OE/+ and OE/OE nerves at P21. The red outlines show the presence of normal Remak bundles in 
WT and OE/+ nerves, yet slightly irregular arrangements of Remak bundles in OE/OE nerves. Scale bar represents 5μm 
(x3000) and 2μm (x10000). Graphs shown in panels B-K are all quantified from WT (n=5), OE/+ (n=4) and OE/OE 
(n=4) mice at P21. (B) Graph to quantify the total number of axons >1.5μm per nerve profile. (C) Graph to quantify the 
number of myelinated axons per nerve profile. (D) Graph to quantify the percentage of axons >1.5μm that are segregated 
per nerve profile. (E) Graph to quantify the number of non-myelinated axons >1.5μm per nerve profile. (F) Graph to 
quantify the number of non-myelinated axons >1.5μm that are in a 1:1 relationship per nerve profile.  (G) Graph to 
quantify the number of non-myelinated axons >1.5μm that are in Schwann cell families or Remak bundles per nerve 
profile. (H) Graph to quantify the percentage of 1:1 >1.5μm myelinated compared to non-myelinated axons per nerve 
profile. (I) Graph to quantify the number of Schwann cell nuclei per nerve profile. (J) Graph to show the g-ratio. (K) 
Graph to show the nerve area. One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis in all graphs 
is represented relative to WT unless shown otherwise. 
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So far, as has been shown in this chapter, there is strong evidence that Schwann cells 
can withstand moderately high levels of c-Jun elevation, such as those seen in OE/+ 
mice, yet levels that exceed those seen in OE/+ such as those in OE/OE, can prove to 
be detrimental to the proper functioning of the Schwann cell, and therefore ultimately 
the nerve itself. Based on this, it is now clear that at least from P1-P21, c-Jun levels in 
OE/+ and OE/OE Schwann cells remain elevated. c-Jun in Schwann cells has a multi-
faceted role, with the key one being its function in successful nerve regeneration, as 
shown by the work of Arthur-Farraj et al., 2012.  
For this reason, it would be crucial to find out if c-Jun levels in OE/+ remain elevated 
into adulthood (P60) and whether the nerves of these mice still resemble those of WT 
ones. It is as important to assess whether or not very high c-Jun elevation in Schwann 
cells seen in in OE/OE mice, affect nerve development or if these nerves end up 
resembling those of WT mice. The characterisation of adult P60 OE/+ and OE/OE 
compared to WT mice is fundamental as it could prove to be a useful tool in vivo for 
studying elevated c-Jun levels in peripheral nerve injury and regeneration.  
 
 
  
	   104	  
3.2.5 Elevated levels of c-Jun in Schwann cells down-regulate myelin related 
genes 
 
As previously shown using in vitro studies by the work of Parkinson et al., 2008,  c-
Jun is a negative regulator of myelination. It was therefore decided to investigate 
whether  c-Jun overexpression in Schwann cells (OE/+ and OE/OE) results in down-
regulation of myelin genes. A crucial myelination transcription factor, that unlike c-
Jun, is a positive regulator of myelination, is Krox20 (Topilko et al., 1994; Murphy et 
al., 1996; Zorick et al., 1999; Ghislain et al., 2002; Jessen and Mirsky, 2005; 
Parkinson et al., 2008; Woodhoo et al., 2009). With this in mind, sciatic nerve 
cryosections from WT, OE/+ and OE/OE nerves at P7 were immunofluorescently 
labelled using Sox10 (Schwann cell marker) and Krox20 (marker of myelination) 
antibodies and with DAPI to label nuclei, to determine whether high levels of c-Jun 
expression in OE/+ and OE/OE nerves caused a down-regulation in Krox20 
expression compared with WT nerves (Figure 3.6). Clear and significant down-
regulation of Krox20 expression in Schwann cells is seen in OE/+ (43%) and OE/OE 
(24%) compared to WT (60%) levels as well as a significant decrease between OE/+ 
and OE/OE nerves. The quantification for the representative immunofluorescence 
images (Figure 3.6A) is shown in Figure 3.6B. To show how Krox20/Sox10 positive 
Schwann cells were quantified, a magnified image is shown in Figure 3.6C, with 
white arrowheads to highlight positive Krox20/Sox10 cells.  
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Figure 3.6 | Elevated levels of c-Jun in Schwann cells at P7 results in significant down-regulation of Krox20 in 
Schwann cells
(A)  Representative  immunofluorescence  images  taken  at  x25  magnification  show the  different  levels  of  Krox20 
expression in WT, OE/+ and OE/OE nerves at P7. Transverse sections of P7 sciatic nerves immunolabelled with Sox10 
(Schwann cell  marker)  and Krox20 (marker of  myelination) antibodies and with DAPI to label  nuclei.  Scale bar 
represents 50μm. (B) Graph to quantify the percentage of positively labelled Krox20/Sox10 cells in WT, OE/+ and OE/
OE nerves.  WT (n=6),  OE/+ (n=4)  and OE/OE (n=3);  One-way ANOVA with Tukey comparison,  p=0.0002.  All 
statistical analysis is represented relative to WT unless shown otherwise. (C) Magnified immunofluorescence images of 
P7 nerve to show how Krox20/Sox10 positive cells were quantified. Scale bar represents 25μm. 
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Figure 3.1A-B shows that c-Jun is elevated in overexpressing mouse nerves as early 
as P1. For this reason, nerve extracts from WT, OE/+ and OE/OE sciatic nerves were 
analysed by Western blot both at P1 and P7 for Krox20 expression. Unlike the results 
seen in Figure 3.6, Western blot results of Krox20 expression in OE/+ and OE/OE 
nerves, were not significantly down-regulated at P1, nor at P7 (Figure 3.7).  Although 
the results in Figures 3.6 and 3.7 appear not to agree with each other, they are not 
necessarily contradictory. At P7 the Western blot analysis (Figure 3.7C-D), shows 
that there is a slight decrease in Krox20 expression in OE/OE mice compared to WT, 
even though this does not reach statistical significance. No statistical analysis was 
done on P1 Western blot results as this experiment was only repeated twice. For 
further discussion of this, please see section 3.3. 
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Figure 3.7 | Krox20 levels remain unaffected in OE/+ and OE/OE nerves by elevated c-Jun levels at P1 and P7 
(A) Representative Western blot image of nerve extracts from P1 WT and OE/+ nerves to show the levels of Krox20 
expression. GAPDH and calnexin are used as reference genes. (B) Graph to quantify Krox20 levels of OE/+ nerves at 
P1 relative to WT. c-Jun was normalised to calnexin and GAPDH, and then expressed as a fold change relative to WT. 
WT (n=2) and OE/+ (n=2); no statistical analysis. (C) Representative Western blot image of nerve extracts from P7 
WT, OE/+ and OE/OE nerves to show the levels of Krox20 expression. GAPDH and calnexin are used as reference 
genes. (D) Graph to quantify Krox20 levels of OE/+ and OE/OE nerves at P7 relative to WT. Krox20 was normalised 
to calnexin and GAPDH, and then expressed as a fold change relative to WT. WT (n=3), OE/+ (n=3) and OE/OE 
(n=3); One-way ANOVA with Tukey comparison. All statistical analysis is represented relative to WT unless shown 
otherwise. 
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If c-Jun elevation in Schwann cells causes down-regulation of pro-myelin 
transcription factors such as Krox20, what happens to the expression of myelin 
proteins in these nerves? To address this, a myelin protein that is a major component 
of peripheral nerve myelin sheaths, Mpz, was analysed (Mirsky et al., 1980; Jessen 
and Mirsky, 1991; Jessen et al., 1991; Cheng and Mudge, 1996; Corfas et al., 2004).  
 
Western blot analysis of P1 and P7 nerve extracts from WT, OE/+ and OE/OE mice 
showed that early on after birth (P1), there was no significant decrease in the levels of 
Mpz expression between WT and OE/+ nerves (Figure 3.8A-B). This similarity of 
Mpz expression in WT and OE/+ nerves was maintained at P7, yet levels of Mpz 
expression in OE/OE nerves at this time point were significantly less compared to 
both WT and OE/+ levels (Figure 3.8C-D). These results, unlike at P1, suggest that a 
7 fold c-Jun elevation (OE/OE) in Schwann cells compared to WT may have a 
detrimental effect on myelin protein expression. This result is in line with the 
evidence shown earlier (Figure 3.4C) where OE/OE nerves have fewer myelinated 
axons, therefore the nerve extracts from these mice might be expected to have lower 
overall levels of Mpz expression.  
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Figure 3.8 | Mpz levels remain constant in OE/+ nerves compared to WT at P1 and P7 but are significantly 
downregulated in OE/OE nerves compared to WT at P7
(A) Representative Western blot image of nerve extracts from P1 WT and OE/+ nerves to show the levels of Mpz 
expression. Mpz is used to show how a myelin-related protein is affected by increased levels of transgenic c-Jun. 
GAPDH and calnexin are used as reference genes. (B) Graph to quantify Mpz levels of OE/+ nerves at P1 relative to 
WT. Mpz was normalised to calnexin and GAPDH, and then expressed as a fold change relative to WT. WT (n=3) and 
OE/+ (n=3); Mann Whitney test, p=0.6825. (C) Representative Western blot image of nerve extracts from P7 WT, OE/
+ and OE/OE nerves to show the levels of Mpz expression. GAPDH and calnexin are used as reference genes. (D) 
Graph to quantify Mpz levels of OE/+ and OE/OE nerves at P7 relative to WT. Mpz was normalised to calnexin and 
GAPDH, and then expressed as a fold change relative to WT. WT (n=3), OE/+ (n=3) and OE/OE (n=3); One-way 
ANOVA with  Tukey  comparison,  p<0.0001.  All  statistical  analysis  is  represented  relative  to  WT unless  shown 
otherwise. 
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3.2.6 Overexpression of Schwann cell c-Jun results in increased Schwann cell 
proliferation 
 
c-Jun elevation is associated with increased cell proliferation in many tissues 
(Schreiber et al., 1999; Vleugel et al., 2006; Mirsky et al., 2008; Arthur-Farraj et al., 
2011; Ma et al., 2012). For this reason, it was of interest to see whether c-Jun 
increased cell proliferation in overexpressing mouse nerves (OE/+ and OE/OE),  
Cyclin D1 is an important cell cycle regulatory switch in proliferating cells and is 
therefore used as a marker of cell proliferation (Baldin et al., 1993; Diehl, 2002; 
Stacey, 2003; Klein and Assoian, 2008; Duronio and Xiong, 2013; Porrello et al., 
2014). For this reason, P7 WT, OE/+ and OE/OE nerve extracts were probed with 
Cyclin D1 antibody to see if there was an increase in cell proliferation in OE/+ and 
OE/OE nerves. Surprisingly, there was no significant increase in cell proliferation, 
regardless of c-Jun elevation in Schwann cells as shown in Figure 3.9A-B.  
Although Cyclin D1 expression in WT, OE/+ and OE/OE nerves did not show 
significant differences in cell proliferation, possibly due to the fact that Cyclin D1 
recognises proliferating cells in fewer stages of the cell cycle than some other 
markers, it was still worth investigating cell proliferation using a different 
proliferation marker. Another reason for the lack of proliferation difference seen using 
Cyclin D1 as a marker, may be due to the fact that other pathways might be the major 
drivers of proliferation at this stage in development.  
 
Ki67 is another commonly used nuclear protein that is expressed in proliferating 
mammalian cells and is able to recognise proliferating cells at more stages of the cell 
cycle than Cyclin D1 (Lopez et al., 1991; Scholzen and Gerdes, 2000; Hoos et al., 
2001; Porrello et al., 2014; Sobecki et al., 2016).  To determine whether Schwann cell 
c-Jun elevation causes proliferation within Schwann cells specifically, nerve 
cryosections from P7 WT, OE/+ and OE/OE were fluorescently immunolabelled with 
Sox10 and Ki67, and with DAPI as shown in Figure 3.9C-E. Sox10 was used as a 
marker for recognising Schwann cells, therefore allowing for specific localisation of 
Ki67 and Sox10 positive cells, unlike Western blot analysis where different cell types 
cannot be determined. The percentage of proliferating Schwann cells in OE/OE 
nerves was significantly higher compared to both WT and OE/+ nerves. These results 
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demonstrate that in P7 nerves, when c-Jun is elevated in Schwann cells to the extent 
seen in OE/OE nerves (7 fold), cell proliferation is increased as determined by the 
percentage of Ki67 positive Schwann cells (Figure 3.9C-E).  
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 Figure 3.9 | Elevated levels of c-Jun in Schwann cells at P7 suggest a modest effect on cell proliferation 
(A) Representative Western blot image of nerve extracts from P7 WT, OE/+ and OE/OE nerves to show the levels of 
Cyclin D1 expression. Cyclin D1 is used as a marker of cell proliferation. GAPDH and calnexin are used as reference 
genes.  (B)  Graph to  quantify  Cyclin  D1 levels  of  OE/+ and OE/OE nerves  at  P7 relative  to  WT.  Cyclin  D1 was 
normalised to calnexin and GAPDH, and then expressed as a fold change relative to WT. WT (n=3), OE/+ (n=3) and OE/
OE (n=3);  One-way ANOVA with Tukey comparison.  (C) Representative immunofluorescence images taken at  x25 
magnification show the different proliferation rates in WT, OE/+ and OE/OE nerves at P7. Transverse sections of P7 
sciatic nerves immunolabelled with Sox10 (Schwann cell marker) and Ki67 (marker of proliferating cells) antibodies and 
DAPI to label nuclei. Scale bar represents 50μm. All statistical analysis is represented relative to WT unless shown 
otherwise. (D) Graph to quantify the percentage of positively labelled Ki67/Sox10 cells in WT, OE/+ and OE/OE nerves. 
WT (n=6), OE/+ (n=4) and OE/OE (n=3); One-way ANOVA with Tukey comparison, p=0.0121. All statistical analysis is 
represented relative to WT unless shown otherwise. (E) Magnified immunofluorescence images of P7 nerve to show how 
Ki67/Sox10 positive cells were quantified. Scale bar represents 25μm.
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3.2.7 c-Jun elevation in OE/+ and OE/OE Schwann cells is maintained at P60 
 
c-Jun was clearly shown to be elevated in both OE/+ and OE/OE nerves, specifically 
in Schwann cells (Figure 3.1). Longitudinal nerve cryosections from P60 WT, OE/+ 
and OE/OE nerves were immunolabelled with c-Jun and Sox10 antibodies, and DAPI 
to label nuclei (Figure 3.10A), and nerve protein extracts probed with c-Jun antibodies 
(Figure 3.10B-C), to show that c-Jun was still elevated in both OE/+ and OE/OE 
nerves at P60, and that this elevation was specific to Schwann cells, as indicated in 
earlier results in this chapter. As expected, both immunofluorescence and Western 
blot analysis clearly showed c-Jun elevation specifically in Schwann cells in OE/+ 
and OE/OE nerves relative to WT. Although the immunofluorescence images were 
not quantified, it was obvious that Schwann cells in WT nerves express the lowest 
level of c-Jun, and progressively higher levels are expressed in OE/+ and OE/OE 
nerve Schwann cells, as determined by co-localisation of c-Jun signal with Sox10 
(Schwann cell marker) (Figure 3.10A).  
The representative Western blot image in Figure 3.10B and its quantification in 3.10C 
show an obvious elevation in c-Jun expression in both OE/+ and OE/OE nerves 
compared to WT. This elevation of OE/+ compared to WT is 6 fold, yet the elevation 
in OE/OE nerves compared to WT is 19 fold. This suggests that Schwann cell c-Jun 
levels are maintained in OE/+ and OE/OE nerves compared to WT levels at P60.  
At P60, whilst the comparative elevation in c-Jun in OE/+ and OE/OE nerves 
compared to WT c-Jun expression may seem high compared to P1 and P7, it should 
be remembered that the comparative increases in c-Jun seen have been measured 
against WT c-Jun expression in mice of the same age (ie. P1 OE/+ and OE/OE 
relative to P1 WT, P7 OE/+ and OE/OE relative to P7  WT, etc.). It is known that c-
Jun levels expressed earlier on postnatally (P1 and P7) in WT, are much higher than at 
P60 a time at which endogenous c-Jun levels are very low at P60 (Parkinson et al., 
2008). This finding is also highlighted in Figure 3.10D-E above. For this reason, c-
Jun may be elevated in OE/+ and OE/OE Schwann cells equally throughout the 
different ages of the mouse lifespan, beginning from the point at which transgenic 
P0cre is activated driving Cre recombinase at E13.5-14.5 (Feltri et al., 1999). 
Nevertheless, to confirm this idea, analysis such as by Western blot would need to be 
	   114	  
done using WT, OE/+ and OE/OE nerves from different aged mice and compared 
together at the same time on the same membrane.  
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Figure 3.10 | c-Jun is overexpressed specifically in Schwann cells 
(A) Representative immunofluorescence images taken at x63 magnification show the different levels of c-Jun expression 
in Schwann cells at P60 in uninjured nerves. Longitudinal sections of P60 sciatic nerves were immunolabelled with Sox10 
(Schwann  cell  marker)  and  c-Jun  antibodies  and  with  DAPI  to  label  nuclei.  These  images  show  that  the  c-Jun 
overexpressing transgene is working and maintained at P60. Scale bar represents 25μm. (B) Representative Western blot 
image of nerve extracts from P60 WT, OE/+ and OE/OE nerves to show the levels of c-Jun expression. c-Jun is used to 
show that  the  c-Jun overexpressing transgene is  working and maintained at  P60.  GAPDH and calnexin are  used as 
reference  genes.  (C)  Graph  to  quantify  c-Jun  levels  of  OE/+ and  OE/OE nerves  at  P60  relative  to  WT.  c-Jun  was 
normalised to calnexin and GAPDH, and then expressed as a fold change relative to WT. WT (n=5), OE/+ (n=4) and OE/
OE (n=5); One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis is represented relative to WT 
unless shown otherwise. (D) Representative Western blot image of nerve extracts from P1, P7 and P60 WT nerves to show 
the levels of c-Jun expression. GAPDH and calnexin are used as reference genes. e-Jun expression in WT nerves declines 
from early postnatal stages (P1-P7) to adulthood (P60). (E) Graph to quantify c-Jun levels of OE/OE nerves at P60 and 
P300 and WT at P300, relative to WT P60 levels. c-Jun was normalised to calnexin and GAPDH, and then expressed as a 
fold change relative to WT P1. P1 (n=3), P7 (n=3), P60 (n=1); no statistical analysis.
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3.2.8 The nerve architecture of adult OE/+ nerves is nearly normal compared to 
WT, yet OE/OE nerves continue to show abnormalities at P60 
 
The integrity of peripheral nerves is strongly determined by the proper development 
and function of its components including Schwann cells, axons and connective tissue. 
Nerves of OE/OE mice began to show abnormalities such as increased Schwann cell 
nuclei, impaired radial sorting of axons, increased number of non-myelinated axons 
(both in a 1:1 relationship with a Schwann cell but also in Remak bundles and 
Schwann cell families), axons with thinner myelin sheaths, increased appearance of 
collagen and also a larger nerve area. These changes became evident from electron 
microscopy analysis at P7 (Figure 3.4), and were more prominent by P21 (Figure 3.5). 
In contrast however, in OE/+ nerves, these changes seemed to be mild compared to 
those seen in OE/OE nerves, in relation to WT. However at P7 (Figure 3.4) there was 
a suggestion of delayed radial sorting and myelination, but unlike in OE/OE nerves, 
this became almost normal by P21 (Figure 3.5).  
The question then arises: do OE/+ nerves remain almost normal regardless of their c-
Jun elevation at P60, and do OE/OE nerves adopt a more abnormal phenotype? 
To address these questions, electron microscopy analysis of P60 WT, OE/+ and 
OE/OE nerves was undertaken in the same manner as that shown in Figures 3.3-3.5.  
 
When dissecting OE/OE nerves from the mouse, the most striking feature is the 
obvious increase in nerve size, compared to WT and OE/+ nerves. This difference is 
highlighted by photographs shown in Figure 3.11A, taken inside the mouse, and then 
overlaid on 1mm x 1mm gridded paper. Analysis of WT, OE/+ and OE/OE nerve 
areas at P7 (Figure 3.4K) and P21 (Figure 3.5K) indicated a marginal yet insignificant 
increase in both OE/+ and OE/OE nerve size compared to WT. Furthermore, the 
magnified electron microscopy images at P7 (Figure 3.4A) and P21 (Figure 3.5A) 
indicated that there was more collagen and extracellular matrix in OE/OE nerves 
compared to WT and OE/+ nerves. Representative electron microscopy images shown 
in Figure 3.11B highlight the differences in the ultrastructure of OE/OE nerves 
compared to both WT and OE/+, which look very similar to each other. Already this 
analysis is indicative of the fact that, at P60, c-Jun elevation in Schwann cells of 
OE/OE nerves is having a strong effect on nerve development and ultimately function, 
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but that the elevated levels of c-Jun in OE/+ nerves are not enough to cause a 
detrimental effect.  
The nerve area was therefore measured from WT, OE/+ and OE/OE nerves at P60 
(Figure 3.11C). It showed that WT and OE/+ nerves were almost the same size, 
123604μm2 and 120121μm2, the size of OE/OE nerves was 245090μm2 , significantly 
larger than both WT and OE/+ nerves.  
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Figure 3.11 | Nerve areas of WT and OE/+ mice are similar, but OE/OE is substantially larger at P60 
(A) Representative photographs taken of WT, OE/+ and OE/OE nerves inside the mouse, which were then placed 
along 1x1mm ruled paper to see the differences in nerve thickness. Scale bar represents 1mm. (B) Representative 
electron microscopy images taken at x3000 magnification to show the ultrastructure of WT, OE/+ and OE/OE nerves at 
P60. Scale bar represents 5μm. (C) Graph to show the nerve area of WT (n=5), OE/+ (n=5) and OE/OE (n=3) mice at 
P60. One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis is represented relative to WT unless 
shown otherwise. 
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Higher magnification electron microscopy images shown in Figure 3.12A reveal even 
more the differences between OE/OE nerve architecture compared to WT and OE/+ 
mice. Further in depth analysis of electron microscopy was carried out, as shown in 
Figure 3.12, that highlighted very distinct differences of OE/OE nerves compared to 
WT and OE/+ nerves, yet also showed how similar WT and OE/+ nerves are at P60.  
 
The number of axons >1.5µm in diameter, both myelinated and unmyelinated were 
virtually the same between WT and OE/+ nerves, 4574 and 4572 respectively (Figure 
3.12B). The total number of axons >1.5µm in diameter (both non-myelinated and 
myelinated) that were quantified in OE/OE (3870) nerves were significantly lower 
compared to WT (4574) and OE/+ (4572) (Figure 3.12B). 
In line with this, the number of myelinated axons between WT and OE/+ was not 
significantly different, 4552 and 4533, respectively, yet it was significantly lower in 
OE/OE (1784) nerves compared to both WT and OE/+ (Figure 3.12C). 
The inhibitory effect seen on radial sorting and on myelination of axons present in 
OE/OE nerves was already visible at P7 (Figure 3.4) and P21 (Figure 3.5), but became 
even more obvious and pronounced at P60, where the percentage of axons >1.5μm 
that were radially sorted was significantly lower at 72% in OE/OE nerves compared to 
WT and OE/+ at 99% (Figure 3.12D). 
The results above indicate that at P60 c-Jun elevation seen in OE/OE nerves (19 fold), 
is enough to impair radial sorting and myelination.  
In line with this, the number of non-myelinated axons >1.5µm in diameter (both in a 
1:1 relationship with a Schwann cell and part of a Remak bundle), was significantly 
higher in OE/OE nerves compared to WT and OE/+ (Figure 3.12E-G). These results 
may indicate that an excess of Schwann cell c-Jun elevation (19 fold) such as that seen 
in P60 OE/OE nerves, affects the number of axons that are myelin competent and may 
therefore explain the increased numbers in non-myelinated 1:1 axons (1028 compared 
to 1 in WT and OE/+), Figure 3.12F. However, it is important to note that this is not a 
definitive conclusion because there is no data presented in this thesis showing what 
the levels of c-Jun elevation between P21 and P60 are. In order to conclude the level 
of Schwann cell c-Jun elevation that is detrimental, Western blot analysis of P60 WT 
nerves would need to be directly compared to levels of c-Jun present in OE/OE nerves 
at P1 and P7 and later time points. This has not been addressed in this thesis.  
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c-Jun also affects the ability of axons to be radially sorted, shown by the increase in 
the number of large diameter non-myelinated axons present in Remak bundles (1046 
compared to 22 in WT and 37 in OE/+), Figure 3.12G.  
The percentage of axons >1.5µm in diameter that were either myelinated or non-
myelinated in WT and OE/+ nerves, was the same where 99% of their nerves were 
myelinated, and the remaining 1% were non-myelinated (Figure 3.12H). These results 
are similar to those seen at P21 (Figure 3.5H). 
 
c-Jun elevation in OE/+ Schwann cells is not substantial enough to cause an increase 
in Schwann cell proliferation as the number of Schwann cell nuclei present in WT and 
OE/+ was similar, 205 and 254 respectively, and not significantly different (Figure 
3.12I). However, c-Jun elevation in OE/OE nerves, resulted in a significant increase in 
Schwann cell nuclei to 1308 compared to WT and OE/+ (Figure 3.12I).  
 
Myelin sheath thickness as determined by g-ratio analysis was also, as expected, 
significantly thinner in OE/OE nerves compared to both WT and OE/+ nerves shown 
in Figure 3.12J, and also thinner in OE/+ nerves compared to WT.  
 
Unlike the small effect seen in OE/+ nerves  compared to WT, in OE/OE nerves, the 
effects of elevated Schwann cell c-Jun were unambiguous, resulting in a strong 
phenotype (Figure 3.12). All morphometric analyses carried out on WT and OE/+ 
nerves indicated no difference between these nerves apart from significantly thinner 
myelin sheaths, even though the Schwann cells of OE/+ nerves have significantly 
elevated c-Jun levels compared to WT. However, as earlier results in this chapter 
(Figures 3.4 and 3.5) indicated, levels of Schwann cell c-Jun in OE/OE nerves has 
strong effects on nerve function and development.  
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Figure 3.12 | Characterisation of WT, OE/+ and OE/OE nerves at P60
(A) Representative electron microscopy images taken at x10000 magnification to show more detail of the ultrastructure of 
WT, OE/+ and OE/OE nerves at P60. Scale bar represents 1μm. Graphs shown in panels B-J are all quantified from WT 
(n=5), OE/+ (n=5) and OE/OE (n=3) mice at P60. (B) Graph to quantify the total number of axons >1.5μm per nerve 
profile. (C) Graph to quantify the number of myelinated axons per nerve profile. (D) Graph to quantify the percentage of 
axons >1.5μm that are segregated per nerve profile. (E) Graph to quantify the number of non-myelinated axons >1.5μm 
per nerve profile. (F) Graph to quantify the number of non-myelinated axons >1.5μm that are in a 1:1 relationship per 
nerve profile. (G) Graph to quantify the number of non-myelinated axons >1.5μm that are in Schwann cell families or 
Remak bundles per nerve profile. (H) Graph to quantify the percentage of 1:1 >1.5μm myelinated compared to non-
myelinated axons per nerve profile. (I) Graph to quantify the number of Schwann cell nuclei per nerve profile. (J) Graph to 
show the g-ratio. One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis in all graphs is represented 
relative to WT unless shown otherwise. 
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3.2.9 c-Jun elevation in OE/+ and OE/OE nerves down-regulates the expression 
of Krox20 and Mpz in WT nerves at P60 
 
As previously mentioned, c-Jun in Schwann cells is an important negative regulator of 
myelination, and results so far strongly support this idea. In development an important 
driver of myelination, Krox20, was mildly down-regulated in Schwann cells in the 
presence of elevated levels of c-Jun seen in OE/+ and OE/OE nerves, as confirmed by 
immunofluorescence experiments (Figures 3.6). With this is mind, Krox20 levels 
were also analysed in P60 WT, OE/+ and OE/OE nerves to determine whether or not 
c-Jun elevation in Schwann cells still had a negative effect on this pro-myelin factor.  
Immunofluorescence images in Figure 3.13A from longitudinal nerve sections show 
that although c-Jun is still elevated in OE/+ nerves compared to WT, these levels do 
not seem to be enough to result in a down-regulation of Krox20 expression. Although 
this result is not quantified, it matches Western blot analysis of WT and OE/+ nerves 
shown in Figure 3.13B-C, which also suggest that Krox20 levels are very similar. 
However, in contrast to this, (seen both in Figure 3.13A immunofluorescence images, 
and later confirmed by Western blot analysis in Figure 3.13B-C), Krox20 expression 
in OE/OE nerve Schwann cells is significantly down-regulated. This suggests that in 
mature P60 WT and OE/+ nerves, c-Jun does not seem to have a negative effect on 
Krox20, and therefore myelination. Yet, in OE/OE nerves, the c-Jun elevation present 
in these Schwann cells is 19 fold compared to WT (Figure 3.10B), which is enough to 
down-regulate Krox20 expression. In order to confirm the effects of c-Jun elevation in 
Schwann cells on Krox20 expression, an immunofluorescence experiment would need 
to be carried out where individual myelinated fibres would be immunolabelled with 
myelin basic protein (MBP) and Krox20 in order to decipher how much Krox20 was 
present in myelinated fibres.  
 
An important component of myelin sheaths that insulate axons is Mpz. Levels of Mpz 
in OE/OE nerves were shown to be down-regulated in development compared to WT, 
and in OE/+ nerves where these levels did not seem to be very different (Figure 3.8). 
As expected, Western blot analysis of protein extract from WT, OE/+ and OE/OE 
nerves shown in Figure 3.13D-E, clearly demonstrate that Mpz levels are unaltered 
between WT and OE/+ nerves, regardless of c-Jun elevation being maintained, yet, in 
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OE/OE nerves, there is a significant down-regulation in Mpz expression compared to 
WT. This down-regulation of Mpz in OE/OE nerves compared to WT is expected due 
to the fact that in OE/OE nerves there are fewer myelin sheaths present. This decrease 
is of significance as is shown in Figure 3.13D-E.  
 
On one hand these results indicate that at P60 where c-Jun elevation is still maintained 
to a higher degree in OE/+ nerves compared to WT, these levels are not high enough 
to affect expression of Krox20 nor Mpz. On the other hand, as was suggested in 
development, c-Jun elevation present in P60 OE/OE nerves appear to strongly down-
regulate expression of Krox20 and therefore Mpz, compared to WT levels. This 
indicates that levels of c-Jun in Schwann cells as high as those in OE/OE nerves, may 
continue to impair nerve function.  
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Figure 3.13 | High levels of c-Jun overexpression in Schwann cells cause down-regulation of positive regulators of 
myelination and myelin proteins
(A)  Representative  immunofluorescence  images  taken  at  x63  magnification  show  the  different  levels  of  Krox20 
expression in Schwann cells at P60 in uninjured nerves of WT, OE/+ and OE/OE nerves. Longitudinal sections of P60 
sciatic nerves were immunolabelled with Sox10 (Schwann cell marker) and Krox20 (marker of myelination) antibodies 
and with DAPI to label nuclei. Scale bar represents 25μm. (B) Representative Western blot image of nerve extracts from 
P60 WT, OE/+ and OE/OE nerves to show the levels of Krox20 expression. GAPDH and calnexin are used as reference 
genes. (C) Graph to quantify Krox20 levels of OE/+ and OE/OE nerves at P60 relative to WT. Krox20 was normalised to 
calnexin and GAPDH, and then expressed as a fold change relative to WT. WT (n=5), OE/+ (n=4) and OE/OE (n=5); 
One-way ANOVA with Tukey comparison, p<0.0001. (D) Representative Western blot image of nerve extracts from P60 
WT, OE/+ and OE/OE nerves to show the levels of Mpz expression. Mpz is used to show how a myelin-related protein is 
affected by increased levels of transgenic c-Jun. GAPDH and calnexin are used as reference genes. (E) Graph to quantify 
Mpz levels of OE/+ and OE/OE nerves at P60 relative to WT. Mpz was normalised to calnexin and GAPDH, and then 
expressed as a fold change relative to WT. One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis is 
represented relative to WT unless shown otherwise.
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3.2.10 c-Jun elevation in OE/OE nerves causes more cell proliferation compared 
to WT and OE/+ nerves at P60  
 
In development, there was some evidence to suggest that Schwann cells in OE/OE 
nerves that express very high levels of c-Jun would continue to proliferate. Yet in 
OE/+ nerves, although there seemed to be a slight increase in cell proliferation, this 
never reached significance (Figure 3.9). A similar outcome is seen at P60 in WT, 
OE/+ and OE/OE nerves (Figure 3.14). Western blot analysis of protein extracts from 
WT, OE/+ and OE/OE nerves indicates strong expression of Cyclin D1 compared to 
both WT and OE/+, which is of statistical significance (Figure 3.14A-B). There is a 
3.5 fold increase in Cyclin D1 expression in OE/OE nerves, compared to WT. This 
suggests that cells are still proliferating in OE/OE nerves, but not significantly so in 
OE/+ nerves. 
To determine whether it was specifically Schwann cells that were proliferating in P60 
OE/OE nerves, transverse cryosections of WT, OE/+ and OE/OE nerves were 
fluorescently immunolabelled with another proliferation marker Ki67 and Sox10 to 
identify Schwann cells, with DAPI to label nuclei. Quantification from these 
immunofluorescence images (shown in Figure 3.14C), showed that there was a 
significant elevation in Schwann cells of OE/OE nerves expressing Ki67 at 2.6% 
compared to OE/+ at 1.6% and WT at 0.7% (Figure 3.14D). Although there was a 
slight elevation in OE/+ Schwann cell proliferation, similar to that of the Western blot 
in Figure 3.14, this did not reach significance. Therefore, the results from both 
Western blot and immunofluorescence analysis using two different markers of 
proliferation, lean towards the fact that in OE/OE nerves, cells are continuously 
proliferating, in particular Schwann cells. High levels of Schwann cell c-Jun such as 
those seen in OE/OE nerves, continue to drive cell proliferation.  
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Figure 3.14 | High levels of c-Jun overexpression in Schwann cells causes proliferation of cells in OE/+ and OE/
OE nerves at P60
(A) Representative Western blot image of nerve extracts from P60 WT, OE/+ and OE/OE nerves to show the levels of 
Cyclin D1 expression. Cyclin D1 is used as a marker for cell proliferation and how these levels are affected by increased 
levels of transgenic c-Jun. GAPDH and calnexin are used as reference genes. (B) Graph to quantify Cyclin D1 levels of 
OE/+ and OE/OE nerves at P60 relative to WT. Cyclin D1 was normalised to calnexin and GAPDH, and then expressed 
as  a  fold  change  relative  to  WT.  WT (n=4)  and  OE/+  (n=4)  and  OE/OE  (n=4);  One-way  ANOVA with  Tukey 
comparison, p=0.0071. (C) Representative immunofluorescence images taken at x25 magnification show the different 
levels of Ki67 expression in Schwann cells at P60 in uninjured WT, OE/+ and OE/OE nerves. Transverse sections of P60 
sciatic  nerves  were  immunolabelled  with  Sox10  (Schwann  cell  marker)  and  Ki67  (marker  of  proliferating  cells) 
antibodies and with DAPI to label nuclei. Scale bar represents 50μm. (D) Graph to quantify the percentage of Ki67/
Sox10 positive cells in WT, OE/+ and OE/OE P60 uninjured nerves. WT (n=3), OE/+ (n=3) and OE/OE (n=5); One-way 
ANOVA with Tukey comparison, p=0.0042. All statistical analysis is represented relative to WT unless shown otherwise. 
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3.2.11 c-Jun elevation in OE/OE nerves results in early formation of onion bulbs 
and increased collagen 
 
The extracellular matrix and its components including collagen form a complex 
matrix network in which axons and supportive cells are found. It is critical  in several 
cell functions such as proliferation, migration and differentiation. It also provides 
mechanical and structural support (Gonzalez-Perez et al., 2013).  
Previous results shown in this chapter have strongly indicated that cell proliferation is 
increased in OE/OE nerves (Figure 3.14). There was also a strikingly visible increase 
in OE/OE nerve size upon dissection (Figure 3.11). It was therefore of interest to see 
whether or not any of these noticeable changes had any effect on the extracellular 
matrix. In order to answer this question, electron microscope images from P60 WT, 
OE/+ and OE/OE nerves (Figure 3.15A) were analysed using ImageJ software to 
determine the percentage of extracellular matrix present within each nerve, quantified 
as shown in the green highlighted images in Figure 3.15A. From the quantification 
shown in Figure 3.15B, it is evident that c-Jun elevation in Schwann cells present in 
OE/OE nerves, is enough to cause abnormalities in these nerves, including an increase 
in the amount of extracellular matrix. There is a significantly higher percentage of 
extracellular matrix in OE/OE nerves at 54% compared to WT (13%) and OE/+ 
(20%). This could be a possible explanation for the visible nerve size increase seen in 
OE/OE mice compared to both WT and OE/+ (Figure 3.15).  
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Figure 3.15 | Overexpression of Schwann cell c-Jun substantially increases the amount of extracellular matrix within the 
nerve of OE/OE mice
(A) Representative electron microscopy images taken at x10000 magnification to show more detail of the ultrastructure of WT, 
OE/+ and OE/OE nerves at P60. In particular these images highlight the increase in extracellular matrix with progressively high 
expression of Schwann cell c-Jun. Scale bar represents 1μm. The panels below (A) show the same electron microscopy images to 
highlight (green) how the % extracellular matrix was determined. (B) Graph to quantify the percentage of extracellular matrix 
present in WT, OE/+ and OE/OE uninjured nerves at P60, per nerve profile. WT (n=5), OE/+ (n=5) and OE/OE (n=3); One-way 
ANOVA with Tukey comparison, p<0.0001. All statistical analysis is represented relative to WT unless shown otherwise. 
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Another prominent feature of OE/OE nerves to the eye with x20000 magnified 
electron microscopy images shown in Figure 3.16A, is the presence of the early 
formation of onion bulbs. Onion bulbs are formed by concentric layers of Schwann 
cell cytoplasm around myelinated or non-myelinated axons, usually visible in 
peripheral nerve neuropathies (Sereda et al., 1996; Naba et al., 2000).  
 
Unregulated, increased cell proliferation can result in tumour formation with a 
potentially malignant outcome. c-Jun is a known oncogene associated with increased 
cell proliferation in other tissues (Vleugel et al., 2006). Cell cycle progression is 
controlled by many regulatory signalling networks, one of them being the RAS-RAF-
MEK-ERK pathway (Samatar and Poulikakos, 2014). Results presented so far show 
that cell proliferation, as determined by the two different markers (Cyclin D1 and 
Ki67) of proliferation, is significantly increased in OE/OE nerves that have 
substantially high levels of c-Jun elevation in Schwann cells (Figures 3.9 and 3.14) 
compared to WT nerves. To this effect, P60 WT, OE/+ and OE/OE nerves were 
analysed by Western blot to see if ERK was more highly activated (as determined by 
its phosphorylation), in OE/OE nerves compared to WT and OE/+. The Western blot 
results in Figure 3.16B-C show an obvious and significant 2 fold increase in ERK 
phosphorylation in OE/OE nerves compared to both WT and OE/+. This is a strong 
indication that elevated levels of Schwann cell c-Jun may lead to increased ERK 
activation, caused by an increase in cell proliferation, or through another mechanism.  
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Figure 3.16 | P60 nerves of OE/OE mice show signs of nerve abnormalities reminiscent of peripheral nerve 
neuropathies
(A) Enlarged representative electron microscopy images taken at various magnifications to show more greater detail of 
some of the abnormalities seen in uninjured P60 OE/OE nerves. x5000 (Scale bar represents 2μm), x15000 and x20000 
(Scale bar represents 1μm). Concentric layers of Schwann cell cytoplasm are highlighted by the red arrows. (B) 
Representative Western blot images of P60 WT, OE/+ and OE/OE protein extract to show levels of p-ERK. Western 
blots were probed with p-ERK, ERK, GAPDH and calnexin. GAPDH and calnexin were used as loading controls. 
Blots were normalised to ERK and then expressed as a fold change relative to WT. (D) Graph to show the fold 
elevation of p-ERK relative to WT levels. WT (n=3), OE/+ (n=4) and OE/OE (n=4); One-way ANOVA with Tukey 
comparison,  p<0.0001. All statistical analysis is compared to WT, unless otherwise shown. 
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3.3 Discussion 
 
The results presented in this chapter show that the new c-Jun overexpressing mouse, 
bred to create a model for elevating c-Jun only in Schwann cells in a gene-dose 
dependent manner, has been achieved successfully. Particularly what needs to be 
highlighted is the fact that this c-Jun elevation is seen specifically in Schwann cells 
(Figures 3.1 and 3.10) and the gene-dose dependent manner of its elevation compared 
to WT levels, is maintained from early on postnatally (P1-P7) (Figure 3.1) and 
maintained into adulthood (P60) (Figure 3.10).  
 
Increases in cell proliferation (Schwann cells alike) shown in Figures 3.9C-E and 
3.14C-D indicate that it may be of interest to see if later on into the mouse’s life span, 
Schwann cells present in OE/OE mice still continue to proliferate, or if they cease to 
do so. If cell proliferation from early on in development (P7) is still continuing into 
adulthood (P60) and already causes such evident modifications in nerve architecture 
and function, this could suggest that cell proliferation even later into the lifespan of 
the mouse may result in the formation of possible tumours, as c-Jun is also an 
oncogene (Vleugel et al., 2006; Gomez-Sanchez et al., 2013).  
 
In summary, morphometric analysis of electron microscopy images  at P1, P7, P21 
and P60 (Figures 3.3-3.5 and 3.11-3.12), showed that in OE/+ mice, myelination was 
transiently delayed at P7 specifically, even though it seemed almost normal at P1 and 
P21. By P60, WT and OE/+ nerves were almost indistinguishable, apart from the 
difference in myelin sheath thickness (Figure 3.12J). In contrast to this, in OE/OE 
mice, myelination was severely impaired from P7 onwards, even into adulthood, 
where the abnormal nerve phenotype was more exaggerated (Figures 3.4-3.5 and 
3.11-3.12). As expected, this is a strong in vivo proof of the previous in vitro work 
showing the importance of c-Jun in Schwann cells as a negative regulator of 
myelination (Jessen and Mirsky, 2008; Parkinson et al., 2008; Arthur-Farraj et al., 
2012;).  
 
A question that arises from the work presented in this chapter is whether or not levels 
of c-Jun in OE/OE nerves continue to increase after P60, or if levels begin to decline 
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as the mouse gets older, similar to that seen in WT ageing mice (Painter et al., 2014). 
This experiment could be carried out using P60 WT and OE/OE mice as “young” and 
P300 WT and OE/OE mice as “old” to determine whether or not c-Jun levels also 
decrease in old mice, regardless of the fact they already have elevated levels of 
Schwann cell c-Jun.   
 
The lack of correlation between immunofluorescence and Western blot results 
regarding Krox20 expression, may be due to the fact that in immunofluorescent 
labelling it is possible to determine Schwann cell nuclei specifically and therefore 
Krox20 nuclear expression, whereas in Western blot analysis, both nuclear and 
cytoplasmic expression is detected. These differences between immunofluorescence 
and Western blot analysis may indicate a possible further role that c-Jun has of 
determining nuclear localisation of Krox20, however this is highly speculative and 
has not been addressed in this thesis. An alternative way of determining the extent of 
the effect of c-Jun overexpression in Schwann cells on Krox20 expression, would be 
to carry out immunofluorescence and Western blot analysis at other postnatal time 
points such as P1 and P21 and compare these results with those seen at P7. This 
premise is not addressed in this thesis. 
The lack of down-regulation of Krox20 seen in OE/+ nerves compared to WT (Figure 
3.13) would suggest that c-Jun does not affect myelin protein expression in nerves. 
However, it is important to note, that the conclusions drawn from results in Figure 
3.13 do stand true, due to the fact that although myelin sheaths in OE/+ nerves are 
thinner, the presence of myelin sheaths around axons, means that Krox20 is still able 
to have a pro-myelin effect in OE/+ nerves at P60.  
 
Results in this chapter have shown, most notably in Figures 3.11 and 3.12, that 
regardless of the c-Jun fold elevation seen in Schwann cells of OE/+ mice, these 
nerves seem to develop normally, similarly to WT. This is the first crucial piece of 
evidence that makes this mouse model so useful in studying c-Jun elevation in 
Schwann cells in an uninjured, but also injured situation.  
 
The activation of ERK as determined by its phosphorylation has also been strongly 
implicated in models of both inherited and infectious neuropathies (Tapinos et al., 
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2006; Fischer et al., 2008; Nadra et al., 2008; Napoli et al., 2012), therefore 
suggesting that if at P60 some onion bulbs in early formation are already visible, they 
are likely to become more complex later on and hence a peripheral neuropathy can 
ensue. Upon closer inspection of older P300 OE/OE mouse nerves by electron 
microscopy, there seem to be more onion bulbs visible, yet they do not seem to have 
become more advanced in their formation (unpublished observations  SV Fazal and 
JA Gomez-Sanchez).  
More ERK activation also occurs in Schwann cell tumours that develop in 
Neurofibromatosis (NF1) (Napoli et al., 2012; Gomez-Sanchez et al., 2013). With this 
in mind, OE/OE nerves that showed a clear increase in ERK activation (Figure 3.16B-
C) were further analysed at electron microscopy level for the presence of any 
tumours, as well as at the point of dissection, to see if any tumours were visible as 
lumps on the nerves, DRGs or spinal cord (Gomez-Sanchez et al., 2013). Both at 
electron microscopy and anatomical level, neither such tumours, nor any structures 
reminiscent of tumours were noticed.  
The suggested conclusions drawn above regarding ERK signalling have been focused 
on its elevation in OE/OE nerves particularly and the potential significance of this, 
however it is also important to remember that ERK activation is involved in many 
other aspects of Schwann cell biology, including: (i) its activation in Schwann cells at 
the injury site and throughout the distal stump following nerve injury (Sheu et al., 
2000; Harrisingh et al., 2004; Napoli et al., 2012), (ii) its continuous activation which 
can override the signals that end myelination, where myelin growth is continuous 
(Sheean et al., 2014; Birchmeier and Bennett, 2016) and (iii) its strongly maintained 
expression which can result in demyelination (Napoli et al., 2012). These observations 
highlight the complexity of ERK signalling in various aspects of Schwann cell 
biology, which have not been addressed in this thesis.  
 
In conclusion, the evidence presented so far would highlight the fact that: (i) c-Jun is a 
negative regulator of myelination as determined by its elevation in Schwann cells 
causing a down-regulation of myelin genes, (ii) increased levels of Schwann cell c-
Jun increase cell proliferation, (iii) substantial elevation of c-Jun in Schwann cells 
causes morphogenetic changes to the nerve and its composition, suggesting possible 
neuropathies later on and (iv) Schwann cells are tolerant of large elevations in c-Jun 
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levels as shown in OE/+ nerves, which seem to look very similar to WT nerves, 
therefore providing a potentially useful model for studying the impact of 
overexpression of c-Jun in Schwann cells in nerve injury and regeneration.  
Further observations on P60 WT and OE/+ nerves in injury and regeneration is the 
subject of the next chapter.  
  
 
 
 
  
	   135	  
4. The role of elevated Schwann cell c-Jun following nerve injury 
 
4.1 Introduction 
 
With the astounding influence of Schwann cell c-Jun on successful nerve regeneration 
following injury, it was only natural to enquire further and carry out a series of 
regeneration assays using the new c-Jun overexpressing mouse (OE/+). The following 
chapter determines whether or not increased levels of Schwann cell c-Jun following 
injury induce a faster regenerative programme, and if this elevation of c-Jun in 
Schwann cells seen following injury, is maintained in OE/+ nerves compared to WT.   
The characterisation of adult P60 WT and OE/+ nerves shown in Chapter 3, justified 
the regeneration studies in vivo using a mouse model that elevates c-Jun in a gene-
dose dependent manner specifically in Schwann cells.  
 
Schwann cell c-Jun is an important regulator of the injury response, triggering crucial 
events that need to take place to create the repair Bungner Schwann cells that favour 
successful nerve regeneration (Arthur-Farraj et al., 2012; Jessen et al., 2015; Jessen 
and Mirsky, 2016). From regeneration experiments conducted in mice that 
conditionally lack Schwann cell c-Jun (cKO), the importance of c-Jun in Schwann 
cells for nerve regeneration became evident. Following nerve crush injury, it became 
clear, that in mice lacking Schwann cell c-Jun, functional recovery assays (as defined 
by sensory and motor tests) that include: (i) toe pinch assay, (ii) toe spread reflex and 
(iii) SFI analysis, were all significantly delayed compared to WT (Arthur-Farraj et al., 
2012).  
 
As c-Jun is a key amplifier of the repair Schwann cell phenotype, increasing its levels 
in Schwann cells might be an appropriate approach for improving nerve repair and 
testing whether or not functional recovery is faster. To test this hypothesis, 
regeneration studies were carried out in P60 WT and OE/+ mice using a nerve crush 
injury model as described in Chapter 2, section 2.3.2.2.  Evidence shown in Chapter 3 
clearly highlighted the obvious differences in OE/OE adult nerves compared to both 
WT and OE/+, therefore making OE/OE mice an unsuitable candidate to study nerve 
regeneration.  
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4.2 Results 
 
4.2.1 c-Jun expression remains elevated in OE/+ nerves compared to WT, 
following nerve injury  
 
As discussed in Chapter 3, the c-Jun overexpressing mouse, OE/+ in particular, which 
is the focus of this chapter, is a unique in vivo model that allows for c-Jun elevation in 
Schwann cells specifically. This c-Jun overexpression is present in early postnatal 
development and maintained into adulthood in OE/+ nerves.  
To determine whether c-Jun is still elevated in OE/+ nerves compared to WT 
following nerve injury, injured P60 WT and OE/+ nerves were analysed by Western 
blot 1D, 7D and 14D following nerve crush. The outcome of this experiment is 
summarised in Figure 4.1. From the representative Western blot image shown in 
Figure 4.1A, there is a clear graded increase in c-Jun elevation in WT nerves from 
uninjured, through to 7D crush where it reaches a peak elevation that appears to be 
maintained at 14D following crush. c-Jun expression in OE/+ nerves following injury 
also follows a graded increase from 1D through to 14D post crush, however the 
elevation seen in these nerves is considerably higher than that seen in WT nerves 
(Figure 4.1B). From the quantification of the Western blot, the ratio of c-Jun elevation 
between OE/+ and WT at 1D (3.5 fold) is highest compared to (2 fold) seen at 7D and 
14D after crush (Figure 4.1B).  
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Figure 4.1 | Analysis of c-Jun expression in WT and OE/+ nerves following sciatic nerve crush injury
 (A) Representative Western blot image of nerve extracts from WT and OE/+ uninjured, 1D, 7D and 14D crushed 
nerves to show the levels of c-Jun expression. GAPDH and calnexin are used as reference genes. (B) Graph to quantify 
c-Jun levels of WT and OE/+ nerves at 1D, 7D and 14D following sciatic nerve crush relative to WT uninjured. c-Jun 
was normalised to calnexin and GAPDH, and then expressed as a fold change relative to WT uninjured. WT (n=4) and 
OE/+ (n=4); One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis is represented relative to WT 
uninjured, unless shown otherwise. 
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4.2.2 Overexpression of c-Jun in OE/+ nerves results in down-regulation of 
Krox20 and Mpz compared to WT following nerve injury 
 
An important constituent of myelin sheaths that wrap around axons, is the myelin 
protein, Mpz. Results described in Chapter 3 highlighted that increased c-Jun 
expression in Schwann cells, caused a decrease in Mpz expression. Bearing in mind 
these results, it was therefore interesting to see whether or not Mpz levels were also 
down-regulated in OE/+ nerves after injury.  
 
As expected, following nerve crush injury in WT nerves, the levels of Mpz expression 
decrease during the time when severed axons with their associated myelin is broken 
down through Schwann cell autophagy and macrophage phagocytosis (Gomez-
Sanchez et al., 2015), as seen in the representative Western blot and its quantification 
in Figure 4.2A-B.   
In OE/+ nerves, this decrease in Mpz expression from 1D to 14D after crush is also 
seen, similarly to that in WT nerves. However, in OE/+ nerves, this decrease in Mpz 
expression is of significance at 7D and 14D after crush where its decrease compared 
to WT is 2.4 fold and 5 fold, respectively (Figure 4.2B). This suggests that 
maintenance of c-Jun elevation to very high levels in OE/+ nerves, at different time 
points following nerve injury (1D-14D, shown in Figure 4.1), is enough to down-
regulate Mpz levels to lower levels than that seen in normal WT nerves at these time 
points (Figure 4.2A-B), which may indicate faster myelin clearance.  
 
These results are in line with work that demonstrated that the lack of c-Jun in 
Schwann cells results in a delay in myelin clearance through the regulation of 
Schwann cell autophagy (Gomez-Sanchez et al., 2015).  
 
Another important myelin related gene is Krox20. Results described in Chapter 3 
showed that overexpression of c-Jun in Schwann cells results in a significant down-
regulation of Krox20 in uninjured nerves. In Western blot analysis shown in Figure 
4.2A-B, Mpz levels are not significantly different between WT and OE/+ nerves at 
1D after crush, but this difference is more striking at 7D and 14D after nerve injury.  
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For these reasons, Krox20 levels were analysed by Western blot 7D and 14D after 
nerve crush in both WT and OE/+ nerves. These results are shown in Figure 4.2C-F. 
Following nerve injury, c-Jun is up-regulated very highly which results in a down-
regulation of Krox20, during the time which axons and their associated myelin are 
broken down (Arthur-Farraj et al., 2012; Jessen and Mirsky, 2016).  
Therefore, in keeping with this reasoning, Krox20 levels were lower in OE/+ nerves 
than in WT, though this only reached significance at 14D after nerve crush, being 
only a trend at 7D following crush (Figure 4.2C-F). In uninjured nerves, c-Jun is 
highly elevated in OE/+ nerves compared to WT.  The further increase in these c-Jun 
levels seen after injury resulted in significantly lower levels of Krox20.  
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Figure 4.2 | Analysis of Mpz and Krox20 expression in WT and OE/+ nerves following sciatic nerve crush injury
(A) Representative Western blot image of nerve extracts from WT and OE/+ uninjured, 1D, 7D and 14D crushed nerves 
to show the levels of Mpz expression. Mpz is used to show how a myelin-related protein is affected by increased levels 
of transgenic c-Jun. GAPDH and calnexin are used as reference genes. (B) Graph to quantify Mpz levels of WT and OE/
+ nerves at 1D, 7D and 14D following sciatic nerve crush relative to WT uninjured. Mpz was normalised to calnexin and 
GAPDH, and then expressed as a fold change relative to WT uninjured. WT (n=4) and OE/+ (n=4); One-way ANOVA 
with Tukey comparison, p<0.0001. (C) Representative Western blot image of nerve extracts from WT and OE/+ 7D 
crushed nerves to show the levels of Krox20 expression. Krox20 is used as a marker of re-myelination. GAPDH and 
calnexin are used as reference genes. (D) Graph to quantify Krox20 levels of WT and OE/+ nerves 7D following sciatic 
nerve crush relative to WT. Krox20 was normalised to calnexin and GAPDH, and then expressed as a fold change 
relative to WT. WT (n=4) and OE/+ (n=4); Mann Whitney test, p=0.2900. (E) Representative Western blot image of 
nerve extracts from WT and OE/+ 14D crushed nerves to show the levels of Krox20 expression. Krox20 is used as a 
marker of re-myelination. GAPDH and calnexin are used as reference genes. (F) Graph to quantify Krox20 levels of WT 
and OE/+ nerves 14D following sciatic nerve crush relative to WT. Krox20 was normalised to calnexin and GAPDH, and 
then expressed as a fold change relative to WT. WT (n=4) and OE/+ (n=4); Mann Whitney test, p=0.0286. All statistical 
analysis is represented relative to WT. !
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4.2.3 Re-myelination after injury in OE/+ is delayed compared WT nerves  
 
In order for successful axonal regeneration to occur, the terrain, into which new axons 
must grow into, needs to be prepared. Schwann cells play a crucial part in this 
process. Injury induces Schwann cell reprogramming to form a new support cell 
known as a repair Bungner Schwann cell by: (i) down-regulating myelin genes, (ii) 
up-regulating trophic factors and cytokines, (iii) clearing myelin debris through the 
process of myelinophagy (Schwann cells) and phagocytosis (macrophages) and (iv) 
forming the regeneration tracks known as the bands of Bungner which act as a guide 
for the regenerating axons to reach their targets (Arthur-Farraj et al., 2012; Gomez-
Sanchez et al., 2015; Jessen and Mirsky, 2016).  
 
Prior to sciatic nerve injury, WT and OE/+ nerves were very similar to each other 
both at macroscopic and microscopic levels (Chapter 3, Figure 3.16). For this reason, 
the nerve cytoarchitecture of WT and OE/+ nerves following nerve injury was 
analysed by electron microscopy in a similar way to that of uninjured WT and OE/+ 
nerves shown in Chapter 3, Figure 3.16.  
 
The time points chosen for electron microscopy analysis were 14D, 28D and 70D 
following nerve crush, selected on the basis of the different stages through which the 
re-myelination process takes place following nerve injury. This was to focus more on 
how elevation of c-Jun in Schwann cells following nerve injury may affect re-
myelination.  
 
By 14D following sciatic nerve injury in the mouse, the majority of myelin debris 
from axonal break down is thought to have been cleared away by Schwann cell 
mediated autophagy also known as myelinophagy, and phagocytosis through the 
recruitment of macrophages (Perry et al., 1992; Vargas et al., 2010; Gomez-Sanchez 
et al., 2015).  
 
Further in depth analysis of WT and OE/+ nerves at electron microscopy level 
following nerve injury revealed some differences that could be explained by the 
maintained levels of c-Jun overexpression following nerve injury in OE/+ nerves 
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(Figure 4.1), and also the down-regulation of myelin-related genes in OE/+ nerves 
(Figure 4.2). Although several aspects of P60 WT and OE/+ uninjured nerves were 
very similar (Chapter 3, Figure 3.16), it later becomes apparent that WT and OE/+ 
nerves do not display the same initial responses to nerve injury. The gross nerve 
cytoarchitecture shown at x3000 magnification and the finer details shown at a higher 
magnification in Figure 4.3A, reveals differences between WT and OE/+ nerves 14D 
following injury in, (i) the number of myelinated axons present, (ii) the increase in 
extracellular matrix and (iii) increase in large diameter axons that are non-myelinated, 
seen more prominently in OE/+ nerves compared to WT.  
 
The number of Schwann cell nuclei is statistically significantly higher in OE/+ nerves 
compared to WT, 906 and 635 respectively (Figure 4.3B). The number of myelinated 
axons is statistically significantly less in OE/+ (566) compared to WT (3110) (Figure 
4.3C). Therefore the same is true for the percentage of myelinated axons in OE/+ 
(25%) compared to WT (93%) (Figure 4.3D). The number of non-myelinated 
axons>1.5µm in diameter is significantly higher in OE/+ (1642) nerves compared to 
WT (225) (Figure 4.3E).  
 
Not surprisingly, this means that the number of non-myelinated axons >1.5µm in 
diameter (which includes those in a 1:1 relationship with a Schwann cell and those 
part of a regenerating axon bundle), are all statistically significantly higher in OE/+ 
nerves compared to WT (Figure 4.3F-G).  
 
The myelin thickness of the myelinated axons present in OE/+ nerves is also 
substantially thinner compared to WT (Figure 4.3H), which is of statistical 
significance. The significant decrease in myelin thickness in OE/+ nerves could be 
due to the lower expression of pro-myelin genes such as Krox20 shown in Figure 
4.2C-F. Although the nerve areas of WT and OE/+ mice were similar prior to nerve 
injury, it was important to see if this similarity was present post nerve injury. The 
nerve areas between WT and OE/+ 14D following nerve crush were not significantly 
different at 122694μm2 and 127933μm2 respectively (Figure 4.3I).  
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Figure 4.3 | Characterisation of WT and OE/+ 14D following sciatic nerve crush
 (A) Representative electron microscopy images taken at x3000 and x10000 magnification to show more detail of the 
ultrastructure of WT and OE/+ nerves 14D following nerve crush. The red outlines show examples of regenerating axon 
bundles. Scale bar represents 5μm (x3000) and 1μm (x10000). Graphs shown in panels B-I are all quantified from WT 
(n=4) and OE/+ (n=4) 14D following nerve crush. An example of a regenerating axon bundle is highlighted in the red 
boxes in panel A. (B) Graph to quantify the number of Schwann cell  nuclei  per nerve profile.  Mann Whitney test, 
p=0.0286. (C) Graph to quantify the number of myelinated axons per nerve profile. Mann Whitney test, p=0.0286. (D) 
Graph to quantify the percentage of myelinated compared to non-myelinated 1:1 axons per nerve profile. Mann Whitney 
test, p=0.0286. (E) Graph to quantify the number of non-myelinated axons >1.5μm per nerve profile. Mann Whitney test, 
p=0.0286. (F) Graph to quantify the number of non-myelinated axons >1.5μm that are in a 1:1 relationship per nerve 
profile. Mann Whitney test, p=0.0286 (G) Graph to quantify the number of non-myelinated axons >1.5μm that are in 
regenerating axon bundles per nerve profile. Mann Whitney test, p=0.0286. (H) Graph to show the g-ratio of WT and OE/
+ nerves. Mann Whitney test, p=0.0286. (I) Graph to show the nerve area of WT and OE/+ mice at 14D after sciatic 
nerve crush. Mann Whitney test, p=0.6571. All statistical analysis in all graphs is represented relative to WT.
Analysis carried out by JA Gomez-Sanchez. 
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By 28D following sciatic nerve crush in the WT mouse, the process of re-myelination 
is normally well underway, by which point some Schwann cells have begun to 
myelinate newly regenerating axons whilst others remain in close contact with 
growing axons to provide them with the necessary support needed for correct target 
re-innervation (Ma et al., 2011; Gaudet at al., 2011; Svennigsen and Dahlin, 2013).  
 
The nerve cytoarchitecture of WT and OE/+ nerves 28D following nerve crush, as 
depicted by electron microscopy images in Figure 4.4A, highlights some visible 
differences including fewer myelinated axons, thinner myelin sheaths and more 
extracellular matrix in OE/+ nerves compared to WT.  
 
Schwann cell nuclei are still very significantly higher in OE/+ (1279) compared to 
WT (605). This could be in line with the reasoning that in WT nerves, by this point in 
the re-myelination process, negative regulators of myelination such as c-Jun are 
suppressed in Schwann cells, whereas, in OE/+ nerves these levels are maintained, 
hence increasing Schwann cell proliferation (Figure 4.4B).  
 
The total number of myelinated axons quantified in WT and OE/+ nerves at 28D 
following crush, is overall higher compared to 14D following nerve crush, indicating 
recovery following nerve injury.  More important, however, is the fact that the ratio of 
myelinated axons between WT and OE/+ at 28D is less than the ratio of myelinated 
axons between WT and OE/+ at 14D following crush injury. At 28D following nerve 
crush, the differences in numbers of myelinated axons between WT and OE/+ are 
4330 and 2772 (statistically significant) respectively (Figure 4.4C).  
The percentage of non-myelinated axons is statistically significantly higher in OE/+ 
(25%) compared to WT (2%) nerves, and conversely, the percentage of myelinated 
axons is statistically significantly lower in OE/+ (75%) compared to WT (98%) 
nerves (Figure 4.4D).  
In line with the aforementioned results, the overall numbers of non-myelinated axons 
>1.5µm in diameter (which includes those in a 1:1 relationship with a Schwann cell 
and those part of a regenerating axon bundle), are also greater in both WT and OE/+ 
nerves compared to 14D following crush. However, when comparing the individual 
ratios 28D following nerve crush of (i) non-myelinated axons (both in 1:1 relationship 
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with a Schwann cell and in regenerating axon bundles), between WT and OE/+ 
nerves, it is clear that these are all statistically significantly higher in OE/+ nerves 
compared to WT (Figure 4.4E-G). Non-myelinated axons are 899 in OE/+ nerves 
compared to 79 in WT nerves (Figure 4.4E). Non-myelinated axons in 1:1 
relationships with Schwann cells or present in regenerating axon bundles are 541 and 
308 respectively in OE/+ nerves, compared to 2 and 69 respectively in WT nerves, all 
differences being statistically significant (Figure 4.4F-G).  
 
Myelin sheath thickness of the fewer myelinated axons present in OE/+ (0.803) 
nerves still remain significantly thinner compared to WT (0.716) (Figure 4.4H) 
suggesting negative regulation of pro-myelin genes by c-Jun elevation in Schwann 
cells.  
 
Similarly to what was seen at 14D post nerve crush, the areas of WT and OE/+ nerves 
are not significantly different, 132075μm2 and 139193μm2, respectively as shown in 
Figure 4.4I.  
 
The results described in Figure 4.4 suggest a significant recovery in the re-
myelination process in OE/+ nerves 28D following nerve injury, though not to the 
same extent as that of WT nerves.  
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Figure 4.4 | Characterisation of WT and OE/+ 28D following sciatic nerve crush
 (A) Representative electron microscopy images taken at x3000 and x10000 magnification to show more detail of the 
ultrastructure of WT and OE/+ nerves 28D following nerve crush. Scale bar represents 5μm (x3000) and 1μm (x10000). 
Graphs shown in panels B-I are all quantified from WT (n=5) and OE/+ (n=5) 28D following nerve crush. (B) Graph to 
quantify the number of Schwann cell nuclei per nerve profile. Mann Whitney test, p=0.0079. (C) Graph to quantify the 
number of myelinated axons per nerve profile. Mann Whitney test, p=0.0079. (D) Graph to quantify the percentage of 
myelinated  compared  to  non-myelinated  1:1  axons  per  nerve  profile.  Mann Whitney  test,  p=0.0079.  (E)  Graph  to 
quantify the number of non-myelinated axons >1.5μm per nerve profile. Mann Whitney test, p=0.0079. (F) Graph to 
quantify the number of non-myelinated axons >1.5μm that are in a 1:1 relationship per nerve profile. Mann Whitney test, 
p=0.0079. (G) Graph to quantify the number of non-myelinated axons >1.5μm that are in regenerating axon bundles per 
nerve profile. Mann Whitney test, p=0.0079. (H) Graph to show the g-ratio of WT and OE/+ nerves. Mann Whitney test, 
p=0.0079. All statistical analysis in all graphs is represented relative to WT. (I) Graph to show the nerve area of WT and 
OE/+ mice at  28D after  sciatic nerve crush.  Mann Whitney test,  p=0.3095.  .All  statistical  analysis  in all  graphs is 
represented relative to WT.
Analysis carried out by JA Gomez-Sanchez. 
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By 70D post nerve injury, the nerve cytoarchitecture should therefore be similar to 
that of uninjured nerves in both WT and OE/+ as re-myelination is complete. For this 
reason and as was expected, the electron microscope images shown in Figure 4.5A 
both at x3000 and x10000 magnification, are very similar between WT and OE/+ 
nerves apart from the presence of slightly fewer myelinated axons, and those that are 
myelinated, are more thinly myelinated in OE/+ nerves compared to WT.  
 
The number of Schwann cells quantified 70D following nerve crush in WT and OE/+ 
nerves are significantly different, 427 and 651 respectively (Figure 4.5B). An 
important comparison to note, however, is that the overall numbers of Schwann cells 
quantified in both WT and OE/+ nerves are lower at 70D post crush compared to 28D 
post crush. This result is expected due to the fact that during peripheral nerve 
regeneration (following nerve crush), similar to what is seen in development 
(Grinspan et al. 1996; Nakao et al. 1997; Syroid et al. 1996; Yang et al., 2008), excess 
Schwann cells that are not in contact with axons are removed by apoptosis to ensure 
the correct ratio between Schwann cells and axons (Yang et al., 2008).  
 
The number of myelinated axons present in WT and OE/+ nerves are not significantly 
different (Figure 4.5C). To this effect, the percentage of myelinated and non-
myelinated axons are also very similar in both WT and OE/+ nerves.  
The percentage of myelinated and non-myelinated axons >1.5μm in diameter is 
similar between WT and OE/+ nerves. The percentage of myelinated axons is 99% in 
WT compared to 98% in OE/+ nerves, and the inverse is true of non-myelinated 
axons (Figure 4.5D).  
Although the number of non-myelinated axons >1.5µm in diameter (both in a 1:1 
relationship with a Schwann cell or in regenerating axon bundles), are not statistically 
different between WT and OE/+ nerves 70D following nerve crush, they do show a 
trend towards more non-myelinated axons being present in OE/+ nerves, as shown in 
Figure 4.5E-G.  
 
Myelin sheath thickness as determined by g-ratio, remains significantly thinner in 
OE/+ (0.797) nerves compared to WT (0.712) (Figure 4.5H). c-Jun elevation in OE/+ 
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nerves is therefore still having an effect on the thickness of myelin sheaths, suggesting 
that it still has a negative regulatory effect on pro-myelin signals.  
 
The nerve areas of WT and OE/+ are almost the same, 108829μm2 and 107572μm2, 
respectively (Figure 4.5I). More importantly however, the nerve cytoarchitecture 
along with different aspects of the nerve analysed 70D following injury are strongly 
indicative of the fact that OE/+ nerves regain a very similar morphological phenotype 
as WT nerves.  
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Figure 4.5 | Characterisation of WT and OE/+ 70D following sciatic nerve crush
(A) Representative electron microscopy images taken at x3000 and x10000 magnification to show more detail of the 
ultrastructure of WT and OE/+ nerves 70D following nerve crush. Scale bar represents 5μm (x3000) and 1μm (x10000). 
Graphs shown in panels B-I are all quantified from WT (n=6) and OE/+ (n=5) 70D following nerve crush. (B) Graph to 
quantify the number of Schwann cell nuclei per nerve profile. Mann-Whitney test, p=0.0286. (C) Graph to quantify the 
number of myelinated axons per nerve profile. Mann-Whitney test, p=0.0571. (D) Graph to quantify the percentage of 
myelinated  compared  to  non-myelinated  1:1  axons  per  nerve  profile.  Mann-Whitney  test,  p=0.0571.  (E)  Graph  to 
quantify the number of non-myelinated axons >1.5μm per nerve profile. Mann-Whitney test, p=0.0857. (F) Graph to 
quantify the number of non-myelinated axons >1.5μm that are in a 1:1 relationship per nerve profile. Mann-Whitney test, 
p=0.1143. (G) Graph to quantify the number of non-myelinated axons >1.5μm that are in regenerating axon bundles per 
nerve profile. Mann-Whitney test, p=0.0571. (H) Graph to show the g-ratio of WT and OE/+ nerves. Mann Whitney test, 
p=0.0286. (I) Graph to show the nerve area of WT and OE/+ mice at 28D after sciatic nerve crush. Mann Whitney test, 
p=0.9004. All statistical analysis is represented relative to WT.
Analysis carried out by JA Gomez-Sanchez. 
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4.2.4 Sensory functional recovery is delayed in OE/+ nerves compared to WT 
following nerve crush injury 
 
The toe pinch assay is a common way to test sensory recovery in mice following 
nerve injury (Collier et al., 1961; Arthur-Farraj et al., 2012; Painter et al., 2014). The 
assay is carried out by pinching toes 3, 4 and 5 of the mice individually and observing 
the response (further details in Chapter 2, section 2.3.3). Sensory nerve conduction is 
reliant on both non-myelinated and myelinated axons (Schmalbruch, 1986).  
 
The results of this analysis in WT and OE/+ mice is represented in two ways: (i) the 
percentage of animals of each genotype that showed a response on a particular day 
post nerve crush injury, and from which toe this response was observed, and (ii) the 
first day following nerve crush injury where a response was seen from the genotypes 
of mice studied. These results are shown in Figure 4.6.  
 
In toe 3 a small percentage (25%) of WT mice showed a response to a toe pinch by 
day 15 post injury, compared to day 17 in OE/+ (Figure 4.6A). When taking into 
account the average time in days per genotype where a response to toe pinch (on toe 
3) was noted (Figure 4.6B), WT mice responded earlier (day 17) on average 
compared to OE/+ mice (day 19).  
 
In toe 4, WT and OE/+ responses are seen on day 17 after injury (Figure 4.6C). When 
considering the average response to toe pinch per genotype, WT mice responded one 
day earlier compared to OE/+ mice (Figure 4.6D), which is of statistical significance.  
 
Finally, in toe 5, the responses seen to toe pinch were similar to those in toe 3, where 
WT and OE/+ mice showed responses by day 15 and 17 post surgery respectively 
(Figure 4.6E). However when taking into account the average response in days per 
genotype (Figure 4.6F), WT mice responded by day 16 post injury whereas OE/+ 
mice responded 18 days after injury. This difference is statistically significant.  
 
These results are an indication that OE/+ mice show delayed regain of sensory 
function compared to WT mice.  
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The results from the toe pinch assay, a measure of sensory recovery are clear cut yet 
unexpected given the previous work of Arthur-Farraj et al., 2012. Their work showed 
that the lack of c-Jun elevation in Schwann cells after injury significantly delayed and 
impaired regeneration because of slower initial axon outgrowth after injury.  
With this in mind, the expected outcome would be that the higher the elevation of 
Schwann cell c-Jun such as that seen in OE/+ nerves, the faster the recovery 
compared to WT nerves. However, it is important to note that in OE/+ nerves, 
evidence is presented showing that re-myelination following injury is retarded 
compared to WT, therefore making the delay in sensory functional recovery in OE/+ 
mice, less surprising. The data presented above therefore implies that increased c-Jun 
expression in Schwann cells alone is not sufficient to result in faster functional 
recovery.  
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Figure 4.6 | Sensory functional recovery following a crush injury is delayed in OE/+ compared to WT mice
Sensory function following different days post sciatic nerve crush was tested in WT (n=10) and OE/+ (n=9) using the 
toe pinch assay. (A) Graph to show the percentage of WT and OE/+ mice that responded to a toe pinch test specifically 
on toe 3. (B) Graph to show the average time in days per genotype for the initial day on which a toe pinch response in 
toe 3 specifically, is seen in WT and OE/+ mice. Mann-Whitney test, p=0.0056. (C) Graph to show the percentage of 
WT and OE/+ mice that responded to a toe pinch test specifically on toe 4. (D) Graph to show the average time in days 
per genotype for the initial day on which a toe pinch response in toe 4 specifically, is seen in WT and OE/+ mice. 
Mann-Whitney test, p=0.0043. (E) Graph to show the percentage of WT and OE/+ mice that responded to a toe pinch 
test specifically on toe 5. (F) Graph to show the average time in days per genotype for the initial day on which a toe 
pinch response in toe 5 specifically,  is  seen in WT and OE/+ mice.  Mann-Whitney test,  p=0.0404.  All  statistical 
analysis is represented relative to WT unless shown otherwise. 
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4.2.5 Motor functional recovery is delayed in OE/+ nerves compared to WT 
following nerve crush injury 
 
A common way to test motor recovery following a sciatic nerve injury is using the 
toe-spread reflex. Injured mice are analysed as explained in Chapter 2, section 2.3.3 
by way of a toe-spread reflex, in response to the mouse being lifted by the tail. This is 
a measure of motor function as described by Siconolfi et al, 2001. Motor coordination 
is reliant on large diameter, myelinated axons as these insulated axons conduct nerve 
impulses very rapidly by a process known as saltatory conduction (Virchow, 1854; 
Ranvier, 1871).  
 
A graph summarising the toe spread reflex responses seen in WT and OE/+ mice over 
several days following sciatic nerve crush injury is shown in Figure 4.7A. There is an 
obvious delay in OE/+ mice spreading their toes to the same extent as WT mice 
between days 11 and 18 post nerve injury, but by day 21, both WT and OE/+ are fully 
recovered. This delay in the toe spread reflex of OE/+ mice compared to WT is only 
of significance at 14 and 15 days post injury.  
 
This difference in response to nerve injury between WT and OE/+ could be due to the 
elevation of c-Jun in Schwann cells of OE/+ nerves. This maintained increase of c-Jun 
elevation appears to has an effect on the presence of fewer myelinated axons in OE/+ 
nerves compared to WT (Figures 4.3C and 4.4C), which is an indication of delayed 
re-myelination following nerve injury. As motor function is reliant on myelinated 
axons, the presence of fewer of these axons in OE/+ nerves, whilst those that are 
present are more thinly myelinated, may provide a reason why OE/+ motor functional 
recovery is delayed compared to WT.   
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A
Figure 4.7 | Motor functional recovery following a crush injury is delayed in OE/+ mice compared to WT
Motor function following different days post sciatic nerve crush was tested in WT and OE/+ mice using the toe spread 
reflex. (A) Graph to show the toe spread reflex of WT and OE/+ mice on different days post sciatic nerve crush. WT 
(n=10)  and  OE/+  (n=9);  Two-way  ANOVA with  Bonferroni  comparison,  p<0.0001.  All  statistical  analysis  is 
represented relative to WT. 
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4.2.6 Following nerve injury, WT and OE/+ mice regain functional recovery as 
determined by sensory-motor assays 
 
Sciatic functional index (SFI) is a technique used to determine sensory-motor 
functional recovery following nerve injury. Injured WT and OE/+ mice were made to 
walk along a wooden track whilst leaving footprints on paper that was later scanned 
and analysed in the same was as described by Inserra et al.,1998. Typical footprints 
seen in WT and OE/+ at the most significantly different days following nerve injury 
are shown in Figure 4.8. It is clear from these representative footprint scanned images 
taken from WT and OE/+ mice at 0, 7, 18, 21, 28 and 70 days post injury that in OE/+ 
mice, recovery is seen similar to WT based on the similarities between the footprints 
over time.  
 
The previous work of Arthur-Farraj et al., 2012 demonstrated that lack of Schwann 
cell c-Jun was detrimental to successful nerve regeneration. The results presented in 
Chapter 3 show clearly that the new and novel mouse model has been successfully 
developed to overexpress Schwann cell c-Jun in a gene-dose dependent manner.  
Taking this information into account, it was of interest to see whether elevated levels 
of c-Jun seen in OE/+ nerves accelerated sensory-motor functional recovery compared 
to WT.  
 
These results of sensory-motor function are summarised in the graph shown in Figure 
4.9A. Full functional recovery as determined by SFI is reached by day 35 post surgery 
in both WT and OE/+, even though the WT response is faster than OE/+ mice, 
particularly at day 21, however this is not of statistical significance. Full functional 
recovery has been determined as and when the SFI has reached the same baseline 
result seen as at day 0, as this serves as the uninjured control. Although both WT and 
OE/+ respond similarly to each other to nerve crush injury, as seen between day 0 and 
day 11, by day 14 post injury, the WT appears to be recovering faster, until day 35 
post injury where both WT and OE/+ responses are the same. The responses are then 
maintained through the duration of the experiment until day 70 post injury.  
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In summary, the sensory and motor functional recovery assays shown in Figures 4.6-
4.9 would suggest that high Schwann cell c-Jun elevation seen in OE/+ mice seems to 
delay the functional recovery modestly compared to WT.  
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Figure 4.8 | Typical footprints from WT and OE/+ mice following sciatic nerve crush injury
(A) Representative scanned footprint images from WT and OE/+ mice from day 0 (uninjured), 7, 18, 21, 28 and 70 
days post injury (dpi). The footprints seen in WT and OE/+ return to normal, comparable to day 0. These were used to 
analyse the normal toe spread, normal print length, experimental toe spread and experimental toe length. Scale bar 
represents 1cm.
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Figure 4.9 | Sensory-motor function was delayed in OE/+ mice compared to WT, following nerve crush injury
Sensory-motor function following different days post sciatic nerve crush was tested in WT and OE/+ mice using the 
sciatic functional index (SFI). (A) Graph to show how SFI changed over time following nerve crush injury in OE/+ 
mice compared to WT. WT (n=10) and OE/+ (n=9); Two-way ANOVA with Bonferroni comparison, p<0.0001. All 
statistical analysis is represented relative to WT.
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4.3 Discussion 
 
Although Western blot analysis of nerves at 28D and 70D post injury has not been 
carried out, it is plausible to posit that in the WT at these time points c-Jun levels 
would have decreased because axons have fully regenerated and begun to myelinate, 
which suppresses the elevation of c-Jun. However in OE/+ nerves, it is likely that this 
elevation seen at 14D, would be maintained at 28D and 70D following crush. 
 
An obvious line of enquiry that would be crucial to investigate is the number of 
macrophages present in OE/+ nerves following injury. Due to the sustained increase 
in c-Jun expression following nerve injury in OE/+ nerves, and the indication that 
myelin clearance may be faster in these nerves, it is possible to hypothesise that there 
would be more macrophages present after injury. 
 
Some evidence presented in this chapter would strongly indicate that myelin clearance 
might be faster in OE/+ nerves. There is already some pilot data to suggest that 
myelin clearance is in fact faster in OE/+ nerves following a short term injury as 
determined by the number of intact myelin rings, which are significantly fewer in 
OE/+ nerves compared to WT (unpublished observations SV Fazal and JA Gomez-
Sanchez). Therefore it would be worth investigating whether or not autophagy 
specific genes were up-regulated more readily in OE/+ nerves compared to WT, in 
line with the work published by Gomez-Sanchez et al., 2015.  
 
The results presented in Figures 4.6-4.9 that addressed functional recovery in WT and 
OE/+ mice using various sensory and motor tests, showed somewhat unexpected 
results. Bearing in mind the generally accepted role of c-Jun in nerve regeneration, 
where the lack of its presence in Schwann cells is detrimental to nerve regeneration 
(Arthur-Farraj et al., 2012), with the corollary of the up-regulation of Schwann cell c-
Jun in a gene-dose dependent manner, faster functional recovery might have been 
expected.  This was not seen in OE/+ nerves compared to WT. In hindsight, the 
modest delay in sensory and motor functional recovery seen in OE/+ mice compared 
to WT is not as unexpected as originally thought since there is a clear delay in the 
onset of myelination in the Schwann cells that surround the regenerating axons. It is 
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important to note, that in OE/+ mice, even though functional recovery is delayed 
following nerve injury compared to WT, these mice still do regain full functional 
recovery, comparable to WT. These functional studies suggest therefore, that this new 
c-Jun overexpressing (OE/+) mouse could be useful in other regeneration studies.  
 
As expected, c-Jun levels remain elevated in OE/+ nerves following injury compared 
to WT as shown in Figure 4.1. For this reason the OE/+ mouse provides a platform 
upon which further studies can be carried out in models where c-Jun expression needs 
to be elevated or maintained. c-Jun expression in Schwann cells is not only down-
regulated during normal nerve development, but it also declines in the distal stumps of 
severed nerves  after chronic injury and in aged adult nerves (Parkinson et al., 2008; 
Painter et al., 2014; Jessen and Mirsky, 2016). In order to study the effects of 
maintenance of c-Jun levels in both uninjured (to study ageing induced c-Jun decline) 
nerves and long term injured nerves (where c-Jun normally declines), the OE/+ mouse 
provides a robust tool in addressing these questions.  
 
Other evidence suggests that OE/+ mice can be useful in assessing the rate of axonal 
regeneration immediately after nerve injury. After nerve crush injury, when the 
numbers of regenerating axons are quantified in WT and OE/+ nerves using peptides 
as markers of regeneration at the short time point of 3D post crush, there are more 
regenerating axons in OE/+ nerves compared to WT (personal communication JA 
Gomez-Sanchez). For this reason, it would be interesting to study whether or not 
OE/+ DRG neurons are able to switch from a “signalling” mode to a “growth” mode 
more readily compared than WT neurons. This is discussed further in Chapter 6. 
An important aspect of the nerve injury response that should be addressed in OE/+ 
mice is whether or not there is less death of injured neurons. The work of Arthur-
Farraj et al., 2012 demonstrated that in mice that had c-Jun conditionally knocked out 
of their Schwann cells, there was a marked increase in the death of injured DRG 
neurons. For this reason, it can be hypothesised that if c-Jun levels are elevated in 
Schwann cells following injury, as seen in the OE/+ mouse, these mice may exhibit 
less death of injured neurons and c-Jun in this instance would act to prevent neuronal 
death.  
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Another obvious line of enquiry would be to look at the number of macrophages 
present in OE/+ nerves following injury. The increase in Schwann cell numbers in 
OE/+ nerves, might indicate a higher presence of macrophages in these nerves 
compared to WT. If there are already more Schwann cells in OE/+ nerves following 
injury, these would in turn release more Schwann cell-derived chemotactic molecules 
such as MCP-1 and LIF that attract macrophages (Tofaris et al., 2002). 
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5. Nerve transection elevates c-Jun expression in proximal stump 
Schwann cells 
 
5.1 Introduction  
 
As already mentioned, c-Jun is an immediate early gene that is rapidly expressed by 
Schwann cells after nerve injury (Shy et al., 1996; Parkinson et al., 2004; Raivich et 
al., 2004). It is widely accepted that c-Jun acts as a global regulator of peripheral 
nerve injury and highly important in determining the successful reprogramming of 
Schwann cells into repair Bungner cells which are essential for successful peripheral 
nerve regeneration after injury (Arthur-Farraj et al., 2012; Jessen et al., 2015; Jessen 
and Mirsky, 2016). Work so far has focused on c-Jun elevation in distal stump 
Schwann cells after periods from 1 hour to several days after injury.  However little is 
known about the role of c-Jun levels in Schwann cells of the proximal stump early 
after nerve injury.  
 
The c-Jun conditional knockout (cKO) mouse model (Behrens et al., 2002; Arthur-
Farraj et al., 2012) was used for determining the importance of c-Jun up-regulation in 
proximal stump Schwann cells after peripheral nerve transection.  As explained in 
Chapter 2 (section 2.2.3), the cKO mouse has c-Jun conditionally knocked out only in 
Schwann cells when the P0-Cre transgene activates Cre-mediated recombination 
between E13.5 and E14.5. 
The significance of this early expression of c-Jun in Schwann cells after sciatic nerve 
transection remains to be explored. 
 
The following chapter is focused on the defining what happens to Schwann cell c-Jun 
levels in the proximal stump following sciatic nerve transection.  
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5.2 Results  
 
5.2.1 c-Jun is elevated in proximal stump cells following short-term injury 
 
Sciatic nerve transection elevates levels of c-Jun expression in WT proximal stump 
cells as early as 1 hour after injury. This is reflected by immunofluorescent labelling 
of proximal stump tissue of WT mice from the first 6mm of the proximal stump 
including the injury site (Figure 5.1A). The immunofluorescence images show the 
different levels of c-Jun expression 1 hour after nerve transection, along different 
distances of the proximal stump starting from the injury site (0-2mm). It is clear from 
both the immunofluorescence images and quantification (Figures 5.1A and C) that the 
injury site has the highest c-Jun expression in proximal stump cells, whereas 1 hour 
after sciatic nerve transection, the further away from the injury site, the lower the 
expression of c-Jun in these cells. These levels of c-Jun in WT proximal cells are 
relative to the very low expression seen in the contralateral uninjured nerve (Figure 
5.1B), which is quantified in Figure 5.1C.  
It is evident from the quantification that following nerve injury, there is a very strong 
c-Jun elevation in proximal stump cells as early as 1 hour after the injury, compared 
to uninjured levels, namely from as little as 7% in the uninjured nerve, to as high as 
72% in the first 2mm of the proximal stump (Figure 5.1C). Further away from the 
injury site at 2-4mm there is also a significant increase in c-Jun expression to 46% 
compared to the uninjured levels. However at a distance of 4-6mm, this elevation is 
no longer seen. 
 
These results demonstrate that c-Jun expression in WT proximal cells is very high as 
early as 1 hour after injury, with the maximal expression being nearest to the injury 
site. However the further away from the injury site, the lower this level of expression 
becomes, as summarised in Figure 5.1. 
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Figure 5.1 | c-Jun expression in proximal stump cells 1 hour after sciatic nerve transection
(A) 5μm thick sciatic nerve cryosections were immunolabelled with c-Jun antibody and with DAPI to label nuclei. 
Immunofluorescence images taken at x25 magnification showing the population of proximal stump cells expressing c-
Jun at different distances along the nerve from the transection site, 1 hour after injury. The proximal stump is divided 
into three 2mm segments. (B) Immunofluorescence images taken at x25 magnification showing the population of cells 
expressing c-Jun in a contralateral uninjured WT nerve. The contralateral uninjured nerve is used for comparison. Scale 
bar represents 50μm. (C) Quantification of the percentage of c-Jun positive cells in the proximal stumps of WT mice 1 
hour after nerve transection. WT (n=3) and cKO (n=3), One-way ANOVA with Sidak comparison, p<0.0001). All 
statistical analysis is compared to WT uninjured levels.
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c-Jun elevation in WT proximal stump cells is rapid in response to sciatic nerve 
transection, however is this elevation maintained after longer periods of injury? To 
address this, the same analysis was carried out as in Figure 5.1 but at 6 hours after 
sciatic nerve transection. Again, the elevation of c-Jun in proximal stump cells was 
compared to uninjured levels. 6 hours after sciatic nerve transection, the elevation of 
c-Jun in proximal stump cells within the first 2mm segment was 63% (Figure 5.2B), 
which was similar to the percentage of c-Jun expression at this same distance 1 hour 
after nerve injury (Figure 5.2C). Interestingly, at the 6 hour time point, c-Jun 
expression in the 2-4mm and 4-6mm segments was also elevated (28% and 29% 
respectively). This was lower than after 1 hour in the 2-4mm segment, but there was 
an increase at 4-6mm compared to at 1 hour. The increases in c-Jun expression seen 
along different distances from the injury site at 6 hours were significantly higher 
compared to uninjured levels (Figure 5.2). 
 
These current results indicate that c-Jun expression in WT proximal stump cells is 
very rapid and is not only maintained, but also spreads along cells further from the 
injury site. Do these cells still express c-Jun as highly as the initial elevation seen at 1 
hour in the first 2mm, or at 6 hours in the next 4-6mm, or do these cells reach a 
maximal elevation which then begins to decline after longer periods following injury? 
To address this hypothesis, WT sciatic nerves were transected and the mice were 
allowed to recover for 48 hours before their proximal stumps were analysed in the 
same way as 1 hour and 6 hours after sciatic nerve transection. These results are 
shown in Figure 5.3. 
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Figure 5.2 | c-Jun expression in proximal stump cells 6 hours after sciatic nerve transection
(A) 5μm thick sciatic nerve cryosections were immunolabelled with c-Jun antibody and with DAPI to label nuclei. 
Immunofluorescence images taken at x25 magnification showing the population of proximal stump cells expressing c-
Jun at different distances along the nerve from the transection site, 6 hours after injury. The proximal stump is divided 
into three 2mm segments. The contralateral uninjured nerve is used for comparison. Scale bar represents 50μm. (B) 
Quantification of  the percentage of  c-Jun positive cells  in the proximal stumps of  WT mice 6 hours after  nerve 
transection. WT (n=3) and cKO (n=3), One-way ANOVA with Sidak comparison, p<0.0001. All statistical analysis is 
compared to WT uninjured levels.
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Allowing proximal stump cells to respond to a longer injury produced surprising 
results. WT proximal cells maintain their c-Jun expression at 65% in the first 2mm, 
and also an increase is seen to 44% and 38% in 2-4mm and 4-6mm respectively 
(Figure 5.3). This is a significant increase compared to the 7% c-Jun expression seen 
in cells of uninjured nerves. This would suggest that there is maintenance of c-Jun 
expression in proximal stump cells nearest to the injury site, but that also there is a 
spread in the percentage of cells expressing c-Jun further from the injury site. 
 
The importance and significance of this rapid response in c-Jun elevation in proximal 
stump cells is unknown, as is the reason for the visible maintenance in c-Jun elevation 
over a period of 48 hours. Nevertheless it can be hypothesised that these cells have 
elevated c-Jun following sciatic nerve transection, and that this is maintained, to assist 
the neuronal response to injury. 
 
The sciatic nerve is composed of many cell populations including (Schwann cells, 
which form the largest majority) but also endoneurial fibroblasts, blood vessels, and 
resident macrophages (Jurecka et al., 1975; Weinberg et al., 1978; Hirose et al., 
1986). 
 
Since elevation of c-Jun in Schwann cells is important in nerve regeneration, to 
determine the number of Schwann cells in the c-Jun positive population after injury, 
the percentage of c-Jun positive cells in the proximal stump of WT and cKO mice was 
compared. This mouse has c-Jun deleted only in Schwann cells, see below (Figure 
5.4).  
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Figure 5.3 | c-Jun expression in proximal stump cells 48 hours after sciatic nerve transection
(A) 5μm thick sciatic nerve cryosections were immunolabelled with c-Jun antibody and with DAPI to label nuclei. 
Immunofluorescence images taken at x25 magnification showing the population of proximal stump cells expressing c-
Jun at different distances along the nerve from the transection site,  48 hours after injury. The proximal stump is 
divided into three 2mm segments. The contralateral uninjured nerve is used for comparison. Scale bar represents 
50μm. (B) Quantification of the percentage of c-Jun positive cells in the proximal stumps of WT mice 48 hours after 
nerve  transection.  WT  (n=3)  and  cKO  (n=3),  One-way  ANOVA with  Sidak  comparison,   p=0.0030   denotes 
significance. All statistical analysis is compared to WT uninjured levels.
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5.2.2 c-Jun is conditionally knocked out specifically from Schwann cells 
 
The following experiments address the specificity of the cKO mouse model. Sciatic 
nerves from adult 6-8 week old WT and cKO mice were dissected and dissociated to 
produce mixed Schwann cell and fibroblast cultures. These cells were cultured for 48 
hours in vitro before being fixed and fluorescently labelled with Sox10 (a Schwann 
cell marker) and c-Jun antibodies and the nuclear dye DAPI. 
Immunofluorescence images of these WT and cKO Schwann cell and fibroblast 
cultures in Figure 5.4 show the cells that labelled positively for Sox10 (Schwann cell 
marker) are c-Jun positive in WT cultures, however c-Jun negative in cKO cultures. 
The magnified images in Figure 5.4C show clearly the positive co-localisation of 
Sox10/c-Jun positive Schwann cells in WT, but not in cKO cultures. Quantification of 
the percentage of Schwann cells that expressed c-Jun in both WT and cKO cultures 
are seen in Figure 5.4B, confirming that c-Jun is not expressed by Schwann cells from 
the cKO mouse. To quantify the number of fibroblasts expressing c-Jun in WT and 
cKO cultures, morphology was used as depicted in Figure 5.4D. The graph in Figure 
5.4E also confirms that c-Jun in only knocked out of Schwann cells in the cKO model 
and not in other cells such as fibroblasts as these expressed c-Jun equally in WT and 
cKO cultures. 
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Figure 5.4 | 48 hours adult Schwann cell and fibroblast culture using sciatic nerves from WT and  cKO mice
(A) Immunofluorescence images taken at x25 magnification showing the population of Schwann cells that express c-
Jun after 48 hours in vitro. Schwann cells were cultured from both adult WT and cKO mice. Coverslips with cultured 
Schwann cells and fibroblasts were immunolabelled with c-Jun and Sox10 (Schwann cell marker) antibodies and with 
DAPI to label nuclei.  The white boxes highlight areas that are magnified to show co-localisation of Sox10/c-Jun 
positive cells. Scale bar represents 50μm. (B) Quantification of the percentage of c-Jun positive Schwann cells in both 
WT and cKO cultures. WT (n=3) and cKO (n=3); Mann-Whitney test, p=0.0002). (C) Magnified immunofluorescence 
images from (A) to demonstrate Sox10/c-Jun co-localisation indicated specifically by white arrowheads. Scale bar 
represents 25μm (D) Phase contrast image taken at x63 magnification to show how fibroblasts were identified in 
culture. Scale bar represents 50μm. (D)  Quantification of c-Jun positive fibroblasts in WT and cKO cultures. WT 
(n=3) and cKO (n=3); Mann-Whitney test, p=0.3308. All statistical analysis is compared to WT.
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To further demonstrate the effective c-Jun ablation specifically from Schwann cells in 
the cKO mouse model, pure macrophages were cultured for 24 hours in vitro from the 
peritoneal cavity of both WT and cKO mice. These macrophage cultures were later 
fixed and fluorescently labelled with F4/80 (a general macrophage marker) and c-Jun 
antibodies and with DAPI to label nuclei. Immunofluorescence images in Figure 5.5 
show that there is equal c-Jun expression in macrophages from WT and cKO mice, 
further confirming specific ablation of c-Jun only in Schwann cells. This is quantified 
in Figure 5.5B. 
 
Thus, results shown in Figures 5.4 and 5.5 validate use of the cKO model to 
determine the percentage of c-Jun expression in proximal stump Schwann cells after 
sciatic nerve transection. 
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Figure 5.5 | 24 hours peritoneal macrophage cultures using adult WT and cKO mice
(A) Immunofluorescence images taken at x25 magnification showing the population of peritoneal macrophages that 
express  c-Jun after  24 hours  in  vitro.  Macrophages  were cultured from both WT and cKO mice.  Cultures  were 
immunolabelled with c-Jun and F4/80 (general macrophage marker) antibodies and with DAPI to label nuclei. Scale 
bar represents 50μm. (B) Quantification of the percentage of F4/80 positive macrophages expressing c-Jun. WT (n=3) 
and cKO (n=3); Mann-Whitney test p=0.4291. All statistical analysis is compared to WT. 
	   173	  
5.2.3 Macrophage recruitment in the proximal stump is similar in both WT and 
cKO mice 48 hours after sciatic nerve transection 
 
In peripheral nerves, myelin break down is a universal result of a wide range of 
conditions, one of which being sciatic nerve transection. The work establishing the 
role of macrophages in injured nerves is mainly done through analysis of the distal 
portion of the nerve that undergoes Wallerian degeneration. A commonly accepted 
idea about macrophages, is that following nerve injury whether transection or crush, 
they are recruited to the injury site through the release of Schwann cell factors such as 
MCP-1 and LIF (Tofaris et al., 2002), to start to break down myelin through the 
process of phagocytosis (Perry et al., 1993). In more recent work however, it has been 
shown that the initial phase of myelin breakdown (5-7 days) (Perry et al., 1993) is 
carried out through the process of autophagy by Schwann cells (Gomez-Sanchez et 
al., 2015), rather than phagocytosis as originally thought (Perry et al., 1993). 
Activated macrophages that invade injured nerves breakdown myelin by phagocytosis 
(Hirata and Kawabuchi, 2002; Ramaglia et al., 2008; Vargas et al., 2010; Dubový et 
al., 2013). This modified explanation of the role of macrophages in myelin clearance 
does not however negate their importance in the proximal stump following short-term 
injury. Work from Arthur-Farraj et al., 2012 demonstrated that initial macrophage 
recruitment in the distal stump of the nerve following injury was lower in the cKO 
compared to WT in the first 3mm of the distal stump but not more distally, therefore 
perhaps adding to the impairment of successful nerve regeneration.  
From experiments shown in Figure 5.6 where macrophage numbers were quantified in 
the proximal stump 48 hours after sciatic nerve transection, it is evident that the 
numbers between WT and cKO are not significantly different (Figure 5.6C). This 
further confirms that in the cKO proximal stump, the population of macrophages 
present may also be expressing c-Jun, which would affect the results of c-Jun 
elevation in WT proximal stump cells in Figure 5.3B. 
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Figure 5.6 | Percentage of F480 positive macrophages in proximal stump 48 hours after nerve 
(A) Immunofluorescence images taken at x25 magnification showing tissue sections of WT and cKO proximal stump 48 hours 
after sciatic nerve. These sections were immunolabelled with F4/80 (general macrophage marker) antibody and with DAPI to label 
nuclei. The contralateral uninjured nerves were used as controls. Scale bar represents 50μm. (B) Merged immunofluorescence 
image to show how positive F4/80 cells were quantified in transverse sections. Scale bar represents 50μm. (C) Quantification of the 
percentage of F4/80 positive macrophages in uninjured and injured nerves 48 hours after nerve transection in WT and cKO mice. 
WT (n=3) and cKO (n=3);  One-way ANOVA with Tukey comparison,  p=0.0206.  All  statistical  analysis  is  compared to WT 
uninjured levels, unless otherwise shown. 
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5.2.4 Rapid c-Jun elevation is localised to proximal stump Schwann cells  
 
To address exactly what the percentage of Schwann cells of the proximal stump 
specifically express c-Jun following sciatic nerve transection, the results shown in 
Figures 5.1-5.3 (analysis in WT mice), was also performed in the cKO mice. The use 
of the cKO allowed the percentage of Schwann cells in the proximal stump that 
express c-Jun after (1 hour, 6 hours and 48 hours) nerve transection to be determined 
exactly. The percentage of c-Jun expression in cKO uninjured nerves and proximal 
stumps reflects the total percentage of c-Jun positive cells and includes other cells in 
the nerve other than Schwann cells, as confirmed in Figures 5.4 and 5.5. Therefore, to 
determine the percentage of c-Jun elevation in Schwann cells only 1 hour, 6 hours and 
48 hours after injury in the proximal stump, c-Jun percentages from cKO mice were 
subtracted from the total percentages quantified in WT nerves. The graph in Figure 
5.7A is a summary of the c-Jun elevation seen in Schwann cells only at different times 
after injury and along the different distances from the injury site. 
The significance of this c-Jun elevation specifically in Schwann cells following 
injury, may be implicated in the ability of DRG neurons to respond to sciatic nerve 
transection, which will be discussed in Chapter 6.  
 
Though it is now clear that at 1 hour and 6 hours after injury in the first 2mm the 
percentage elevation of c-Jun in proximal stump Schwann cells is maintained at 62%, 
there is a decrease in this elevation at 48 hours down to 45% which is due to the fact 
that at this time point more macrophages, which also express c-Jun are likely to have 
been recruited to the injury site. The percentage of c-Jun elevation seen in the next 2-
4mm segment is slightly higher at 1 hour (43%) whereas at 6 hours and 48 hours this 
is less (27%). Finally, at the 4-6mm segment, c-Jun expression is lowest at 1 hour 
(7%) and increases significantly to 27% at 6 hours and 48 hours. A summary diagram 
is shown in Figure 5.7B to illustrate these changes in Schwann cell c-Jun expression 
in proximal stumps over time and along distances from the injury site. 
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Figure 5.7 | c-Jun expression in proximal stump Schwann cells increases in time and space 
(A) Quantification of the percentage of c-Jun expression in WT proximal stump Schwann cells from uninjured levels to 
1 hour, 6 hours and 48 hours following nerve transection, at different distances from the transection site. WT (n=3) and 
cKO (n=3); Two-way ANOVA with Sidak comparison, p<0.0001. Statistical analysis is all relative to 1 hour at each 
distance. (B) Summary diagram to show how levels of c-Jun expression in WT proximal stump Schwann cells change 
within time and along different distances from the injury site. 
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5.2.5 c-Jun elevation after injury is equal in Remak and Myelin Schwann cells 
 
Schwann cells mature into two distinct subpopulations depending on axon size and 
signals from them to form Myelin or Remak Schwann cells. Myelin Schwann cells 
form a 1:1 relationship with an axon, whereas Remak Schwann cells ensheath several 
axons. Figure 5.1 shows that WT proximal stump Schwann cells express c-Jun highly 
1 hour after sciatic nerve transection, however from these results it is not clear 
whether the expression of c-Jun seen is in Myelin or Remak Schwann cells. To 
answer this question, teased nerve fibre preparations were taken from both WT and c-
Jun cKO proximal stumps 1 hour (first 2mm) following nerve transection, where 
highest c-Jun elevation was observed. These were fixed and fluorescently 
immunolabelled using L1 as a Remak Schwann cell marker (Hantke et al., 2014), c-
Jun and DAPI to label nuclei, while the morphology of the nerve fibre under phase 
contrast optics was used to determine which cells were myelinating Schwann cells. 
Immunofluorescence images in Figure 5.8A reveal some weak c-Jun expression in 
24% of WT uninjured nerves, which then increases to 73% after injury, conversely to 
what is seen in the cKO nerves where there is no c-Jun expression in Remak Schwann 
cells. This difference in the WT was statistically significant compared to WT 
uninjured nerves (Figure 5.8B). 
Immunofluorescence images in Figure 5.8C show the lack of c-Jun expression in 
uninjured Myelin Schwann cells, but the elevation of c-Jun in these cells can still be 
detected after injury in the WT.  This elevation in WT teased fibre preparations from 
uninjured (2%) to injured (45%) was also statistically significant as shown in Figure 
5.8D. The lack of c-Jun expression in both uninjured and injured nerves of the c-Jun 
cKO, further demonstrates that the specificity of this c-Jun expression after nerve 
transection is within Schwann cells. 
 
Therefore c-Jun is expressed to very high levels and rapidly following nerve injury, 
equally in Remak and Myelin Schwann cells. This c-Jun elevation in proximal stump 
Schwann cells increases further away from the injury site with time, but the initial 
elevation at the injury site is maintained over several hours. 
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Figure 5.8 | Teased nerve fibres 1 hour after nerve transection from 0-2mm of WT and cKO proximal stumps
(A) Immunofluorescence images taken at x63 magnification showing teased fibres 1 hour after sciatic nerve transection 
from the site most proximal to the injury (0-2mm) using both WT and cKO mice. Teased fibre preparations were 
immunolabelled with L1 (Remak Schwann cell  marker)  and c-Jun antibodies and with DAPI to label  nuclei.  (B) 
Quantification of the percentage of Remak Schwann cells expressing c-Jun 1 hour after injury in WT and cKO sciatic 
nerves. WT (n=3) and cKO (n=3); Student T-test, p=0.0087). Scale bar represents 50μm. (C) Immunofluorescence 
images taken at x25 magnification showing teased fibres 1 hour after sciatic nerve transection from the site most 
proximal to the injury (0-2mm) using both WT and cKO mice. Teased fibre preparations were immunolabelled with c-
Jun  antibody  and  with  DAPI  to  label  nuclei.  Phase  contrast  was  used  to  determine  Myelin  Schwann  cells.  (D) 
Quantification of the percentage of Myelin Schwann cells expressing c-Jun 1 hour after injury in WT and cKO sciatic 
nerves.  Student  T-test,  p=0.0012.   Scale bar  represents  50μm. 200 cells  were quantified from each genotype.  All 
statistical analysis is compared to WT uninjured levels.
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In summary, proximal stump Schwann cells express very high levels of c-Jun as early 
as 1 hour following sciatic nerve transection. These levels are maintained near the 
injury site, and with longer time point after injury, c-Jun levels become more and 
more elevated further from the injury site. c-Jun expression in proximal stump 
Schwann cells is equally present in Remak and Myelin Schwann cells following nerve 
injury. Schwann cell c-Jun however does not affect the expression of retrograde 
axonal injury signals to the neuronal cell body.  
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5.3 Discussion 
 
Schwann cell c-Jun is an important determining factor in the response to nerve injury, 
most notably its role in the cellular reprogramming of Remak and Myelin Schwann 
cells into repair Bungner Schwann cells (Arthur-Farraj et al., 2012; Fontana et al., 
2012; Jessen et al., 2015; Jessen and Mirsky, 2016).  
The results presented in this chapter shed some light on the role of Schwann cell c-Jun 
in the proximal stump in contrast to previous work on the distal stump, in determining 
the role of Schwann cell c-Jun in nerve regeneration. Although work from Arthur-
Farraj et al., 2012 shows that high levels of Schwann cell c-Jun result in Schwann 
cells being reprogrammed into functionally distinct repair Bungner Schwann cells that 
aid nerve regeneration, one could question whether the high levels of c-Jun expression 
seen in proximal stump Schwann cells would result in the same effect. One important 
difference to reiterate is that when the Schwann cell c-Jun elevation seen in this 
chapter at short time points after injury in the proximal stump, and is compared with 
levels seen at longer time points after injury in the distal stump, the levels of c-Jun 
seen measured by Western blotting in proximal stump Schwann cells are much lower 
than those seen in the distal stump Schwann cells that become repair Bungner 
Schwann cells (unpublished observations JA Gomez-Sanchez).  
The results presented here do not determine the signalling cascade through which 
these effects take place following c-Jun elevation in Schwann cells following injury, 
however the work of Charlotta Lindwall Blom and others published in 2014 using 
Schwann cell experiments confirmed that nerve injury induced Schwann cell c-Jun 
activation is JNK independent.  
 
Inflammatory cytokines such as LIF, IL-6 and TNFα that are expressed following 
nerve injury have been shown to activate MAPKs or the JAK/STAT signalling 
pathway, both of which are strongly implicated in neuronal activation (Sheu et al., 
2006; Qiu et al., 2005). IL-6 is thought to modulate neuronal outgrowth through the 
activation of the JAK/STAT signalling pathway within the axon, which leads to an 
increase in the level of p-STAT3 and hence this is subsequently retrogradely 
transported back to the soma, where it promotes the up-regulation of GAP-43 (Qiu et 
al., 2005). With this in mind, it would be interesting to see if levels of such 
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inflammatory cytokines are different in the proximal stump of cKO mice compared to 
WT, as this could be important in determining the possible role of levels of c-Jun 
expression in proximal stump Schwann cells after injury, and their role in neuronal 
cell body response to axotomy, when many genes associated with regeneration are 
expressed in DRG neurons within hours following nerve injury (Lindwall et al., 2004; 
Qiu et al., 2005; Zou et al., 2009). Although macrophages also express these 
inflammatory cytokines, their numbers in the nerve only rise significantly 48 hours 
after nerve transection (Stoll et al., 1989; Perry et al., 1987).  
 
The experiments in the following chapter address the question of whether c-Jun 
dependent signalling from the proximal stump Schwann cells controls the growth 
response of neurons.  
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6. Schwann cell c-Jun dependent neuronal activation in response to 
nerve injury 
 
6.1 Introduction  
 
As previously mentioned, in contrast to central nerves, peripheral nerves have the 
remarkable ability to re-generate (albeit to a limited extent) following nerve injury. 
This is due to the glial cells of peripheral nerves and also the responses of the 
neuronal cell body to axotomy (Abe and Cavalli, 2008). Following nerve injury, DRG 
neurons express many RAGs that are crucial for successful neuronal outgrowth, 
unlike in the CNS, where this is not seen to the same extent (Chandran et al., 2016). 
Peripheral nerve injury causes neurons to switch from a signalling mode to a growth 
one, which promotes successful peripheral nerve regeneration (Navarro et al., 2007; 
Abe and Cavalli, 2008).  
Further evidence highlighting the importance of the response of peripheral neurons to 
injury, is the work which demonstrated that following a conditioning lesion of the 
peripheral branch of DRG neurons, the intrinsic molecular changes that take places, 
are sufficient to cause the central axons of DRG neurons to regenerate (McQuarrie, 
1985; Neumann and Woolf, 1999).  
 
The neuronal cell body response to peripheral nerve injury is as important as that of 
the cells proximal to the injury site. In the Chapter 5, following sciatic nerve 
transection, c-Jun was elevated in proximal stump Schwann cells as early as 1 hour 
following nerve injury, and this elevation was maintained up to 48 hours later. The 
time course of this proximal stump Schwann cell c-Jun elevation is suggestive of the 
fact that c-Jun is present in Schwann cells at the necessary time required to drive a 
signalling cascade that would result in neuronal activation. It was therefore of interest 
to see whether or not the early and rapid elevation of proximal stump Schwann cell c-
Jun following nerve injury, was sufficient to affect the neuronal cell body response to 
nerve axotomy and whether c-Jun elevation in proximal stump Schwann cells has a 
role in the crucial switch of DRG neurons from signalling to growth.  
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6.2 Results 
 
6.2.1 RAG expression in L4 DRG neurons following sciatic nerve transection 
 
Is proximal stump Schwann cell c-Jun elevation important for the up-regulation of 
well known RAGs following sciatic nerve transection? To address this question, 
sciatic nerves from WT and cKO mice were transected at the sciatic notch and these 
mice were allowed to recover for 48 hours after the transection before being culled (as 
described in Chapter 2, section 2.3.2.3). The L4 DRG neurons (uninjured and injured) 
from WT and cKO mice were analysed by immunofluorescence and Western blot for 
the expression of several known RAGs which included c-Jun, ATF3, p-STAT3 
Tyr705, p-STAT3 Ser727 and GAP43 in the neuronal soma (Figures 6.1-6.10). For all 
L4 DRG immunofluorescence quantification presented below, the most strongly 
expressing neurons were determined as defined in Chapter 2, section 2.3.9.2.  
 
An obvious RAG candidate to analyse was c-Jun, and its expression in neurons 
following nerve transection. The cKO mouse model is only a knockout of c-Jun in 
Schwann cells (Figures 5.4 and 5.5); therefore it was of interest to see if proximal 
stump Schwann cell c-Jun was important for neuronal c-Jun expression. Previous 
studies have shown the importance of neuronal c-Jun activation following nerve 
injury to promote successful nerve regeneration through use of a neuronal c-Jun 
knockout mouse (Raivich et al., 2004; Makwana et al., 2010; Fontana et al., 2012). 
With this in mind, it was valid to address the question of whether proximal stump 
Schwann cell c-Jun affects neuronal c-Jun expression, ultimately affecting nerve 
regeneration. Figure 6.1A shows nuclear expression of c-Jun in L4 uninjured and 
injured DRG neurons 48 hours after sciatic nerve transection. From the representative 
immunofluorescence images shown in Figure 6.1A, it is clear that levels of c-Jun 
expression in uninjured L4 DRG neurons of WT and cKO mice are barely detectable, 
yet as expected, there is a clear elevation of nuclear c-Jun expression in neurons 
following nerve transection.  
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This elevation of neuronal c-Jun appears to be similar in both WT and cKO injured 
L4 DRG neurons (Figure 6.1A), yet upon closer inspection through quantification of 
this c-Jun expression (Figures 6.1B and 6.1C), there is a mild decrease in c-Jun 
expression in the cKO mouse following injury. This mild decrease in neuronal c-Jun 
expression in the cKO does not reach significance (Figure 6.1B) when counting c-
Jun/NF200 positive neurons, regardless of their signal intensity where WT levels are 
51% compared to cKO levels of 47%. Nevertheless, as seen in Figure 6.1C, if these c-
Jun expression levels are quantified by analysing only the strongest expressing c-Jun 
positive neurons, the mild decrease of c-Jun expression seen in the cKO becomes 
statistically significant, decreasing from 35% in the WT to 29% in the cKO neurons. 
Although there is only a modest decrease seen in neuronal c-Jun expression 48 hours 
following sciatic nerve transection in the cKO mouse, this may be of significance later 
on in the regenerative process, as there is a body of evidence that shows how 
important c-Jun is both in neurons (Makwana et al., 2004; Fontana et al., 2012) and 
Schwann cells of the distal stump (Parkinson et al., 2008; Arthur-Farraj et al., 2012).  
Western blot analysis of WT and cKO L4 DRGs (uninjured and injured) 48 hours 
after sciatic nerve transection (Figure 6.2) supported the findings from Figure 6.1. The 
c-Jun band seen in cKO injured DRG lane in the representative Western blot image 
(Figure 6.2A) is less intense compared to the WT one. Important to note however is 
that the levels of c-Jun expression in L4 uninjured DRGs from WT and cKO mice are 
equal, therefore further indicating that c-Jun is only knocked out of Schwann cells in 
the cKO model, which is seen both in the immunofluorescence quantification (Figures 
6.1B and 6.1C) and Western blot quantification (Figure 6.2B).  Western blot 
quantification agrees with the immunofluorescence quantification where a mild 
decrease is seen in cKO mice, although this does not reach significance when 
normalised to WT uninjured levels (Figure 6.2B).  
Although there is a mild decrease seen in c-Jun expression in DRG neurons following 
sciatic nerve injury, this may be enough to affect the rate of neuronal outgrowth. This 
possible hypothesis that lack of Schwann cell c-Jun decreases neuronal outgrowth 
after injury will be addressed later in this chapter.  
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Figure 6.1 | c-Jun expression in L4 DRGs 48 hours after sciatic nerve transection
(A) 5μm thick L4 DRGs (uninjured and injured) cryosections from WT and cKO were immunolabelled with NF200 
(neuronal marker)  and c-Jun antibodies and with DAPI to label  nuclei.  Immunofluorescence images taken at  x25 
magnification showing the population of neurons (NF200 positive) that were also c-Jun positive in L4 uninjured and 
injured DRGs. (B) Quantification of the percentage of c-Jun/NF200 positive neurons in WT and cKO L4 uninjured and 
injured  DRG  neurons.  WT  (n=4)  and  cKO  (n=4);  One-way  ANOVA with  Tukey  comparison,  p<0.0001.  (C) 
Quantification of the percentage of the strongest c-Jun/NF200 positive neurons in WT and cKO L4 uninjured and 
injured DRG neurons. One-way ANOVA with Tukey comparison, p<0.0001). All statistical analysis is compared to 
WT uninjured levels, unless otherwise shown.
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Figure 6.2 | Western blot of c-Jun expression in L4 DRGs 48 hours after sciatic nerve transection 
(A) Representative Western blot of c-Jun expression in L4 uninjured and injured DRG protein extracts from WT and 
cKO mice 48 hours after sciatic nerve transection. GAPDH is used as a reference gene. (B) Quantification of the level 
of c-Jun expression in WT and cKO L4 uninjured and injured DRGs. c-Jun expression in normalised to GAPDH, and 
then expressed as a fold change relative to WT uninjured levels. WT (n=3) and cKO (n=3); One-way ANOVA with 
Tukey comparison, p<0.0001. All statistical analysis is compared to WT uninjured levels, unless otherwise shown. 
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Another important RAG transcription factor is ATF3. It is specifically expressed in 
neurons following injury and is associated with promoting neurite outgrowth, neurite 
elongation and cell survival (Nakagomi et al., 2003; Seijffers et al., 2007; Kiryu-Seo 
et al., 2008; Linda et al., 2011; Hunt et al., 2012; Fu and Killberg, 2012). This means 
that ATF3 is a very important RAG not only for these reasons, but also because it 
works with c-Jun to bring about certain aspects of effective regeneration (Fagoe et al., 
2015). Analysis of ATF3 neuronal expression in L4 uninjured and injured DRG 
neurons from WT and cKO mice showed no difference in expression (Figure 6.3A-C). 
Whether analysing all neurons expressing ATF3 in WT and cKO (uninjured and 
injured) L4 DRG neurons (Figure 6.3B) or specifically the strongly positive ATF3 
neurons (Figure 6.3C), no difference was observed. Levels of ATF3 expression seen 
in WT injured neurons were 45% compared to 43% in cKO injured DRG neurons 
(Figure 6.3B). When comparing only the most strongly expressing ATF3 neurons, 
WT injured levels were 22% compared to cKO injured levels of 23% (Figure 6.3C). 
In conclusion, the lack of c-Jun in proximal stump Schwann cells is not enough to 
affect the up-regulation of ATF3 in DRG neurons following nerve injury.  
 
The results depicted in Figure 6.3 were confirmed by Western blot analysis where a 
representative image is shown in Figure 6.4A and the quantification relative to WT 
uninjured levels in Figure 6.4B. 
The results in Figures 6.3 and 6.4 suggest that neuronal ATF3 activation in L4 DRGs 
48 hours after nerve transection is not determined by the presence of high and 
maintained levels of Schwann cell c-Jun expression in the proximal stump.  
 
  
	   188	  
  
Figure 6.3 | ATF3 expression in L4 DRGs 48 hours after sciatic nerve transection
(A) 5μm thick L4 DRGs (uninjured and injured) cryosections from WT and cKO were immunolabelled with NF200 
(neuronal marker) and ATF3 antibodies and with DAPI to label nuclei.  Immunofluorescence images taken at  x25 
magnification showing the population of neurons (NF200 positive) that were also ATF3 positive in L4 uninjured and 
injured DRGs. (B) Quantification of the percentage of ATF3/NF200 positive neurons in WT and cKO L4 uninjured and 
injured  DRG  neurons.  WT  (n=4)  and  cKO  (n=4);  One-way  ANOVA with  Tukey  comparison,  p<0.0001.  (C) 
Quantification of the percentage of the strongest ATF3/NF200 positive neurons in WT and cKO L4 uninjured and 
injured DRG neurons. One-way ANOVA with Tukey comparison, p<0.0001. All statistical analysis is compared to WT 
uninjured levels, unless otherwise shown.
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Figure 6.4 | Western blot of ATF3 expression in L4 DRGs 48 hours after sciatic nerve transection 
(A) Representative Western blot of ATF3 expression in L4 uninjured and injured DRG protein extracts from WT and 
cKO mice 48 hours after sciatic nerve transection. GAPDH is used as a reference gene. (B) Quantification of the level 
of ATF3 expression in WT and cKO L4 uninjured and injured DRGs. ATF3 expression was normalised to GAPDH, 
and then expressed as a fold change relative to WT uninjured levels. WT (n=3) and cKO (n=3); One-way ANOVA with 
Tukey comparison, p=0.0533. All statistical analysis is compared to WT uninjured levels, unless otherwise shown. 
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STAT3, c-Jun and ATF3 are the most commonly investigated transcription factor 
RAGs that are expressed in response to nerve injury (Haas et al., 1999; Tsujino et al., 
2000; Nakagomi et al., 2003; Raivich et al., 2004; Patodia and Raivich, 2012). This 
means that STAT3 is also a prime candidate for expression analysis in (uninjured and 
injured) L4 DRG neurons in WT and cKO mice following sciatic nerve transection. 
Classically, phosphorylation of STAT3 on the tyrosine 705 (Tyr705) residue is 
analysed (Lee et al., 2004; Qiu et al., 2005; Bareyre et al., 2011; Ben-Yaakov et al., 
2012; Shin et al., 2012), yet phosphorylation of STAT3 on the serine 727 (Ser727) 
residue is also important, but not necessary for the translocation of STAT3 into the 
nucleus (Lee et al., 2009; Zhou and Too, 2013; Mandal et al., 2014). For these 
reasons, both Tyr705 and Ser727 phosphorylation of STAT3 were analysed in L4 
DRG neurons of WT and cKO mice 48 hours after sciatic nerve transection (Figures 
6.5-6.8). Immunofluorescence images in Figure 6.5A, along with their quantification 
in Figures 6.5B and 6.5C show that the lack of Schwann cell c-Jun expression after 
sciatic nerve transection does not affect the expression of p-STAT3 Tyr705 in 
(uninjured and injured) L4 DRG neurons. Though there was clear up-regulation of p-
STAT3 Tyr705 in WT and cKO L4 DRG neurons 48 hours after injury, from 13% to 
38% (WT) and 11% to 38% (cKO), this was not significantly different between WT 
and cKO mice (Figure 6.5B). Quantifying only the strongest p-STAT3 Tyr705 
expressing neurons showed the same result (Figure 6.5C). These immunofluorescence 
results were confirmed by Western blot analysis, shown in Figure 6.6. 
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Figure 6.5 | p-STAT3 Tyr705 expression in L4 DRGs 48 hours after sciatic nerve transection
(A) 5μm thick L4 DRGs (uninjured and injured) cryosections from WT and cKO were immunolabelled with NF200 
(neuronal marker) and p-STAT3 Tyr705 antibodies and with DAPI to label nuclei. Immunofluorescence images taken 
at x25 magnification showing the population of neurons (NF200 positive) that were also p-STAT3 Tyr705 positive in 
L4 uninjured and injured DRGs. (B) Quantification of the percentage of p-STAT3 Tyr705/NF200 positive neurons in 
WT and cKO L4 uninjured and injured DRG neurons.  WT (n=3) and cKO (n=3); One-way ANOVA with Tukey 
comparison, p<0.0001. (C) Quantification of the percentage of the strongest p-STAT3 Tyr705/NF200 positive neurons 
in WT and cKO L4 uninjured and injured DRG neurons. One-way ANOVA with Tukey comparison, p<0.0001. All 
statistical analysis is compared to WT uninjured levels, unless otherwise shown.
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Figure 6.6 | Western blot of p-STAT3 Tyr705 expression in L4 DRGs 48 hours after sciatic nerve transection 
(A) Representative Western blot of p-STAT3 Tyr705 expression in L4 uninjured and injured DRG protein extracts from 
WT and cKO mice 48 hours after sciatic nerve transection. GAPDH is used as a loading control, and the reference 
gene is STAT3. (B) Quantification of the level of p-STAT3 Tyr705 expression in WT and cKO L4 uninjured and 
injured DRGs. p-STAT3 Tyr705 expression was normalised to STAT3, and then expressed as a fold change relative to 
WT uninjured levels. WT (n=2) and cKO (n=2). No statistical analysis was carried out.
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Quantification of p-STAT3 phosphorylation on the Ser727 residue was measured by 
counting the total number of positively labelled Ser727/NF200 neurons regardless of 
intensity. These results are shown in Figure 6.7A and 6.7B. A surprising outcome was 
that the uninjured levels in the cKO (29%) were higher than in the WT (20%), and 
that following nerve transection, there was no significant elevation seen in the injured 
L4 DRG neurons of WT (19%) and cKO (27%) mice.  
It was unexpected to see that expression of p-STAT3 Ser727 was not higher after 
injury compared to uninjured levels as it is well documented that STAT3 becomes 
phosphorylated after injury on the Tyr705 residue, but this appears not to be the case 
for Ser727 in DRG neurons. Further analysis would be needed to elucidate the 
significance of this finding.  
The result seen by immunofluorescence of p-STAT3 Ser727 expression in L4 DRG 
neurons of uninjured and injured mice was confirmed by Western blot analysis 
(Figure 6.8). The Western blot results (Figure 6.8) also showed that there was no 
higher expression of p-STAT3 Ser727 expression in L4 DRG neurons of WT and 
cKO mice in injured compared with uninjured levels.  
The results above shown in Figures 6.5-6.8 suggest that the lack of Schwann cell c-
Jun does not determine the phosphorylation of STAT3 (both Tyr705 and Ser727) in 
L4 DRG neurons following sciatic nerve injury.  
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Figure 6.7 | p-STAT3 Ser727 expression in L4 DRGs 48 hours after sciatic nerve transection
(A) 5μm thick L4 DRGs (uninjured and injured) cryosections from WT and cKO were immunolabelled with NF200 
(neuronal marker) and p-STAT3 Ser727 antibodies and with DAPI to label nuclei. Immunofluorescence images taken 
at x25 magnification showing the population of neurons (NF200 positive) that were also p-STAT3 Ser727 positive in 
L4 uninjured and injured DRGs. (B) Quantification of the percentage of p-STAT3 Ser727/NF200 positive neurons in 
WT and cKO L4 uninjured and injured DRG neurons.  WT (n=3) and cKO (n=3); One-way ANOVA with Tukey 
comparison, p=0.0076. All statistical analysis is compared to WT uninjured levels, unless otherwise shown. 
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Figure 6.8 | Western blot of p-STAT3 Ser727 expression in L4 DRGs 48 hours after sciatic nerve transection 
(A) Representative Western blot of p-STAT3 Ser727 expression in L4 uninjured and injured DRG protein extracts from 
WT and cKO mice 48 hours after sciatic nerve transection. GAPDH is used as a loading control, and the reference 
gene is STAT3. (B) Quantification of the level of p-STAT3 Ser727 expression in WT and cKO L4 uninjured and 
injured DRGs. p-STAT3 Ser727 expression was normalised to STAT3, and then expressed as a fold change relative to 
WT uninjured levels. WT (n=3) and cKO (n=3); One-way ANOVA with Tukey comparison, p=0.2287. All statistical 
analysis is compared to WT uninjured levels, unless otherwise shown. 
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A well-studied and characterised gene associated with successful nerve regeneration 
is GAP43, which is more strongly expressed in sensory neurons following nerve 
injury (Schreyer and Skene, 1993; Chong et al., 1994; Zhang et al., 2005; Hunt et al., 
2012). The importance of GAP43 expression in neurons has been shown both in vivo 
and in vitro (Meiri et al., 1988; Woolf et al., 1990; Schreyer and Skene, 1991; 
Schreyer et al., 1997; Cafferty et al., 2004). 
To determine whether or not Schwann cell c-Jun elevation in the proximal stump 
could act as a positive signal to the neuron to express more GAP43 following nerve 
injury and therefore increase the chances of successful nerve repair was one of 
importance. To do this, WT and cKO mice with transected sciatic nerves for 48 hours, 
had their L4 DRG neurons (uninjured and injured) dissected and analysed by 
immunofluorescent labelling and Western blot analysis (Figures 6.9 and 6.10).   
 
GAP43 expression in L4 DRG (uninjured and injured) neurons 48 hours after nerve 
transection from WT and cKO mice was significantly higher in WT injured (59%) 
compared to cKO injured (47%) whereas the uninjured levels in WT and cKO were 
not significantly different, 31% and 29% respectively (Figures 6.9A and 6.9B). This 
significant decrease in GAP43 expression in injured cKO neurons compared to WT 
injured was maintained when quantifiying only the strongest GAP43/NF200 
expressing neurons as shown in Figure 6.9C. The results in Figure 6.9 suggest that 
Schwann cell c-Jun in the proximal stump is having a small but significant effect on 
the expression of GAP43 in neurons 48 hours after injury. since the number of 
GAP43 positive neurons in the cKO injured L4 DRG  is lower compared to WT.  
 
Western blot analysis of GAP43 expression in L4 DRGs (uninjured and injured) of 
WT and cKO mice correlated with the immunofluorescence results shown in Figure 
6.9, and although the decrease in GAP43 elevation seen in cKO mice compared to 
WT, 2.4 fold compared to 3.1 fold, respectively, did not reach significance the trend 
was clear (Figure 6.10). The quantification suggests that GAP43 is elevated less in 
cKO mice L4 DRG neurons following injury compared to those of WT mice.  
The results from Figures 6.9 and 6.10 suggest that the lack of Schwann cell c-Jun in 
the proximal stump is affecting the ability of L4 DRG neurons to up-regulate GAP43 
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expression. This difference in expression of GAP43 between WT and cKO L4 DRG 
neurons may be important in determining the outcome of growth cone progression, 
which is not addressed in this thesis (Skene and Virag, 1989).  
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Figure 6.9 | GAP43 expression in L4 DRGs 48 hours after sciatic nerve transection
(A) 5μm thick L4 DRGs (uninjured and injured) cryosections from WT and cKO were immunolabelled with NF200 
(neuronal marker) and GAP43 antibodies and with DAPI to label nuclei. Immunofluorescence images taken at x25 
magnification showing the population of neurons (NF200 positive) that were also GAP43 positive in L4 uninjured and 
injured DRGs. (B) Quantification of the percentage of GAP43/NF200 positive neurons in WT and cKO L4 uninjured 
and injured DRG neurons.  WT (n=3)  and cKO (n=3);  One-way ANOVA with  Tukey comparison,  p<0.0001.  All 
statistical analysis is compared to WT uninjured levels, unless otherwise shown. (C) Quantification of the percentage 
of the strongest GAP43/NF200 positive neurons in WT and cKO L4 uninjured and injured DRG neurons. One-way 
ANOVA with  Tukey  comparison,  p<0.0001.  All  statistical  analysis  is  compared  to  WT uninjured  levels,  unless 
otherwise shown.
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Figure 6.10 | Western blot of GAP43 expression in L4 DRGs 48 hours after sciatic nerve transection 
(A) Representative Western blot of GAP43 expression in L4 uninjured and injured DRG protein extracts from WT and 
cKO mice 48 hours after sciatic nerve transection. GAPDH is used as a reference gene. (B) Quantification of the level 
of GAP43 expression in WT and cKO L4 uninjured and injured DRGs. GAP43 expression was normalised to GAPDH, 
and then expressed as a fold change relative to WT uninjured levels. WT (n=3) and cKO (n=3); One-way ANOVA with 
Tukey comparison, p=0.0014. All statistical analysis is compared to WT uninjured levels, unless otherwise shown. 
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Cytokine release has also been shown to induce expression of c-Jun, STAT3 and 
GAP43, so to address whether differential expression of some RAGs was due to 
macrophage populations, WT and cKO uninjured and injured L4 DRG neurons were 
quantified using F4/80 as a general macrophage marker, 48 hours after sciatic nerve 
transection. This experiment was repeated only twice, therefore no concrete 
conclusions can be drawn, but it provides a potential insight into what is happening. 
Levels of F4/80 expression were analysed by immunofluorescent labelling of L4 
DRG sections and quantified to show that the level of macrophage expression in WT 
and cKO uninjured L4 DRGs was 21% and 27% respectively, and both levels were 
elevated to 41% (WT) and 42% (cKO) after sciatic nerve injury, shown in Figure 
6.11. As the experiment was only done twice, the slight elevation of macrophages in 
the cKO uninjured may not be of significance because the presence of macrophages in 
the injured DRGs is very similar in WT and cKO mice.   
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Figure 6.11 | Percentage of F480 positive macrophages in L4 DRGs 48 hours after sciatic nerve transection
(A) 5μm thick L4 DRGs (uninjured and injured) cryosections from WT and cKO were immunolabelled with NF200 
(neuronal  marker)  and  F4/80  (general  macrophage  marker)  antibodies  and  with  DAPI  to  label  nuclei. 
Immunofluorescence images taken at x25 magnification showing the population of neurons (NF200 positive) that were 
also F4/80 positive in L4 uninjured and injured DRGs. (B) Quantification of the percentage of F4/80/NF200 positive 
neurons in WT and cKO L4 uninjured and injured DRG neurons. WT (n=2) and cKO (n=2). No statistical analysis was 
done. 
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6.2.2 Proximal stump Schwann cell c-Jun modestly affects neuronal outgrowth 
following a conditioning lesion in vivo 
 
As mentioned earlier, axons of adult CNS nerves show very poor regeneration 
following nerve injury in contrast to those of peripheral nerves. The idea that 
increasing the ability of the neurons to respond to nerve injuries by upregulating 
important factors such as RAGs, is much discussed. CNS neurons following injury 
have limited expression of RAGs, compared to PNS neurons. As mentioned earlier, 
DRG neurons are unique in that they possess a single axon that is branched, with 
terminations both in the CNS and the PNS.  A commonly used paradigm to increase 
the ability of CNS neurons to show axonal outgrowth following injury, is the 
“conditioning lesion paradigm”. This is achieved by injuring the peripheral branch of 
DRG neurons before injuring the central branch, as the prior lesion of the peripheral 
branch primes the neuron to respond to the initial injury, so that when the central 
branch is injured, these primed neurons show some axonal outgrowth (McQuarrie, 
1985; Ramer et al., 2000; Neumann et al., 2002; Qiu et al., 2002). Using this 
paradigm, motor neurons originating in the CNS and projecting to the PNS and 
peripheral branches of DRG neurons also show increased outgrowth after prior injury. 
 
To address whether c-Jun elevation in proximal stump Schwann cells is important in 
the conditioning lesion effect, experiments were designed using WT and cKO mice. It 
is important to note however, that the following experiments were carried out only in 
the peripheral nerves, using the injury model described in Chapter 2, section 2.3.2.4. 
The comparison between the WT and cKO conditioning lesion effects is important as 
this is what would address the question of whether the absence of proximal stump 
Schwann cell c-Jun has a detrimental effect on the ability of neurons to be primed to 
an initial injury and therefore regenerate their injured axons. The effects from this 
lesion were analysed by assessing the number of positively regenerating axons using 
CGRP and galanin as markers for regenerating axons, at distances of 2mm and 3mm 
from the crush site in the PNS (sciatic notch). Although there is still extensive debate 
about which types of neurons both CGRP and galanin label, for the following 
experiments, they were used for analysis in the same way as Arthur-Farraj et al., 
2012. These results are shown in Figures 6.12 and 6.13. The controls for these 
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experiments were a single crush for 2.5D, where regenerating axons were quantified 
in the same way as for the conditioning lesion experiment, using CGRP and galanin. 
(For full details of how the experiment was carried out and specific time points please 
refer to Chapter 2, section 2.3.1.4). Both CGRP and galanin primarily label sensory 
axons (Gibson et al., 1984; Li et al., 2004), yet this distinction is still widely debated 
as some suggest that both CGRP and galanin are also expressed in motor neurons 
(Holmes et al., 2000; Fontana et al., 2012). 
 
A representative immunofluorescence image is shown in Figure 6.12A to demonstrate 
what CGRP positively labelled regenerating axons looked like. The number of CGRP 
positive regenerating axons in WT and cKO nerves 2.5D following nerve crush at 
2mm are very similar, 6 and 5 respectively (Figure 6.12B). Following a conditioning 
lesion at this same distance of 2mm from the crush site, the number of CGRP 
positively labelled regenerating axons increases both in WT (14) and cKO (8) as 
shown in Figure 6.12C. In terms of the conditioning effect, this is working in both 
WT and cKO mice as there is an obvious increase in the number of positively labelled 
regenerating CGRP axons in both genotypes, when comparing 2.5D crush (Figure 
6.12B) and conditioning lesion (Figure 6.12C). The marginal differences seen 
between WT and cKO CGRP positively labelled regenerating axons in the 
conditioning lesion experiment, suggest that Schwann cell c-Jun might have an effect 
on the priming of the DRG neurons to respond to the injury. However this does not 
reach significance, and it remains a trend (Figure 6.12C).  
 
At a distance of 3mm from the crush site both at 2.5D after crush (Figure 6.12D) and 
following a conditioning lesion (Figure 6.12E), the number of positively labelled 
regenerating CGRP follow a similar trend to that seen at 2mm. The conditioning 
effect is still seen in both WT and cKO, where the number of WT regenerating axons 
increases from 2 (2.5D crush) to 7 (conditioning lesion) and cKO from 1 (2.5D crush) 
to 5 (conditioning lesion). Again this difference between WT and cKO conditioning 
lesion effect does not reach significance and remains a trend. One thing to note 
however, is that at a distance of 3mm compared to 2mm, there are fewer regenerating 
axons altogether in both WT and cKO, which is expected.  
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Figure 6.12 | CGRP positive axons in WT and cKO mice following crush and conditioned lesion in vivo 
(A) 10μm thick longitudinal cryosections from 2.5D crushed WT sample. These sections were immunolabelled with 
CGRP  (primarily  recognises  sensory  neurons)  antibody  and  with  DAPI  to  label  nuclei.  A  representative 
immunofluorescent  image  taken  at  x25  magnification  to  show  an  example  of  CGRP positively  immunolabelled 
regenerating axons. Scale bar represents 50μm. (see Chapter 2, section 2.3.9.3 for full method of quantification) (B-C) 
Quantification to show the number of CGRP positively labelled regenerating axons at a distance of 2mm from the 
crush site were quantified. These CGRP positive axons were quantified from WT and cKO mice at 2.5D after crush (B) 
and following a conditioning lesion in vivo (C). (B) WT (n=4) and cKO (n=4); Mann-Whitney test, p=0.9714 /(C) WT 
(n=5) and cKO (n=5); Mann-Whitney test, p=0.6571. (D-E) Quantification to show the number of CGRP positively 
labelled regenerating axons at a distance of 3mm from the crush site were quantified. These CGRP positive axons were 
quantified from WT and cKO mice at 2.5D after crush (D) and following a conditioning lesion in vivo (E). (D) WT 
(n=4) and cKO (n=4); Mann-Whitney test, p=0.2063/ (E) WT (n=5) and cKO (n=5); Mann-Whitney test, p=0.3095. All 
statistical analysis is compared to WT.
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Another commonly used marker to label regenerating axons is galanin. A 
representative immunofluorescence image is shown in Figure 6.13A to demonstrate 
what galanin positively labelled regenerating axons look like. WT and cKO nerve 
samples from 2.5D and conditioning lesion experiments used in CGRP analysis were 
also used to analyse the number of galanin positive axons. Figure 6.13 shows the 
results obtained from this analysis. Positively labelled galanin regenerating axons at 
2mm from the crush site were higher in the conditioning lesion experiment in both 
WT and cKO nerves where positively labelled axons increased from 2 to 8 in WT and 
2 to 6 in cKO (Figure 6.13B and 6.13C). There is no significant difference between 
these results, although a slight trend can be seen. At a distance of 3mm from the crush 
site, as was seen with CGRP labelled axons, overall the number of positive axons was 
less in both WT and cKO compared to the 2mm distance (Figure 6.13B-D). The 
analysis of galanin positive axons in WT and cKO mice both at 2.5D after crush and 
after conditioning lesion experiments show almost identical numbers in both 
situations (Figure 6.13D and 16.3E), suggesting that at this distance, Schwann cell c-
Jun is not having a significant effect on the ability of galanin positive neurons to 
respond to the injury although numbers are small so this conclusion must be qualified.  
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Figure 6.13 | Galanin positive axons in WT and cKO mice following crush and conditioned lesion in vivo 
(A) 10μm thick longitudinal cryosections from 2.5D crushed WT sample. These sections were immunolabelled with 
galanin  (recognises  sensory  and  motorneurons)  antibody  and  with  DAPI  to  label  nuclei.  A  representative 
immunofluorescent image taken at x25 magnification to show an example of galanin positively labelled regenerating 
axons.  Scale  bar  represents  50μm.  (see  Chapter  2,  section  2.3.9.3  for  full  method  of  quantification)  (B-C) 
Quantification to show the number of galanin positively labelled regenerating axons at a distance of 2mm from the 
crush site were quantified. These galanin positive axons were quantified from WT and cKO mice at 2.5D after crush 
(B) and following a conditioning lesion in vivo (C). (B) WT (n=4) and cKO (n=4); Mann-Whitney test, p=0.5714  /(C)  
WT (n=5)  and  cKO (n=5);  Mann-Whitney  test,  p=0.3429.  (D-E)  Quantification  to  show the  number  of  galanin 
positively labelled regenerating axons at a distance of 3mm from the crush site were quantified. These galanin positive 
axons were quantified from WT and cKO mice at 2.5D after crush (D) and following a conditioning lesion in vivo (E). 
(D) WT (n=4) and cKO (n=4); Mann-Whitney test, p> 0.9999 / (E) WT (n=5) and cKO (n=5); Mann-Whitney test, p> 
0.9999. All statistical analysis is compared to WT.
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6.2.3 The effect of c-Jun elevation in proximal stump Schwann cells on neuronal 
outgrowth following a conditioning lesion in vitro 
 
In vivo analysis of the number of regenerating axons determined by CGRP and 
galanin labelling (Figure 6.12 and Figure 6.13) suggested a possible trend towards the 
idea that Schwann cell proximal stump c-Jun expression might have a modest effect 
on the ability of neurons to regenerate following a conditioning lesion injury. With 
this in mind, it was of interest to see if this possible influence of Schwann cell c-Jun 
on neuronal outgrowth after a conditioning lesion could be tested using dissociated L4 
DRG neurons in an in vitro model in which neurons are cultured on a permissive 
(PLL/laminin) and an inhibitory substrate (myelin) (for further details of the 
experimental procedure see Chapter 3, section 2.3.8.6).  
 
To address this question, it was important to define certain parameters:  
(i) the length of time the DRGs should be cultured for (ii) whether the myelin 
extracted is actually an inhibitory substrate (iii) whether both uninjured and injured 
L4 DRGs should be analysed and (iv) what concentration of myelin should be used.  
Figure 6.14 summarises all the tests that were carried out using WT L4 DRGs to 
determine optimal culture conditions, although no quantification is shown. Figure 
6.14A shows representative immunofluorescence images of WT uninjured L4 DRG 
neurons cultured on PLL/laminin for 24 hours or 48 hours to determine how much 
outgrowth was seen at these two time points. Several processes were seen at both time 
points, however at 48 hours the outgrowth was more evident. This experiment was 
repeated twice. Already by 24 hours considerable outgrowth seen from an injured L4 
DRG, so this is why in Figure 6.14B, the WT uninjured and injured L4 DRGs were 
cultured for a shorter period of time of 20 hours. This was to test the effect of a 
conditioning lesion injury to the sciatic nerve on the amount of outgrowth from L4 
DRG neurons on PLL/laminin and on a PLL/myelin surface in an uninjured and 
injured state.  It is clear from this that at 20 hours after plating there in enough 
outgrowth from L4 DRG neurons plated on both PLL/laminin and PLL/myelin, but 
that injury induces more outgrowth in both situations. This difference between 
uninjured and injured is less obvious on PLL/myelin, therefore suggesting that myelin 
at a concentration of 10μg/ml is concentrated enough to inhibit axonal outgrowth. 
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This experiment was repeated twice, and from these results, the final test of what 
would be the best myelin substrate to use was determined by using only injured WT 
L4 DRG neurons. These neurons were cultured for 20 hours on four different 
substrates: (i) PLL/laminin as a positive control to show the culture was working (ii) 
PLL/myelin (10μg/ml) (iii) PLL/myelin (1μg/ml)  (iv) PLL/laminin + myelin 
(1μg/ml). These experiments were repeated twice, and from the results in Figure 
6.14C, it was clear that both concentrations of myelin had the same effect on 
outgrowth, and that whether myelin is present or not, the presence of laminin 
particularly overcomes the inhibitory effects of myelin. For these reasons, myelin was 
used at a concentration of 1μg/ml without laminin, however PLL/laminin was used in 
each experiment as a positive control.  
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Figure 6.14 | Optimal DRG (conditioned lesion) culture conditions using PLL/laminin and PLL/myelin substrates
(A) 13mm round coverslips were fluorescently labelled with Tuj1 (neuronal marker) to determine the number of neurons 
present in the culture from WT uninjured L4 DRGs. These were cultured on PLL/laminin substrate for 24 hours  or 48 
hours in vitro before being fixed with 4% PFA. These are representative immunofluorescence images taken at  x25 
magnification. Scale bar represents 50μm. (B) 13mm round coverslips were fluorescently labelled with Tuj1 (neuronal 
marker) antibody to determine the number of neurons present in the culture from WT uninjured and injured (2.5D crush) 
L4 DRGs . Quantification not shown. These were cultured on PLL/laminin, PLL/myelin substrate for 20 hours in vitro 
before being fixed with 4% PFA. These are representative immunofluorescence images taken at x25 magnification. Scale 
bar represents 50μm. (C) 13mm round coverslips were fluorescently labelled with Tuj1 (neuronal marker) antibody and 
with DAPI (nuclear marker) to determine the number of neurons present in the culture from WT injured (2.5D crush) L4 
DRGs. Quantification not shown. These DRGs were cultured on PLL/laminin or PLL/myelin (10μg/ml), PLL/myelin 
(1μg/ml) and PLL/laminin + myelin (1μg/ml) substrates for 20 hours in vitro before being fixed with 4% PFA. These are 
representative immunofluorescence images taken at x25 magnification. Scale bar represents 50μm. 
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Taking into account this information, L4 DRG cultures were prepared from both WT 
and cKO mice that had their sciatic nerves transected for 2.5D (conditioning injury) 
after which the injured L4 DRGs from these mice were dissociated and the neurons 
cultured for a further 20 hours (PLL/laminin) or 48 hours (PLL/myelin), which was 
the equivalent of the second injury in vivo. Figure 6.15A and 6.15B show 
immunofluorescence images of WT and cKO injured L4 DRG cultures on both 
PLL/laminin and PLL/myelin. It is clear that the growth seen on PLL/laminin is much 
greater than that seen on PLL/myelin. The cultures grown on PLL/laminin served as a 
positive control for the experiment, and no further analysis was carried out on these. 
From the WT and cKO myelin cultures, quantification of number of neurons with 
neurites with or without supporting cells and the length of the longest neurite with or 
without supporting cells, was carried out as described in Chapter 3, section 2.3.9.5. 
The quantification shown in Figure 6.15C and 6.15D demonstrates that the average 
number of neurons counted with neurites in each experiment from WT and cKO, was 
very similar regardless of whether these neurons had supporting cells associated with 
them or not. Of the neurons counted with neurites in both situations from WT and 
cKO mice (Figure 6.15E and 6.15F), it is clear that whether or not there are 
supporting glial cells around the neurons, the average length of the longest neurite is 
virtually the same between both genotypes. When there are no glial cells associated 
with the neurons, the length of the longest neurite in both WT and cKO is shorter 
overall, which is not surprising, as the glial cells can provide support to the neurons to 
be able to grow further and longer. The results shown in Figure 6.15 are preliminary 
as they were only repeated twice, however they indicate that in vitro, Schwann cell c-
Jun does not affect the ability of neurons to grow on an inhibitory substrate following 
a conditioning lesion.  
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Figure 6.15 | Conditioned lesion L4 injured DRG cultures from WT and cKO mice
(A) 13mm round coverslips were fluorescently immunolabelled with Tuj1 (neuronal marker) antibody and DAPI to label 
nuclei, to determine the number of neurons present in the conditioned lesion L4 injured DRG culture from WT and cKO 
mice. These were cultured on PLL/laminin substrate for 20 hours in vitro before being fixed with 4% PFA. These are 
representative immunofluorescence images taken at x25 magnification. Scale bar represents 50μm. No quantification 
was made from these cultures, but they were used as a positive control to ensure that the culture was successful. (B) 
13mm round coverslips were fluorescently labelled with Tuj1 (neuronal marker) antibody and with DAPI to label nuclei 
to determine the number of neurons present in the conditioned lesion L4 injured DRG culture from WT and cKO mice. 
These  were  cultured  on  PLL/myelin  substrate  for  20  hours  in  vitro  before  being  fixed  with  4% PFA.  These  are 
representative immunofluorescence images taken at x25 magnification. Scale bar represents 50μm. (C-D) Quantification 
of the number of neurons (Tuj1 positive) that had neurites as well as supporting glial cells associated (C) and the number 
of neurons that had neurites without the presence of supporting glial cells (D). This analysis was done both in WT and 
cKO cultures. (n=2, no statistical analysis was done). (E-F) Quantification of the length of the longest neurite of neurons 
(Tuj1 positive) that had supporting glial cells associated (C) and the length of the longest neurite of those neurons 
without supporting glial cells (E). This analysis was done both in WT and cKO cultures. WT (n=2) and cKO (n=2). No 
statistical analysis was done. 
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6.3 Discussion 
 
Peripheral nerve injury causes activation of neurons resulting in a switch from a 
signalling mode to a growth one which promotes axonal outgrowth and successful 
peripheral nerve regeneration. The idea underlying this chapter was to try to 
understand the mechanisms through which this crucial switch takes place within the 
DRGs and whether Schwann cells might have a role to play. It is known that Schwann 
cells of the distal stump and c-Jun within these Schwann cells is important in 
successful peripheral nerve regeneration (Arthur-Farraj et al., 2012), however, results 
shown so far also suggest that Schwann cell c-Jun of the proximal stump might also 
be important in the process of peripheral nerve regeneration. Evidence is provided to 
support the idea that the lack of c-Jun in Schwann cells and therefore the lack of its 
up-regulation in Schwann cells of cKO mice, results in reduced levels of expression 
of certain RAGs, (particularly c-Jun and more strongly GAP43) in the DRGs.  Both of 
these are important in the neuronal cell response to nerve injury (Abe and Cavalli, 
2008; Ma and Willis, 2015; Chandran et al., 2016).  
The rapid up-regulation of c-Jun seen in Schwann cells at the injury site as early as 1 
hour after nerve transection, fits well with the early onset of RAG up-regulation that 
can be seen as early as 6 hours after nerve transection (Hunt et al., 2012). This 
strongly suggests that c-Jun would be present in Schwann cells at the necessary time 
required to drive a signalling cascade that would result in neuronal growth activation. 
Although the sciatic nerve is made up of many different cell types, the majority are 
Schwann cells and it is unlikely that at the early time point of 1 hour after nerve 
transection, invading cells such as macrophages would be present in significant 
numbers except at the immediate injury site, nevertheless these cell types should be 
taken into consideration at longer time points such as 48 hours after nerve transection. 
 
Although it is rather surprising that lack of Schwann cell c-Jun does not cause a 
greater down-regulation in neuronal expression of c-Jun in injured L4 DRGs 
compared to WT (Figures 6.1-6.2), it is possible to conclude that even the modest 
difference in c-Jun expression shown is enough to alter the neuronal cell body 
response to axotomy. The effect of proximal stump Schwann cell c-Jun on its 
neuronal expression is likely to be important early on following nerve injury (up to 48 
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hours) when the neuron is primed to change its program from one of signal 
transmission to target tissues, to one of growth in response to nerve injury. This 
important regulatory effect of c-Jun elevation in neurons is strengthened by recent 
work (Chandran et al., 2016), which shows that c-Jun is at the hub of the gene 
regulatory network controlling the peripheral nerve injury induced axonal growth 
program.  
 
The difference in uninjured levels of F4/80 seen between WT and cKO L4 DRGs may 
not be significant, although it may provide a possible explanation for the surprising 
result seen in p-STAT3 Ser727 expression levels. Although the differences between 
WT and cKO uninjured F4/80 levels in L4 DRG neurons are marginal (WT 21% and 
cKO 27%) and not significantly different, this slight increase in macrophage numbers 
in cKO might suggest that there are higher levels of cytokines such as TNF-α IL-1 
and IL-6 present in the cKO and these are known to increase phosphorylation of 
STAT3 (Qiu et al., 2005; Nguyen et al., 2015).  
 
 
Expression of GAP43 is an important part of the neuronal activation programme, as in 
its absence regeneration is impaired (Aigner et al., 1995). Figures 6.9 and 6.10 show 
that lack of Schwann cell c-Jun affects the expression of GAP43 in injured L4 DRG 
neurons, it would therefore be interesting to find out if this difference between WT 
and cKO is a transient one, or if it is maintained over long periods of time. 
Preliminary experiments in which analysis of cryosections of uninjured and injured 
(7D cut) WT and cKO L4 DRGs via immunofluorescent labelling with GAP43, 
NF200 and DAPI was carried out, suggest that this difference is a transient one. 7D 
following nerve cut, the levels of GAP43 expressed in L4 injured DRG neurons in 
WT and cKO are the same. This experiment was only repeated twice and was not 
analysed statistically (data not shown). It may be that levels of Schwann cell c-Jun in 
the proximal stump are important for the initial switch in the neuronal program from 
one of “transmission” to one of “growth” (Abe and Cavalli, 2008), but after this 
period, even though proximal stump c-Jun levels remain elevated, this is no longer 
critical/essential in terms of neuronal response to axotomy and in particular that of 
GAP43.  
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WT and c-Jun overexpressing mice, in particular OE/+ are very similar in terms of 
their nerve architecture, even though c-Jun is substantially elevated in Schwann cells. 
For this reason, in order to further elucidate the importance of Schwann cell c-Jun 
elevation in the proximal stump following injury and whether it has an effect in RAG 
expression, and therefore successful axonal regeneration, the OE/+ mouse could be 
analysed in a similar way as that shown in Figures 6.1-6.10. Preliminary data suggests 
that in terms of GAP43 expression (as this was most affected by lack of Schwann cell 
c-Jun), there seems to already be an increase in its neuronal expression in L4 
uninjured DRGs compared to WT levels. This experiment has only been done once, 
and so is statistically insignificant, yet it would slot in very nicely with the hypothesis 
that high expression of Schwann cell c-Jun is important in the neuronal cell body 
response to nerve axotomy and determines the levels of expression of certain RAGs.  
L4 DRG neurons from both WT and OE/+ mice could also be used to replicate the in 
vitro conditioning lesion model shown above (Figure 6.15), as well as creating DRG-
Schwann cell co-cultures to determine if already elevated Schwann cell c-Jun in OE/+ 
mice would result in better initial axonal outgrowth compared to WT.  
 
It is possible that although the lack of Schwann cell c-Jun has a modest effect in vivo 
on the ability of DRG neurons to respond to injury in the experiments tested here, this 
effect could be stronger if the conditioning lesion paradigm were carried out in the 
central nervous system, where the environment is shown to limit central nerve 
regeneration. Preliminary results suggest that when spinal cord sections are 
immunofluorescently labelled with cholera toxin B (CTB) following a conditioning 
lesion where firstly the sciatic nerve is cut and a crush is performed 7D later, at the 
level of T6 in the spinal cord, the number of axonal sprouts growing past the lesion in 
the CNS is higher in WT compared to cKO (unpublished observations Professor 
Elizabeth Bradbury). In these experiments the lack of Schwann cell c-Jun appears to 
be important in the conditioning lesion paradigm.  
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7. General discussion 
 
Very early studies indicated the importance of Schwann cells in peripheral nerve 
development and following nerve injury. A key transcription factor that has a critical 
importance during development and following nerve injury where it amplifies the 
Schwann cell injury response is c-Jun. The work presented in this thesis has 
highlighted further the importance of the transcription factor c-Jun in Schwann cell 
biology.  
 
The work presented in this thesis has used two contrasting mouse models to study the 
effect of levels of c-Jun expression in Schwann cells. First, c-Jun elevation in 
Schwann cells was studied using mice where these levels were overexpressed in a 
gene-dose dependent manner from development into adulthood, and the effects of this 
up-regulation following nerve injury (using sciatic nerve crush as a model) were also 
studied. Second, the rapid Schwann cell c-Jun elevation in the proximal stump 
following nerve transection was measured. To study effects of this elevation in the 
proximal stump on the neuronal cell body response to nerve injury, responses in 
proximal stump and in the neurons of the L4 DRG from mice in which c-Jun was 
conditionally ablated (cKO) from Schwann cells were compared with the response of 
neurons in the L4 DRG in WT nerves.  
 
There is clear evidence from this and previous studies to suggest that controlling the 
levels of Schwann cell c-Jun elevation is crucial for the successful development and 
function of peripheral nerves, as well as peripheral nerve regeneration following 
injury (Chapters 3 and 4).  
The new Schwann cell specific c-Jun overexpressing mice (OE/+ and OE/OE) 
characterised in Chapter 3 have provided further insight in vivo of the effects that c-
Jun elevation in Schwann cells has on many aspects of nerve development and 
Schwann cell biology. Some of these findings corroborate previous results from in 
vitro work, showing that c-Jun is a negative regulator of myelination and the 
antagonistic relationship between Krox20 and c-Jun (Parkinson et al., 2008). One of 
the most important findings from the work shown in Chapter 3, which characterised 
OE/+ and OE/OE nerves, showed that the c-Jun elevation seen in Schwann cells of 
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uninjured nerves early in development is still maintained into adulthood. It is this 
maintenance of Schwann cell c-Jun elevation, particularly in OE/+ nerves, which 
provides an in vivo model to study the effects of c-Jun elevation in Schwann cells 
both at short and long time points following nerve injury, as described in Chapter 4. It 
is important to note as well, that this work has emphasised that excessive c-Jun 
elevation (OE/OE) is detrimental to nerve development and function, resulting in 
severe phenotypic abnormalities.  
 
It is already well known that c-Jun is a key amplifier of the Schwann cell injury 
response (Arthur-Farraj et al., 2012), however through the evidence shown in the 
thesis, it has become clearer that c-Jun elevation in Schwann cells needs to be finely 
controlled, as excessive c-Jun elevation is detrimental both during nerve development 
and after injury.  
Although at first glance it may seem that overexpressing Schwann cell c-Jun might be 
key to accelerating peripheral nerve regeneration because axon outgrowth after nerve 
injury is slower in cKO mice, at least initially, suggesting that elevating c-Jun levels 
further might promote faster axonal growth (Arthur-Farraj et al. 2012), the evidence 
shown above has highlighted that fact that the picture is more complex, This is 
because c-Jun expression affects aspects of Schwann cell biology, such as 
myelination, which are crucial to functional recovery.  It may be important to design a 
system in which c-Jun elevation in Schwann cells can be finely regulated in a dose-
dependent manner in order to achieve the maximum c-Jun elevation that promotes 
faster regeneration without significant effects on remyelination. This could be 
achieved using an inducible transgenic mouse, or by finding a drug delivery 
mechanism that can elevate c-Jun in a dose-dependent manner for a limited period of 
time after injury.  
 
The levels of c-Jun elevation in Schwann cells after injury are important not only in 
determining the terrain into which newly regenerating axons grow, they may also 
however, be important in the proximal stump following a nerve transection in 
influencing the way in which the neuronal cell body responds to injury (Chapters 5 
and 6).  
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Schwann cell c-Jun elevation in the proximal stump following nerve injury is rapid 
and maintained over several hours. This elevation has a mild effect on the ability of 
the neuronal cell body to express RAGs and therefore determine the neuronal 
outgrowth seen following injury. In order to confirm the importance of c-Jun 
elevation in proximal stump Schwann cells on the neuronal cell body response to 
injury, a wider analysis of RAG expression would need to be carried out, as this thesis 
looks at a few RAG candidates from the wide network that is known. It would also be 
interesting to use the c-Jun overexpressing mouse to determine whether or not with 
higher levels of c-Jun elevation, more RAG expression is seen in neurons, and 
whether this results in more neuronal outgrowth.  
In conclusion, Schwann cell c-Jun following nerve injury in the proximal stump may 
be influencing the ability of neurons to respond to nerve injury, however a more in 
depth analysis would need to be carried out to confirm this finding.  
 
The new Schwann cell specific c-Jun overexpressing mouse provides a robust tool for 
studying the importance of c-Jun elevation in Schwann cells following nerve injury. 
This is of importance; especially in the ageing process and following chronic nerve 
injury, where levels of c-Jun elevation falter. Further studies using this c-Jun 
overexpressing mouse might provide an insight into how c-Jun expression can be 
manipulated in a clinical setting, therefore translating work from the “bench side” to 
the “bedside”.   
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